Gene Symbol | Gene ID | Gene Info |
---|---|---|
Gcm2
|
ENSMUSG00000021362.6 | glial cells missing homolog 2 |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chr13_41103946_41104133 | Gcm2 | 1644 | 0.267698 | -0.34 | 1.1e-02 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr11_4572974_4574056 | 122.97 |
Gm11960 |
predicted gene 11960 |
9883 |
0.16 |
chr14_118812628_118813057 | 94.98 |
n-R5s51 |
nuclear encoded rRNA 5S 51 |
14189 |
0.15 |
chr5_112239158_112239879 | 76.48 |
Miat |
myocardial infarction associated transcript (non-protein coding) |
10123 |
0.11 |
chr3_127698278_127698609 | 76.20 |
Gm16238 |
predicted gene 16238 |
5923 |
0.12 |
chr19_61225302_61226760 | 43.79 |
Csf2ra |
colony stimulating factor 2 receptor, alpha, low-affinity (granulocyte-macrophage) |
541 |
0.67 |
chr4_154019719_154020381 | 42.21 |
Lrrc47 |
leucine rich repeat containing 47 |
411 |
0.72 |
chr18_12947284_12947832 | 37.17 |
Osbpl1a |
oxysterol binding protein-like 1A |
5717 |
0.19 |
chr10_81559146_81561402 | 36.48 |
Tle5 |
TLE family member 5, transcriptional modulator |
770 |
0.38 |
chr2_132029196_132030408 | 31.97 |
Rassf2 |
Ras association (RalGDS/AF-6) domain family member 2 |
199 |
0.94 |
chrX_135053750_135054274 | 30.74 |
3632454L22Rik |
RIKEN cDNA 3632454L22 gene |
6324 |
0.19 |
chr15_25754647_25755340 | 30.48 |
Myo10 |
myosin X |
2014 |
0.38 |
chr1_137323467_137323922 | 25.95 |
1700006P03Rik |
RIKEN cDNA 1700006P03 gene |
2148 |
0.36 |
chr9_83806172_83806700 | 25.15 |
Elovl4 |
elongation of very long chain fatty acids (FEN1/Elo2, SUR4/Elo3, yeast)-like 4 |
159 |
0.96 |
chr6_8956269_8957017 | 24.57 |
Nxph1 |
neurexophilin 1 |
6967 |
0.32 |
chr4_141048548_141049235 | 23.99 |
Crocc |
ciliary rootlet coiled-coil, rootletin |
4770 |
0.13 |
chr8_4492910_4494136 | 23.00 |
Cers4 |
ceramide synthase 4 |
2 |
0.97 |
chr7_60003898_60004931 | 22.81 |
Snurf |
SNRPN upstream reading frame |
635 |
0.26 |
chr13_15759168_15760299 | 22.69 |
Gm48408 |
predicted gene, 48408 |
10387 |
0.18 |
chr9_75625075_75626579 | 21.50 |
Lysmd2 |
LysM, putative peptidoglycan-binding, domain containing 2 |
68 |
0.96 |
chr2_113828734_113829247 | 20.26 |
Scg5 |
secretogranin V |
131 |
0.96 |
chr8_46210360_46210863 | 19.40 |
Slc25a4 |
solute carrier family 25 (mitochondrial carrier, adenine nucleotide translocator), member 4 |
419 |
0.73 |
chr13_14522874_14523297 | 18.51 |
Hecw1 |
HECT, C2 and WW domain containing E3 ubiquitin protein ligase 1 |
20 |
0.92 |
chr8_4206127_4207837 | 18.33 |
4932443L11Rik |
RIKEN cDNA 4932443L11 gene |
100 |
0.88 |
chr2_82052991_82053222 | 18.28 |
Zfp804a |
zinc finger protein 804A |
116 |
0.98 |
chr1_9299450_9300170 | 18.14 |
Sntg1 |
syntrophin, gamma 1 |
68 |
0.97 |
chr19_38054215_38055320 | 18.03 |
I830134H01Rik |
RIKEN cDNA I830134H01 gene |
239 |
0.48 |
chr3_37419062_37420017 | 17.71 |
Nudt6 |
nudix (nucleoside diphosphate linked moiety X)-type motif 6 |
18 |
0.84 |
chr1_155233440_155234889 | 17.61 |
BC034090 |
cDNA sequence BC034090 |
1253 |
0.38 |
chr12_3236518_3237725 | 17.52 |
Rab10os |
RAB10, member RAS oncogene family, opposite strand |
510 |
0.74 |
chr5_137734700_137735086 | 17.26 |
Nyap1 |
neuronal tyrosine-phosphorylated phosphoinositide 3-kinase adaptor 1 |
4825 |
0.1 |
chr11_6065587_6066320 | 17.20 |
Camk2b |
calcium/calmodulin-dependent protein kinase II, beta |
205 |
0.94 |
chr14_118812110_118812296 | 17.18 |
n-R5s51 |
nuclear encoded rRNA 5S 51 |
14828 |
0.15 |
chr10_80145825_80146996 | 17.01 |
Midn |
midnolin |
1862 |
0.15 |
chr8_70119106_70119336 | 16.99 |
Ncan |
neurocan |
1652 |
0.18 |
chr9_83145596_83146040 | 16.95 |
Gm29054 |
predicted gene 29054 |
97 |
0.9 |
chr16_9994079_9994581 | 16.62 |
Grin2a |
glutamate receptor, ionotropic, NMDA2A (epsilon 1) |
60 |
0.98 |
chr8_71569766_71570805 | 16.61 |
Slc27a1 |
solute carrier family 27 (fatty acid transporter), member 1 |
113 |
0.9 |
chr3_88230737_88231417 | 16.36 |
Gm3764 |
predicted gene 3764 |
2294 |
0.13 |
chr9_41375999_41376652 | 16.34 |
Mir100hg |
Mir100 Mirlet7a-2 Mir125b-1 cluster host gene |
4 |
0.98 |
chr4_133055540_133056727 | 16.29 |
Ahdc1 |
AT hook, DNA binding motif, containing 1 |
10116 |
0.19 |
chr12_33035669_33036432 | 16.21 |
Cdhr3 |
cadherin-related family member 3 |
16936 |
0.14 |
chr7_29318515_29319251 | 16.11 |
Gm44632 |
predicted gene 44632 |
519 |
0.66 |
chr10_53750991_53751762 | 16.04 |
Fam184a |
family with sequence similarity 184, member A |
253 |
0.94 |
chr1_6752243_6752413 | 15.74 |
St18 |
suppression of tumorigenicity 18 |
14753 |
0.25 |
chr6_42709318_42710223 | 15.32 |
Tcaf1 |
TRPM8 channel-associated factor 1 |
301 |
0.81 |
chr7_31127074_31128340 | 15.29 |
Scn1b |
sodium channel, voltage-gated, type I, beta |
704 |
0.47 |
chr2_24761902_24762681 | 15.20 |
Cacna1b |
calcium channel, voltage-dependent, N type, alpha 1B subunit |
756 |
0.65 |
chr1_33719747_33720478 | 14.95 |
Rab23 |
RAB23, member RAS oncogene family |
26 |
0.97 |
chr16_14361004_14362068 | 14.88 |
Abcc1 |
ATP-binding cassette, sub-family C (CFTR/MRP), member 1 |
22 |
0.97 |
chr3_108085301_108086522 | 14.83 |
Gm12500 |
predicted gene 12500 |
65 |
0.8 |
chr7_89632412_89633229 | 14.78 |
Me3 |
malic enzyme 3, NADP(+)-dependent, mitochondrial |
66 |
0.79 |
chr12_105336106_105336602 | 14.71 |
Tunar |
Tcl1 upstream neural differentiation associated RNA |
240 |
0.93 |
chr4_101235020_101235347 | 14.71 |
Gm12785 |
predicted gene 12785 |
24596 |
0.12 |
chr7_121391616_121392029 | 14.57 |
Hs3st2 |
heparan sulfate (glucosamine) 3-O-sulfotransferase 2 |
37 |
0.97 |
chr18_89768868_89769818 | 14.54 |
Dok6 |
docking protein 6 |
185 |
0.96 |
chr8_70476397_70477967 | 14.49 |
Klhl26 |
kelch-like 26 |
214 |
0.86 |
chr5_37245988_37246869 | 14.48 |
Crmp1 |
collapsin response mediator protein 1 |
583 |
0.76 |
chr2_109678215_109678406 | 14.42 |
Bdnf |
brain derived neurotrophic factor |
1278 |
0.37 |
chr13_34133930_34134147 | 14.38 |
Gm36500 |
predicted gene, 36500 |
178 |
0.9 |
chr3_55461650_55461996 | 14.31 |
Dclk1 |
doublecortin-like kinase 1 |
65 |
0.97 |
chr3_55242068_55243398 | 14.26 |
Dclk1 |
doublecortin-like kinase 1 |
207 |
0.94 |
chr7_63956761_63957700 | 14.12 |
Gm45052 |
predicted gene 45052 |
5010 |
0.15 |
chr1_128471971_128472514 | 14.08 |
Gm23902 |
predicted gene, 23902 |
17798 |
0.13 |
chrX_100767870_100768490 | 14.05 |
Dlg3 |
discs large MAGUK scaffold protein 3 |
185 |
0.93 |
chr13_42709847_42710338 | 14.05 |
Phactr1 |
phosphatase and actin regulator 1 |
511 |
0.85 |
chr16_23224637_23225757 | 14.01 |
BC106179 |
cDNA sequence BC106179 |
171 |
0.76 |
chr7_98177614_98179153 | 13.95 |
Capn5 |
calpain 5 |
109 |
0.93 |
chr2_102451171_102452295 | 13.93 |
Fjx1 |
four jointed box 1 |
766 |
0.72 |
chr8_29219544_29220019 | 13.93 |
Unc5d |
unc-5 netrin receptor D |
145 |
0.97 |
chr8_123411336_123412017 | 13.91 |
Tubb3 |
tubulin, beta 3 class III |
86 |
0.91 |
chr7_63444022_63445137 | 13.85 |
4930554H23Rik |
RIKEN cDNA 4930554H23 gene |
50 |
0.67 |
chr7_125262700_125262978 | 13.78 |
Gm21957 |
predicted gene, 21957 |
42953 |
0.14 |
chr9_52679712_52680046 | 13.74 |
Gm1715 |
predicted gene 1715 |
16 |
0.58 |
chr13_54874229_54874840 | 13.69 |
Gm29431 |
predicted gene 29431 |
12936 |
0.13 |
chr14_64595318_64595919 | 13.68 |
Mir3078 |
microRNA 3078 |
4433 |
0.18 |
chr15_25412769_25413237 | 13.68 |
Basp1 |
brain abundant, membrane attached signal protein 1 |
695 |
0.5 |
chr10_83722468_83723424 | 13.65 |
1500009L16Rik |
RIKEN cDNA 1500009L16 gene |
20 |
0.98 |
chr6_94631038_94631254 | 13.65 |
Lrig1 |
leucine-rich repeats and immunoglobulin-like domains 1 |
24379 |
0.17 |
chr1_124045661_124045934 | 13.50 |
Dpp10 |
dipeptidylpeptidase 10 |
238 |
0.96 |
chr9_91383908_91384564 | 13.39 |
Zic4 |
zinc finger protein of the cerebellum 4 |
1826 |
0.22 |
chr13_83727100_83727308 | 13.34 |
C130071C03Rik |
RIKEN cDNA C130071C03 gene |
902 |
0.45 |
chr6_29023980_29024534 | 13.31 |
Mir129-1 |
microRNA 129-1 |
1638 |
0.36 |
chr8_105320451_105321442 | 13.25 |
Lrrc29 |
leucine rich repeat containing 29 |
5313 |
0.07 |
chr11_6605194_6605847 | 13.24 |
Nacad |
NAC alpha domain containing |
533 |
0.58 |
chr12_4523765_4524306 | 13.22 |
Gm31938 |
predicted gene, 31938 |
78 |
0.96 |
chr7_73637071_73637452 | 13.18 |
Gm44737 |
predicted gene 44737 |
6644 |
0.1 |
chr8_84990346_84991110 | 13.16 |
Hook2 |
hook microtubule tethering protein 2 |
86 |
0.9 |
chr10_81364518_81366962 | 13.09 |
4930404N11Rik |
RIKEN cDNA 4930404N11 gene |
50 |
0.91 |
chr18_25678184_25678915 | 13.02 |
0710001A04Rik |
RIKEN cDNA 0710001A04 gene |
35221 |
0.19 |
chr14_60554058_60554987 | 13.01 |
Gm47810 |
predicted gene, 47810 |
42380 |
0.15 |
chr18_84722178_84722761 | 12.98 |
Dipk1c |
divergent protein kinase domain 1C |
1586 |
0.22 |
chr1_34666183_34666826 | 12.95 |
Arhgef4 |
Rho guanine nucleotide exchange factor (GEF) 4 |
11684 |
0.13 |
chr8_77610315_77610937 | 12.89 |
Tmem184c |
transmembrane protein 184C |
27 |
0.75 |
chr6_22834709_22835019 | 12.80 |
Gm43629 |
predicted gene 43629 |
29535 |
0.14 |
chr7_119185205_119185629 | 12.72 |
Gpr139 |
G protein-coupled receptor 139 |
814 |
0.71 |
chr6_127766930_127768435 | 12.70 |
Gm42738 |
predicted gene 42738 |
140 |
0.91 |
chr8_4216526_4217378 | 12.68 |
Prr36 |
proline rich 36 |
40 |
0.94 |
chrX_152644385_152644551 | 12.64 |
Shroom2 |
shroom family member 2 |
75 |
0.98 |
chr1_166308870_166309730 | 12.64 |
5330438I03Rik |
RIKEN cDNA 5330438I03 gene |
285 |
0.91 |
chr11_33843303_33843965 | 12.64 |
Kcnip1 |
Kv channel-interacting protein 1 |
49 |
0.99 |
chr7_64533404_64533751 | 12.60 |
Gm44721 |
predicted gene 44721 |
4152 |
0.22 |
chr15_89453930_89454500 | 12.59 |
Mapk8ip2 |
mitogen-activated protein kinase 8 interacting protein 2 |
302 |
0.77 |
chr1_66387135_66387333 | 12.56 |
Map2 |
microtubule-associated protein 2 |
223 |
0.94 |
chr10_58812655_58813414 | 12.45 |
Gm9987 |
predicted gene 9987 |
108 |
0.77 |
chrX_135796271_135796923 | 12.41 |
Gprasp1 |
G protein-coupled receptor associated sorting protein 1 |
991 |
0.31 |
chr15_57745156_57745804 | 12.40 |
9330154K18Rik |
RIKEN cDNA 9330154K18 gene |
6814 |
0.22 |
chr5_32713265_32714499 | 12.34 |
Gm43852 |
predicted gene 43852 |
106 |
0.94 |
chr7_79536149_79536360 | 12.25 |
Gm35040 |
predicted gene, 35040 |
211 |
0.87 |
chr3_88205532_88206477 | 12.18 |
Gm3764 |
predicted gene 3764 |
809 |
0.34 |
chr1_93101519_93102308 | 12.13 |
Kif1a |
kinesin family member 1A |
38 |
0.97 |
chr1_132581858_132582427 | 12.13 |
Nfasc |
neurofascin |
4998 |
0.21 |
chr17_55985980_55986972 | 12.12 |
Fsd1 |
fibronectin type 3 and SPRY domain-containing protein |
33 |
0.94 |
chr8_12947304_12948554 | 12.11 |
Mcf2l |
mcf.2 transforming sequence-like |
10 |
0.49 |
chr18_45896851_45897467 | 12.09 |
A330093E20Rik |
RIKEN cDNA A330093E20 gene |
650 |
0.79 |
chr6_88872895_88873493 | 12.08 |
Podxl2 |
podocalyxin-like 2 |
851 |
0.44 |
chr13_18948548_18948967 | 12.05 |
Amph |
amphiphysin |
359 |
0.84 |
chr4_53253649_53254014 | 12.04 |
4930522O17Rik |
RIKEN cDNA 4930522O17 gene |
7635 |
0.18 |
chr9_20726843_20728134 | 12.02 |
Olfm2 |
olfactomedin 2 |
551 |
0.72 |
chr7_75868535_75868959 | 11.94 |
Klhl25 |
kelch-like 25 |
20306 |
0.21 |
chr4_107830355_107830587 | 11.92 |
Lrp8os1 |
low density lipoprotein receptor-related protein 8, apolipoprotein e receptor, opposite strand 1 |
373 |
0.53 |
chr19_10041145_10042475 | 11.90 |
Fads3 |
fatty acid desaturase 3 |
78 |
0.96 |
chr5_37162967_37163149 | 11.89 |
Gm1043 |
predicted gene 1043 |
209 |
0.94 |
chr5_37289066_37289316 | 11.87 |
Crmp1 |
collapsin response mediator protein 1 |
5292 |
0.18 |
chr17_24689202_24689794 | 11.86 |
Syngr3 |
synaptogyrin 3 |
457 |
0.54 |
chr16_72028718_72029587 | 11.86 |
Gm49667 |
predicted gene, 49667 |
150108 |
0.04 |
chr5_92698263_92699271 | 11.84 |
Shroom3 |
shroom family member 3 |
15142 |
0.16 |
chr10_125388906_125389759 | 11.83 |
Slc16a7 |
solute carrier family 16 (monocarboxylic acid transporters), member 7 |
36 |
0.95 |
chr2_33593309_33593623 | 11.82 |
Gm38011 |
predicted gene, 38011 |
20932 |
0.15 |
chr9_83805509_83806110 | 11.77 |
Elovl4 |
elongation of very long chain fatty acids (FEN1/Elo2, SUR4/Elo3, yeast)-like 4 |
443 |
0.84 |
chr2_17730264_17731671 | 11.74 |
Nebl |
nebulette |
76 |
0.98 |
chr8_84148129_84148503 | 11.71 |
4930432K21Rik |
RIKEN cDNA 4930432K21 gene |
64 |
0.8 |
chr14_103649953_103650335 | 11.69 |
Slain1 |
SLAIN motif family, member 1 |
84 |
0.85 |
chr1_125911939_125912615 | 11.65 |
Lypd1 |
Ly6/Plaur domain containing 1 |
63 |
0.98 |
chr12_102640402_102640771 | 11.65 |
Itpk1 |
inositol 1,3,4-triphosphate 5/6 kinase |
348 |
0.83 |
chr17_24168620_24169265 | 11.64 |
Atp6v0c |
ATPase, H+ transporting, lysosomal V0 subunit C |
124 |
0.91 |
chr3_17785987_17786458 | 11.64 |
Mir124-2hg |
Mir124-2 host gene (non-protein coding) |
3699 |
0.23 |
chr6_101198772_101199080 | 11.62 |
Pdzrn3 |
PDZ domain containing RING finger 3 |
260 |
0.49 |
chr8_123514747_123515742 | 11.61 |
Dbndd1 |
dysbindin (dystrobrevin binding protein 1) domain containing 1 |
146 |
0.78 |
chr16_34573842_34574276 | 11.61 |
Kalrn |
kalirin, RhoGEF kinase |
527 |
0.86 |
chr1_132007251_132008431 | 11.61 |
Elk4 |
ELK4, member of ETS oncogene family |
35 |
0.96 |
chr3_80800657_80801686 | 11.58 |
Gria2 |
glutamate receptor, ionotropic, AMPA2 (alpha 2) |
1408 |
0.52 |
chr13_3633932_3634751 | 11.57 |
Asb13 |
ankyrin repeat and SOCS box-containing 13 |
242 |
0.91 |
chr8_32884176_32884360 | 11.53 |
Nrg1 |
neuregulin 1 |
14 |
0.99 |
chr12_3238767_3239202 | 11.45 |
Rab10os |
RAB10, member RAS oncogene family, opposite strand |
2373 |
0.24 |
chr4_119338861_119339361 | 11.43 |
Ldha-ps2 |
lactate dehydrogenase A, pseudogene 2 |
3666 |
0.13 |
chr17_8800581_8801529 | 11.41 |
Pde10a |
phosphodiesterase 10A |
638 |
0.79 |
chr2_151740625_151741514 | 11.38 |
Psmf1 |
proteasome (prosome, macropain) inhibitor subunit 1 |
224 |
0.9 |
chr6_42692170_42692944 | 11.36 |
Tcaf1 |
TRPM8 channel-associated factor 1 |
446 |
0.72 |
chr3_135485492_135486205 | 11.33 |
Manba |
mannosidase, beta A, lysosomal |
223 |
0.87 |
chr7_4119309_4120004 | 11.32 |
Ttyh1 |
tweety family member 1 |
34 |
0.91 |
chr1_177257163_177257666 | 11.31 |
Akt3 |
thymoma viral proto-oncogene 3 |
178 |
0.94 |
chr15_74563715_74564797 | 11.26 |
Adgrb1 |
adhesion G protein-coupled receptor B1 |
355 |
0.54 |
chr2_143545112_143545712 | 11.23 |
Pcsk2os1 |
proprotein convertase subtilisin/kexin type 2, opposite strand 1 |
565 |
0.54 |
chr15_25413961_25414576 | 11.22 |
Gm5468 |
predicted gene 5468 |
76 |
0.84 |
chr11_54304287_54304643 | 11.21 |
Acsl6 |
acyl-CoA synthetase long-chain family member 6 |
263 |
0.89 |
chr11_17658924_17659075 | 11.20 |
Gm12016 |
predicted gene 12016 |
19816 |
0.28 |
chr2_74426718_74427115 | 11.19 |
Lnpk |
lunapark, ER junction formation factor |
106190 |
0.05 |
chr12_3364588_3366025 | 11.18 |
Kif3c |
kinesin family member 3C |
116 |
0.94 |
chr8_12396567_12397039 | 11.18 |
Gm25239 |
predicted gene, 25239 |
400 |
0.74 |
chr6_28981268_28981880 | 11.16 |
Gm3294 |
predicted gene 3294 |
60 |
0.98 |
chr2_33130296_33131698 | 11.16 |
Garnl3 |
GTPase activating RANGAP domain-like 3 |
389 |
0.84 |
chr3_34649198_34650117 | 11.14 |
Sox2 |
SRY (sex determining region Y)-box 2 |
748 |
0.5 |
chr18_60926924_60927473 | 11.14 |
Camk2a |
calcium/calmodulin-dependent protein kinase II alpha |
249 |
0.89 |
chr11_47988672_47989535 | 11.08 |
Sgcd |
sarcoglycan, delta (dystrophin-associated glycoprotein) |
134 |
0.98 |
chr15_38470164_38471480 | 11.07 |
G930009F23Rik |
RIKEN cDNA G930009F23 gene |
15688 |
0.13 |
chr17_15380918_15381780 | 11.06 |
Dll1 |
delta like canonical Notch ligand 1 |
4477 |
0.18 |
chr3_33142428_33143483 | 11.02 |
Pex5l |
peroxisomal biogenesis factor 5-like |
121 |
0.97 |
chr16_63806441_63806811 | 11.02 |
Epha3 |
Eph receptor A3 |
56787 |
0.15 |
chr10_76810009_76810204 | 11.01 |
Pcbp3 |
poly(rC) binding protein 3 |
6600 |
0.23 |
chr9_16500048_16500722 | 10.99 |
Fat3 |
FAT atypical cadherin 3 |
900 |
0.73 |
chr9_106156100_106156774 | 10.97 |
D030055H07Rik |
RIKEN cDNA D030055H07 gene |
97 |
0.88 |
chr9_83326128_83326304 | 10.94 |
Gm46123 |
predicted gene, 46123 |
19943 |
0.18 |
chr5_45639206_45639588 | 10.91 |
9630001P10Rik |
RIKEN cDNA 9630001P10 gene |
16 |
0.73 |
chr9_96888753_96890030 | 10.89 |
Pxylp1 |
2-phosphoxylose phosphatase 1 |
22 |
0.97 |
chr3_107150875_107151233 | 10.88 |
Kcna10 |
potassium voltage-gated channel, shaker-related subfamily, member 10 |
32002 |
0.12 |
chr2_91328381_91328716 | 10.86 |
Gm13787 |
predicted gene 13787 |
15641 |
0.15 |
chr13_83744885_83745867 | 10.80 |
C130071C03Rik |
RIKEN cDNA C130071C03 gene |
6513 |
0.13 |
chr1_9299226_9299428 | 10.79 |
Sntg1 |
syntrophin, gamma 1 |
45 |
0.97 |
chr1_3671269_3672324 | 10.79 |
Xkr4 |
X-linked Kx blood group related 4 |
298 |
0.89 |
chr5_112371951_112372551 | 10.71 |
Gm43758 |
predicted gene 43758 |
700 |
0.47 |
chr4_5643828_5644015 | 10.70 |
Fam110b |
family with sequence similarity 110, member B |
169 |
0.95 |
chr3_108433472_108434154 | 10.68 |
Gm22942 |
predicted gene, 22942 |
7517 |
0.09 |
chr9_46603190_46603378 | 10.68 |
Gm48945 |
predicted gene, 48945 |
3971 |
0.2 |
chr5_33982851_33984205 | 10.65 |
Gm1673 |
predicted gene 1673 |
6 |
0.96 |
chr2_181159175_181159525 | 10.65 |
Eef1a2 |
eukaryotic translation elongation factor 1 alpha 2 |
2336 |
0.17 |
chr3_66220508_66221318 | 10.61 |
Ptx3 |
pentraxin related gene |
668 |
0.71 |
chr2_82053234_82053891 | 10.60 |
Zfp804a |
zinc finger protein 804A |
340 |
0.93 |
chr1_79581487_79581688 | 10.59 |
Gm37886 |
predicted gene, 37886 |
39447 |
0.15 |
chr14_12877121_12877289 | 10.57 |
Gm5457 |
predicted pseudogene 5457 |
9652 |
0.24 |
chr3_8866082_8866744 | 10.55 |
Gm15467 |
predicted gene 15467 |
14786 |
0.17 |
chr1_178529956_178530555 | 10.53 |
Kif26b |
kinesin family member 26B |
1130 |
0.58 |
chr8_94118890_94119066 | 10.51 |
Mt4 |
metallothionein 4 |
18219 |
0.1 |
chr9_86695289_86696275 | 10.48 |
Me1 |
malic enzyme 1, NADP(+)-dependent, cytosolic |
171 |
0.66 |
chr7_44246001_44246569 | 10.41 |
1700028J19Rik |
RIKEN cDNA 1700028J19 gene |
410 |
0.26 |
chr15_26308516_26308700 | 10.40 |
Marchf11 |
membrane associated ring-CH-type finger 11 |
440 |
0.9 |
chr14_34819764_34820558 | 10.38 |
Grid1 |
glutamate receptor, ionotropic, delta 1 |
53 |
0.98 |
chr10_92162409_92163019 | 10.37 |
Rmst |
rhabdomyosarcoma 2 associated transcript (non-coding RNA) |
47 |
0.98 |
chr19_41746384_41746957 | 10.35 |
Slit1 |
slit guidance ligand 1 |
3005 |
0.27 |
chr5_8367672_8368337 | 10.35 |
Adam22 |
a disintegrin and metallopeptidase domain 22 |
22 |
0.98 |
chr13_12105853_12107098 | 10.32 |
Ryr2 |
ryanodine receptor 2, cardiac |
16 |
0.98 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
16.6 | 49.9 | GO:0097118 | neuroligin clustering involved in postsynaptic membrane assembly(GO:0097118) |
9.6 | 57.3 | GO:0098596 | vocal learning(GO:0042297) imitative learning(GO:0098596) learned vocalization behavior or vocal learning(GO:0098598) |
9.3 | 9.3 | GO:0009449 | gamma-aminobutyric acid biosynthetic process(GO:0009449) |
8.5 | 25.4 | GO:0070094 | positive regulation of glucagon secretion(GO:0070094) |
8.2 | 24.7 | GO:0061368 | behavioral response to chemical pain(GO:0061366) behavioral response to formalin induced pain(GO:0061368) |
7.6 | 22.7 | GO:0071205 | protein localization to juxtaparanode region of axon(GO:0071205) |
7.1 | 21.2 | GO:0033058 | directional locomotion(GO:0033058) |
7.0 | 34.8 | GO:0007171 | activation of transmembrane receptor protein tyrosine kinase activity(GO:0007171) |
6.7 | 20.1 | GO:1901529 | positive regulation of anion channel activity(GO:1901529) |
6.4 | 19.1 | GO:0097091 | synaptic vesicle clustering(GO:0097091) |
6.3 | 18.8 | GO:0045200 | establishment or maintenance of neuroblast polarity(GO:0045196) establishment of neuroblast polarity(GO:0045200) |
6.2 | 12.5 | GO:0060166 | olfactory pit development(GO:0060166) |
6.1 | 24.6 | GO:0090427 | activation of meiosis(GO:0090427) |
6.0 | 41.9 | GO:0097011 | cellular response to granulocyte macrophage colony-stimulating factor stimulus(GO:0097011) |
6.0 | 17.9 | GO:0072069 | distal convoluted tubule development(GO:0072025) DCT cell differentiation(GO:0072069) metanephric distal convoluted tubule development(GO:0072221) metanephric distal tubule development(GO:0072235) metanephric DCT cell differentiation(GO:0072240) |
5.9 | 23.7 | GO:0070779 | D-aspartate transport(GO:0070777) D-aspartate import(GO:0070779) |
5.9 | 5.9 | GO:0050955 | thermoception(GO:0050955) |
5.9 | 17.6 | GO:0060178 | regulation of exocyst localization(GO:0060178) |
5.9 | 17.6 | GO:0030070 | insulin processing(GO:0030070) |
5.7 | 40.2 | GO:0019367 | fatty acid elongation, saturated fatty acid(GO:0019367) fatty acid elongation, unsaturated fatty acid(GO:0019368) fatty acid elongation, monounsaturated fatty acid(GO:0034625) fatty acid elongation, polyunsaturated fatty acid(GO:0034626) |
5.6 | 11.2 | GO:0097477 | lateral motor column neuron migration(GO:0097477) |
5.6 | 55.8 | GO:0060013 | righting reflex(GO:0060013) |
5.5 | 16.4 | GO:0071873 | response to norepinephrine(GO:0071873) |
5.4 | 27.1 | GO:0071698 | olfactory placode formation(GO:0030910) olfactory placode development(GO:0071698) olfactory placode morphogenesis(GO:0071699) |
5.4 | 16.1 | GO:0021564 | vagus nerve development(GO:0021564) |
5.3 | 15.8 | GO:1902109 | negative regulation of mitochondrial membrane permeability involved in apoptotic process(GO:1902109) |
5.3 | 15.8 | GO:0061092 | regulation of phospholipid translocation(GO:0061091) positive regulation of phospholipid translocation(GO:0061092) |
5.2 | 15.5 | GO:2000302 | positive regulation of synaptic vesicle exocytosis(GO:2000302) |
5.2 | 25.8 | GO:0097151 | positive regulation of inhibitory postsynaptic potential(GO:0097151) |
5.1 | 20.6 | GO:0007412 | axon target recognition(GO:0007412) |
5.1 | 5.1 | GO:1901321 | positive regulation of heart induction(GO:1901321) |
4.9 | 19.6 | GO:0098910 | regulation of atrial cardiac muscle cell action potential(GO:0098910) |
4.9 | 4.9 | GO:0098828 | modulation of inhibitory postsynaptic potential(GO:0098828) |
4.8 | 19.0 | GO:0006659 | phosphatidylserine biosynthetic process(GO:0006659) |
4.7 | 4.7 | GO:1990035 | calcium ion import into cell(GO:1990035) |
4.7 | 14.1 | GO:0032289 | central nervous system myelin formation(GO:0032289) |
4.7 | 4.7 | GO:0042322 | negative regulation of circadian sleep/wake cycle, REM sleep(GO:0042322) |
4.6 | 27.7 | GO:0016198 | axon choice point recognition(GO:0016198) |
4.6 | 23.1 | GO:0021631 | optic nerve morphogenesis(GO:0021631) |
4.5 | 13.6 | GO:1901656 | glycoside transport(GO:1901656) |
4.5 | 9.0 | GO:0033602 | negative regulation of dopamine secretion(GO:0033602) |
4.5 | 13.4 | GO:0071492 | cellular response to UV-A(GO:0071492) |
4.4 | 13.2 | GO:0072092 | ureteric bud invasion(GO:0072092) |
4.4 | 8.8 | GO:0060523 | prostate epithelial cord elongation(GO:0060523) |
4.4 | 8.8 | GO:0042662 | negative regulation of mesodermal cell fate specification(GO:0042662) |
4.4 | 30.6 | GO:0045199 | maintenance of epithelial cell apical/basal polarity(GO:0045199) |
4.4 | 17.5 | GO:0021698 | cerebellar cortex structural organization(GO:0021698) |
4.3 | 21.7 | GO:0031547 | brain-derived neurotrophic factor receptor signaling pathway(GO:0031547) |
4.3 | 17.3 | GO:0015015 | heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
4.3 | 8.6 | GO:0008355 | olfactory learning(GO:0008355) |
4.3 | 17.2 | GO:0007196 | adenylate cyclase-inhibiting G-protein coupled glutamate receptor signaling pathway(GO:0007196) |
4.3 | 4.3 | GO:0021586 | pons maturation(GO:0021586) |
4.3 | 8.5 | GO:1902474 | positive regulation of protein localization to synapse(GO:1902474) |
4.2 | 12.7 | GO:0072137 | condensed mesenchymal cell proliferation(GO:0072137) |
4.2 | 16.7 | GO:0036135 | Schwann cell migration(GO:0036135) regulation of Schwann cell migration(GO:1900147) |
4.2 | 33.4 | GO:0021796 | cerebral cortex regionalization(GO:0021796) |
4.1 | 20.6 | GO:0090273 | regulation of somatostatin secretion(GO:0090273) |
4.1 | 4.1 | GO:0001661 | conditioned taste aversion(GO:0001661) |
4.0 | 12.0 | GO:1990034 | calcium ion export from cell(GO:1990034) |
4.0 | 12.0 | GO:1901843 | positive regulation of high voltage-gated calcium channel activity(GO:1901843) |
4.0 | 11.9 | GO:0032058 | positive regulation of translational initiation in response to stress(GO:0032058) |
4.0 | 7.9 | GO:2000598 | regulation of cyclin catabolic process(GO:2000598) negative regulation of cyclin catabolic process(GO:2000599) |
4.0 | 19.8 | GO:0045113 | regulation of integrin biosynthetic process(GO:0045113) |
4.0 | 11.9 | GO:0097503 | sialylation(GO:0097503) |
4.0 | 19.8 | GO:1902866 | regulation of retina development in camera-type eye(GO:1902866) |
3.9 | 7.8 | GO:0021529 | spinal cord oligodendrocyte cell differentiation(GO:0021529) spinal cord oligodendrocyte cell fate specification(GO:0021530) |
3.9 | 47.0 | GO:0035235 | ionotropic glutamate receptor signaling pathway(GO:0035235) |
3.9 | 7.8 | GO:0060748 | tertiary branching involved in mammary gland duct morphogenesis(GO:0060748) |
3.9 | 3.9 | GO:1904468 | negative regulation of tumor necrosis factor secretion(GO:1904468) |
3.9 | 30.9 | GO:0003139 | secondary heart field specification(GO:0003139) |
3.8 | 19.2 | GO:0070120 | ciliary neurotrophic factor-mediated signaling pathway(GO:0070120) |
3.8 | 11.5 | GO:0060478 | acrosomal vesicle exocytosis(GO:0060478) |
3.8 | 19.0 | GO:0021869 | forebrain ventricular zone progenitor cell division(GO:0021869) |
3.8 | 30.4 | GO:0060080 | inhibitory postsynaptic potential(GO:0060080) |
3.8 | 7.5 | GO:0086045 | membrane depolarization during AV node cell action potential(GO:0086045) |
3.7 | 3.7 | GO:0060737 | prostate gland morphogenetic growth(GO:0060737) |
3.7 | 11.1 | GO:1900452 | regulation of long term synaptic depression(GO:1900452) |
3.7 | 11.0 | GO:0050717 | positive regulation of interleukin-1 alpha secretion(GO:0050717) |
3.6 | 18.2 | GO:0003357 | noradrenergic neuron differentiation(GO:0003357) |
3.6 | 25.4 | GO:1901223 | negative regulation of NIK/NF-kappaB signaling(GO:1901223) |
3.6 | 7.2 | GO:0050705 | regulation of interleukin-1 alpha secretion(GO:0050705) |
3.6 | 10.7 | GO:1901475 | pyruvate transmembrane transport(GO:1901475) |
3.6 | 28.6 | GO:2000009 | negative regulation of protein localization to cell surface(GO:2000009) |
3.6 | 21.4 | GO:0035881 | amacrine cell differentiation(GO:0035881) |
3.6 | 10.7 | GO:1901078 | negative regulation of relaxation of muscle(GO:1901078) |
3.5 | 28.3 | GO:0045217 | cell-cell junction maintenance(GO:0045217) |
3.5 | 14.0 | GO:0007258 | JUN phosphorylation(GO:0007258) |
3.5 | 62.8 | GO:0021952 | central nervous system projection neuron axonogenesis(GO:0021952) |
3.5 | 7.0 | GO:0086029 | Purkinje myocyte action potential(GO:0086017) Purkinje myocyte to ventricular cardiac muscle cell signaling(GO:0086029) Purkinje myocyte to ventricular cardiac muscle cell communication(GO:0086068) |
3.5 | 20.8 | GO:0071625 | vocalization behavior(GO:0071625) |
3.5 | 55.3 | GO:0031290 | retinal ganglion cell axon guidance(GO:0031290) |
3.4 | 6.9 | GO:0060221 | retinal rod cell differentiation(GO:0060221) |
3.4 | 3.4 | GO:0070672 | response to interleukin-15(GO:0070672) |
3.4 | 10.2 | GO:0036515 | serotonergic neuron axon guidance(GO:0036515) |
3.4 | 20.4 | GO:0061003 | positive regulation of dendritic spine morphogenesis(GO:0061003) |
3.4 | 6.7 | GO:0035262 | gonad morphogenesis(GO:0035262) |
3.4 | 188.7 | GO:0051965 | positive regulation of synapse assembly(GO:0051965) |
3.4 | 6.7 | GO:0051944 | positive regulation of neurotransmitter uptake(GO:0051582) positive regulation of dopamine uptake involved in synaptic transmission(GO:0051586) positive regulation of catecholamine uptake involved in synaptic transmission(GO:0051944) |
3.4 | 23.5 | GO:0021830 | interneuron migration from the subpallium to the cortex(GO:0021830) |
3.4 | 46.9 | GO:0001964 | startle response(GO:0001964) |
3.3 | 9.9 | GO:0035990 | tendon cell differentiation(GO:0035990) tendon formation(GO:0035992) |
3.3 | 39.4 | GO:0048268 | clathrin coat assembly(GO:0048268) |
3.3 | 13.1 | GO:0046958 | nonassociative learning(GO:0046958) |
3.3 | 6.5 | GO:1903802 | L-glutamate(1-) import into cell(GO:1903802) L-glutamate import into cell(GO:1990123) |
3.2 | 9.7 | GO:2000224 | regulation of testosterone biosynthetic process(GO:2000224) |
3.2 | 6.4 | GO:0031587 | positive regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0031587) |
3.2 | 3.2 | GO:0046532 | regulation of photoreceptor cell differentiation(GO:0046532) |
3.2 | 12.9 | GO:0046881 | positive regulation of follicle-stimulating hormone secretion(GO:0046881) |
3.2 | 16.0 | GO:0032229 | negative regulation of synaptic transmission, GABAergic(GO:0032229) |
3.2 | 12.8 | GO:0021542 | dentate gyrus development(GO:0021542) |
3.2 | 12.7 | GO:0016560 | protein import into peroxisome matrix, docking(GO:0016560) |
3.1 | 3.1 | GO:0032100 | positive regulation of response to food(GO:0032097) positive regulation of appetite(GO:0032100) |
3.1 | 21.8 | GO:0006108 | malate metabolic process(GO:0006108) |
3.1 | 21.8 | GO:0021859 | pyramidal neuron differentiation(GO:0021859) |
3.1 | 15.4 | GO:0031339 | negative regulation of vesicle fusion(GO:0031339) |
3.1 | 9.2 | GO:1902630 | regulation of membrane hyperpolarization(GO:1902630) |
3.0 | 9.1 | GO:0033693 | neurofilament bundle assembly(GO:0033693) |
3.0 | 12.1 | GO:0071947 | protein deubiquitination involved in ubiquitin-dependent protein catabolic process(GO:0071947) |
3.0 | 9.0 | GO:2000211 | regulation of glutamate metabolic process(GO:2000211) |
3.0 | 9.0 | GO:0030327 | prenylated protein catabolic process(GO:0030327) |
3.0 | 18.0 | GO:0046069 | cGMP catabolic process(GO:0046069) |
3.0 | 9.0 | GO:1903961 | positive regulation of anion transmembrane transport(GO:1903961) |
3.0 | 6.0 | GO:0090258 | negative regulation of mitochondrial fission(GO:0090258) |
3.0 | 9.0 | GO:0021764 | amygdala development(GO:0021764) |
3.0 | 5.9 | GO:0061642 | chemoattraction of axon(GO:0061642) |
2.9 | 41.2 | GO:0045956 | positive regulation of calcium ion-dependent exocytosis(GO:0045956) |
2.9 | 5.9 | GO:0090027 | negative regulation of monocyte chemotaxis(GO:0090027) |
2.9 | 14.6 | GO:0022038 | corpus callosum development(GO:0022038) |
2.9 | 5.8 | GO:0070366 | regulation of hepatocyte differentiation(GO:0070366) |
2.9 | 5.7 | GO:0035989 | tendon development(GO:0035989) |
2.9 | 5.7 | GO:1903279 | regulation of calcium:sodium antiporter activity(GO:1903279) |
2.8 | 8.5 | GO:0070634 | transepithelial ammonium transport(GO:0070634) |
2.8 | 8.4 | GO:0015746 | tricarboxylic acid transport(GO:0006842) citrate transport(GO:0015746) |
2.8 | 2.8 | GO:0046122 | purine deoxyribonucleoside metabolic process(GO:0046122) |
2.8 | 5.6 | GO:0097155 | fasciculation of sensory neuron axon(GO:0097155) |
2.8 | 5.6 | GO:0014734 | skeletal muscle hypertrophy(GO:0014734) |
2.8 | 22.2 | GO:0008038 | neuron recognition(GO:0008038) |
2.8 | 2.8 | GO:0060837 | blood vessel endothelial cell differentiation(GO:0060837) |
2.7 | 19.2 | GO:2000310 | regulation of N-methyl-D-aspartate selective glutamate receptor activity(GO:2000310) |
2.7 | 13.7 | GO:0010587 | miRNA catabolic process(GO:0010587) |
2.7 | 8.2 | GO:0001927 | exocyst assembly(GO:0001927) |
2.7 | 8.1 | GO:0007195 | adenylate cyclase-inhibiting dopamine receptor signaling pathway(GO:0007195) |
2.7 | 8.1 | GO:0021978 | telencephalon regionalization(GO:0021978) |
2.7 | 2.7 | GO:0071503 | response to heparin(GO:0071503) cellular response to heparin(GO:0071504) |
2.7 | 10.7 | GO:0031117 | positive regulation of microtubule depolymerization(GO:0031117) |
2.7 | 16.0 | GO:0021683 | cerebellar granular layer morphogenesis(GO:0021683) |
2.7 | 8.0 | GO:0052203 | modulation of catalytic activity in other organism involved in symbiotic interaction(GO:0052203) modulation by host of symbiont catalytic activity(GO:0052422) |
2.6 | 7.9 | GO:0038095 | Fc-epsilon receptor signaling pathway(GO:0038095) |
2.6 | 5.3 | GO:1901301 | regulation of cargo loading into COPII-coated vesicle(GO:1901301) |
2.6 | 5.3 | GO:0060666 | dichotomous subdivision of terminal units involved in salivary gland branching(GO:0060666) |
2.6 | 13.1 | GO:1901386 | negative regulation of voltage-gated calcium channel activity(GO:1901386) |
2.6 | 13.1 | GO:0048681 | negative regulation of axon regeneration(GO:0048681) |
2.6 | 7.9 | GO:0050966 | detection of mechanical stimulus involved in sensory perception of pain(GO:0050966) |
2.6 | 13.0 | GO:0048496 | maintenance of organ identity(GO:0048496) |
2.6 | 5.2 | GO:2001025 | positive regulation of response to drug(GO:2001025) |
2.6 | 5.2 | GO:0035434 | copper ion transmembrane transport(GO:0035434) |
2.6 | 10.3 | GO:0090244 | Wnt signaling pathway involved in somitogenesis(GO:0090244) |
2.6 | 5.2 | GO:0021797 | forebrain anterior/posterior pattern specification(GO:0021797) |
2.6 | 10.3 | GO:0042138 | meiotic DNA double-strand break formation(GO:0042138) |
2.6 | 10.3 | GO:0000160 | phosphorelay signal transduction system(GO:0000160) |
2.5 | 12.7 | GO:0030432 | peristalsis(GO:0030432) |
2.5 | 5.0 | GO:0030035 | microspike assembly(GO:0030035) |
2.5 | 9.9 | GO:0006538 | glutamate catabolic process(GO:0006538) |
2.5 | 5.0 | GO:0000189 | MAPK import into nucleus(GO:0000189) |
2.5 | 9.9 | GO:1900736 | regulation of phospholipase C-activating G-protein coupled receptor signaling pathway(GO:1900736) |
2.5 | 7.4 | GO:0015014 | heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0015014) |
2.4 | 24.5 | GO:0048172 | regulation of short-term neuronal synaptic plasticity(GO:0048172) |
2.4 | 4.8 | GO:0038128 | ERBB2 signaling pathway(GO:0038128) |
2.4 | 7.2 | GO:0032383 | regulation of intracellular lipid transport(GO:0032377) regulation of intracellular sterol transport(GO:0032380) regulation of intracellular cholesterol transport(GO:0032383) |
2.4 | 4.8 | GO:0021554 | optic nerve development(GO:0021554) |
2.4 | 9.6 | GO:0034047 | regulation of protein phosphatase type 2A activity(GO:0034047) |
2.4 | 7.2 | GO:2000586 | regulation of platelet-derived growth factor receptor-beta signaling pathway(GO:2000586) negative regulation of platelet-derived growth factor receptor-beta signaling pathway(GO:2000587) |
2.4 | 7.1 | GO:0019355 | nicotinamide nucleotide biosynthetic process from aspartate(GO:0019355) 'de novo' NAD biosynthetic process from aspartate(GO:0034628) |
2.4 | 7.1 | GO:2000381 | negative regulation of mesoderm development(GO:2000381) |
2.4 | 7.1 | GO:0042851 | L-alanine metabolic process(GO:0042851) |
2.3 | 7.0 | GO:2000118 | regulation of sodium-dependent phosphate transport(GO:2000118) |
2.3 | 11.6 | GO:0014042 | positive regulation of neuron maturation(GO:0014042) |
2.3 | 6.9 | GO:0061152 | trachea submucosa development(GO:0061152) trachea gland development(GO:0061153) |
2.3 | 36.6 | GO:0035418 | protein localization to synapse(GO:0035418) |
2.3 | 2.3 | GO:0061669 | spontaneous neurotransmitter secretion(GO:0061669) spontaneous synaptic transmission(GO:0098814) |
2.3 | 2.3 | GO:0003278 | apoptotic process involved in heart morphogenesis(GO:0003278) |
2.3 | 15.8 | GO:0015858 | nucleoside transport(GO:0015858) |
2.3 | 4.5 | GO:0021871 | forebrain regionalization(GO:0021871) |
2.2 | 2.2 | GO:0051466 | positive regulation of corticotropin-releasing hormone secretion(GO:0051466) |
2.2 | 2.2 | GO:0097212 | lysosomal membrane organization(GO:0097212) |
2.2 | 6.6 | GO:0035609 | C-terminal protein deglutamylation(GO:0035609) |
2.2 | 19.8 | GO:0097094 | craniofacial suture morphogenesis(GO:0097094) |
2.2 | 43.9 | GO:0007214 | gamma-aminobutyric acid signaling pathway(GO:0007214) |
2.2 | 11.0 | GO:0060159 | regulation of dopamine receptor signaling pathway(GO:0060159) |
2.2 | 11.0 | GO:0071420 | cellular response to histamine(GO:0071420) |
2.2 | 4.4 | GO:0061502 | early endosome to recycling endosome transport(GO:0061502) |
2.2 | 2.2 | GO:0021943 | formation of radial glial scaffolds(GO:0021943) |
2.2 | 2.2 | GO:0071787 | endoplasmic reticulum tubular network assembly(GO:0071787) |
2.2 | 6.5 | GO:1902308 | regulation of peptidyl-serine dephosphorylation(GO:1902308) |
2.1 | 2.1 | GO:0072338 | isoleucine metabolic process(GO:0006549) creatinine metabolic process(GO:0046449) cellular lactam metabolic process(GO:0072338) |
2.1 | 62.3 | GO:0019228 | neuronal action potential(GO:0019228) |
2.1 | 6.4 | GO:0097105 | presynaptic membrane assembly(GO:0097105) |
2.1 | 8.5 | GO:2001184 | positive regulation of interleukin-12 secretion(GO:2001184) |
2.1 | 14.9 | GO:0035437 | maintenance of protein localization in endoplasmic reticulum(GO:0035437) |
2.1 | 2.1 | GO:0007354 | zygotic determination of anterior/posterior axis, embryo(GO:0007354) |
2.1 | 4.2 | GO:1903261 | regulation of serine phosphorylation of STAT3 protein(GO:1903261) |
2.1 | 6.3 | GO:0072318 | clathrin coat disassembly(GO:0072318) |
2.1 | 6.3 | GO:0021892 | cerebral cortex GABAergic interneuron differentiation(GO:0021892) |
2.1 | 6.3 | GO:0030208 | dermatan sulfate biosynthetic process(GO:0030208) |
2.1 | 25.0 | GO:0060997 | dendritic spine morphogenesis(GO:0060997) |
2.1 | 16.7 | GO:2000671 | regulation of motor neuron apoptotic process(GO:2000671) |
2.1 | 6.2 | GO:2000686 | regulation of rubidium ion transmembrane transporter activity(GO:2000686) |
2.1 | 2.1 | GO:0097485 | neuron projection guidance(GO:0097485) |
2.1 | 14.5 | GO:0007216 | G-protein coupled glutamate receptor signaling pathway(GO:0007216) |
2.1 | 6.2 | GO:0014028 | notochord formation(GO:0014028) |
2.1 | 6.2 | GO:0015755 | fructose transport(GO:0015755) |
2.1 | 6.2 | GO:1902564 | negative regulation of neutrophil activation(GO:1902564) |
2.0 | 4.1 | GO:0019276 | UDP-N-acetylgalactosamine metabolic process(GO:0019276) |
2.0 | 2.0 | GO:0048382 | mesendoderm development(GO:0048382) |
2.0 | 2.0 | GO:0071415 | cellular response to caffeine(GO:0071313) cellular response to purine-containing compound(GO:0071415) |
2.0 | 10.1 | GO:0030259 | lipid glycosylation(GO:0030259) |
2.0 | 6.1 | GO:0086064 | cell communication by electrical coupling involved in cardiac conduction(GO:0086064) |
2.0 | 4.0 | GO:0010996 | response to auditory stimulus(GO:0010996) |
2.0 | 24.0 | GO:0016486 | peptide hormone processing(GO:0016486) |
2.0 | 31.8 | GO:0050650 | chondroitin sulfate proteoglycan biosynthetic process(GO:0050650) |
2.0 | 6.0 | GO:0042231 | interleukin-13 biosynthetic process(GO:0042231) |
2.0 | 9.9 | GO:1903887 | motile primary cilium assembly(GO:1903887) |
2.0 | 4.0 | GO:0023041 | neuronal signal transduction(GO:0023041) |
2.0 | 5.9 | GO:0015820 | branched-chain amino acid transport(GO:0015803) leucine transport(GO:0015820) |
2.0 | 13.7 | GO:0097369 | sodium ion import(GO:0097369) sodium ion import across plasma membrane(GO:0098719) sodium ion import into cell(GO:1990118) |
1.9 | 1.9 | GO:0097374 | sensory neuron axon guidance(GO:0097374) |
1.9 | 7.6 | GO:0033564 | anterior/posterior axon guidance(GO:0033564) |
1.9 | 140.6 | GO:0007156 | homophilic cell adhesion via plasma membrane adhesion molecules(GO:0007156) |
1.9 | 9.5 | GO:0097466 | glycoprotein ERAD pathway(GO:0097466) response to glycoprotein(GO:1904587) |
1.9 | 13.2 | GO:2001258 | negative regulation of cation channel activity(GO:2001258) |
1.9 | 26.1 | GO:0032011 | ARF protein signal transduction(GO:0032011) regulation of ARF protein signal transduction(GO:0032012) |
1.9 | 3.7 | GO:0007386 | compartment pattern specification(GO:0007386) |
1.9 | 3.7 | GO:0071798 | response to prostaglandin D(GO:0071798) cellular response to prostaglandin D stimulus(GO:0071799) |
1.9 | 5.6 | GO:0060468 | prevention of polyspermy(GO:0060468) |
1.9 | 24.2 | GO:0016048 | detection of temperature stimulus(GO:0016048) |
1.8 | 1.8 | GO:0014722 | regulation of skeletal muscle contraction by calcium ion signaling(GO:0014722) |
1.8 | 5.5 | GO:0006532 | aspartate biosynthetic process(GO:0006532) |
1.8 | 3.6 | GO:0021773 | striatal medium spiny neuron differentiation(GO:0021773) |
1.8 | 10.9 | GO:0048935 | peripheral nervous system neuron differentiation(GO:0048934) peripheral nervous system neuron development(GO:0048935) |
1.8 | 9.1 | GO:0014051 | gamma-aminobutyric acid secretion(GO:0014051) |
1.8 | 9.1 | GO:0051823 | regulation of synapse structural plasticity(GO:0051823) |
1.8 | 5.4 | GO:0097694 | establishment of RNA localization to telomere(GO:0097694) |
1.8 | 3.6 | GO:0061743 | motor learning(GO:0061743) |
1.8 | 5.4 | GO:1904219 | regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904217) positive regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904219) regulation of serine C-palmitoyltransferase activity(GO:1904220) positive regulation of serine C-palmitoyltransferase activity(GO:1904222) |
1.8 | 5.4 | GO:0046077 | dUDP biosynthetic process(GO:0006227) pyrimidine nucleoside diphosphate biosynthetic process(GO:0009139) pyrimidine deoxyribonucleoside diphosphate metabolic process(GO:0009196) pyrimidine deoxyribonucleoside diphosphate biosynthetic process(GO:0009197) dUDP metabolic process(GO:0046077) |
1.8 | 5.4 | GO:0015824 | proline transport(GO:0015824) |
1.8 | 9.0 | GO:0015884 | folic acid transport(GO:0015884) |
1.8 | 12.5 | GO:1904153 | negative regulation of protein exit from endoplasmic reticulum(GO:0070862) negative regulation of retrograde protein transport, ER to cytosol(GO:1904153) |
1.8 | 8.9 | GO:0007042 | lysosomal lumen acidification(GO:0007042) |
1.8 | 5.3 | GO:0030050 | vesicle transport along actin filament(GO:0030050) |
1.8 | 7.1 | GO:0016557 | peroxisome membrane biogenesis(GO:0016557) |
1.8 | 7.1 | GO:0061577 | calcium ion transmembrane transport via high voltage-gated calcium channel(GO:0061577) |
1.8 | 3.5 | GO:0060279 | positive regulation of ovulation(GO:0060279) |
1.7 | 3.5 | GO:0031585 | regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0031585) |
1.7 | 5.2 | GO:0003199 | endocardial cushion to mesenchymal transition involved in heart valve formation(GO:0003199) |
1.7 | 6.9 | GO:0035641 | locomotory exploration behavior(GO:0035641) |
1.7 | 15.5 | GO:0006054 | N-acetylneuraminate metabolic process(GO:0006054) |
1.7 | 19.0 | GO:0036065 | fucosylation(GO:0036065) |
1.7 | 17.2 | GO:0072010 | renal filtration cell differentiation(GO:0061318) glomerular epithelium development(GO:0072010) glomerular visceral epithelial cell differentiation(GO:0072112) glomerular epithelial cell differentiation(GO:0072311) |
1.7 | 6.9 | GO:2000766 | negative regulation of cytoplasmic translation(GO:2000766) |
1.7 | 3.4 | GO:0035826 | rubidium ion transport(GO:0035826) |
1.7 | 22.3 | GO:0095500 | acetylcholine receptor signaling pathway(GO:0095500) postsynaptic signal transduction(GO:0098926) signal transduction involved in cellular response to ammonium ion(GO:1903831) response to acetylcholine(GO:1905144) cellular response to acetylcholine(GO:1905145) |
1.7 | 12.0 | GO:0060004 | reflex(GO:0060004) |
1.7 | 3.4 | GO:0070346 | positive regulation of fat cell proliferation(GO:0070346) |
1.7 | 5.1 | GO:0046084 | adenine metabolic process(GO:0046083) adenine biosynthetic process(GO:0046084) |
1.7 | 6.8 | GO:0035627 | ceramide transport(GO:0035627) |
1.7 | 6.7 | GO:0048505 | regulation of timing of cell differentiation(GO:0048505) |
1.7 | 1.7 | GO:1900020 | regulation of protein kinase C activity(GO:1900019) positive regulation of protein kinase C activity(GO:1900020) |
1.7 | 5.0 | GO:1904849 | positive regulation of cell chemotaxis to fibroblast growth factor(GO:1904849) positive regulation of endothelial cell chemotaxis to fibroblast growth factor(GO:2000546) |
1.7 | 1.7 | GO:0052428 | negative regulation by host of symbiont molecular function(GO:0052405) modification by host of symbiont molecular function(GO:0052428) |
1.6 | 11.5 | GO:0031536 | positive regulation of exit from mitosis(GO:0031536) |
1.6 | 4.9 | GO:1900368 | regulation of RNA interference(GO:1900368) |
1.6 | 8.2 | GO:0002043 | blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:0002043) |
1.6 | 1.6 | GO:0014834 | skeletal muscle satellite cell maintenance involved in skeletal muscle regeneration(GO:0014834) |
1.6 | 3.3 | GO:1902809 | regulation of skeletal muscle fiber differentiation(GO:1902809) |
1.6 | 9.8 | GO:0045760 | positive regulation of action potential(GO:0045760) |
1.6 | 6.5 | GO:0030091 | protein repair(GO:0030091) |
1.6 | 3.2 | GO:2000574 | regulation of microtubule motor activity(GO:2000574) |
1.6 | 4.8 | GO:0061511 | centriole elongation(GO:0061511) |
1.6 | 3.2 | GO:0070100 | negative regulation of chemokine-mediated signaling pathway(GO:0070100) |
1.6 | 14.5 | GO:0010642 | negative regulation of platelet-derived growth factor receptor signaling pathway(GO:0010642) |
1.6 | 9.6 | GO:0051415 | interphase microtubule nucleation by interphase microtubule organizing center(GO:0051415) microtubule nucleation by microtubule organizing center(GO:0051418) |
1.6 | 1.6 | GO:0051081 | membrane disassembly(GO:0030397) nuclear envelope disassembly(GO:0051081) |
1.6 | 4.8 | GO:0016344 | meiotic chromosome movement towards spindle pole(GO:0016344) |
1.6 | 12.8 | GO:0019800 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
1.6 | 8.0 | GO:0042761 | very long-chain fatty acid biosynthetic process(GO:0042761) |
1.6 | 3.2 | GO:0060584 | regulation of prostaglandin-endoperoxide synthase activity(GO:0060584) positive regulation of prostaglandin-endoperoxide synthase activity(GO:0060585) |
1.6 | 4.8 | GO:0006578 | amino-acid betaine biosynthetic process(GO:0006578) |
1.6 | 3.2 | GO:2000019 | negative regulation of male gonad development(GO:2000019) |
1.6 | 3.2 | GO:0089700 | protein kinase D signaling(GO:0089700) |
1.6 | 1.6 | GO:2000111 | positive regulation of macrophage apoptotic process(GO:2000111) |
1.6 | 3.1 | GO:0051612 | negative regulation of neurotransmitter uptake(GO:0051581) regulation of serotonin uptake(GO:0051611) negative regulation of serotonin uptake(GO:0051612) |
1.6 | 26.7 | GO:0071475 | cellular hyperosmotic salinity response(GO:0071475) |
1.6 | 17.1 | GO:1902259 | regulation of delayed rectifier potassium channel activity(GO:1902259) |
1.6 | 15.6 | GO:2000311 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000311) |
1.6 | 4.7 | GO:0072051 | juxtaglomerular apparatus development(GO:0072051) |
1.5 | 4.6 | GO:0061302 | smooth muscle cell-matrix adhesion(GO:0061302) |
1.5 | 1.5 | GO:0032349 | positive regulation of aldosterone metabolic process(GO:0032346) positive regulation of aldosterone biosynthetic process(GO:0032349) |
1.5 | 3.1 | GO:0001978 | regulation of systemic arterial blood pressure by carotid sinus baroreceptor feedback(GO:0001978) norepinephrine-epinephrine vasoconstriction involved in regulation of systemic arterial blood pressure(GO:0001994) |
1.5 | 4.6 | GO:0034184 | positive regulation of maintenance of sister chromatid cohesion(GO:0034093) positive regulation of maintenance of mitotic sister chromatid cohesion(GO:0034184) |
1.5 | 6.1 | GO:0048003 | antigen processing and presentation of lipid antigen via MHC class Ib(GO:0048003) antigen processing and presentation, exogenous lipid antigen via MHC class Ib(GO:0048007) |
1.5 | 6.0 | GO:0046655 | folic acid metabolic process(GO:0046655) |
1.5 | 12.0 | GO:0015813 | L-glutamate transport(GO:0015813) |
1.5 | 4.5 | GO:0048852 | diencephalon morphogenesis(GO:0048852) |
1.5 | 6.0 | GO:0021895 | cerebral cortex neuron differentiation(GO:0021895) |
1.5 | 4.5 | GO:1903215 | negative regulation of protein targeting to mitochondrion(GO:1903215) |
1.5 | 1.5 | GO:0042428 | serotonin metabolic process(GO:0042428) |
1.5 | 4.5 | GO:0061589 | calcium activated phospholipid scrambling(GO:0061588) calcium activated phosphatidylserine scrambling(GO:0061589) calcium activated phosphatidylcholine scrambling(GO:0061590) calcium activated galactosylceramide scrambling(GO:0061591) |
1.5 | 2.9 | GO:0043490 | malate-aspartate shuttle(GO:0043490) |
1.5 | 4.4 | GO:0001806 | type IV hypersensitivity(GO:0001806) |
1.5 | 16.0 | GO:0090036 | regulation of protein kinase C signaling(GO:0090036) |
1.4 | 13.0 | GO:0031629 | synaptic vesicle fusion to presynaptic active zone membrane(GO:0031629) vesicle fusion to plasma membrane(GO:0099500) |
1.4 | 7.2 | GO:1903071 | positive regulation of ER-associated ubiquitin-dependent protein catabolic process(GO:1903071) |
1.4 | 7.2 | GO:0099625 | regulation of ventricular cardiac muscle cell membrane repolarization(GO:0060307) ventricular cardiac muscle cell membrane repolarization(GO:0099625) |
1.4 | 5.7 | GO:0048149 | behavioral response to ethanol(GO:0048149) |
1.4 | 5.7 | GO:0038030 | non-canonical Wnt signaling pathway via MAPK cascade(GO:0038030) non-canonical Wnt signaling pathway via JNK cascade(GO:0038031) |
1.4 | 2.9 | GO:2000821 | regulation of grooming behavior(GO:2000821) |
1.4 | 2.9 | GO:1903899 | positive regulation of PERK-mediated unfolded protein response(GO:1903899) |
1.4 | 8.6 | GO:0031915 | positive regulation of synaptic plasticity(GO:0031915) |
1.4 | 2.9 | GO:0030916 | otic vesicle formation(GO:0030916) |
1.4 | 4.3 | GO:0072321 | chaperone-mediated protein transport(GO:0072321) |
1.4 | 10.0 | GO:0032509 | endosome transport via multivesicular body sorting pathway(GO:0032509) |
1.4 | 4.3 | GO:1904742 | regulation of telomeric DNA binding(GO:1904742) |
1.4 | 2.8 | GO:0000720 | pyrimidine dimer repair by nucleotide-excision repair(GO:0000720) |
1.4 | 7.0 | GO:1904424 | regulation of GTP binding(GO:1904424) |
1.4 | 2.8 | GO:0090071 | negative regulation of ribosome biogenesis(GO:0090071) |
1.4 | 4.2 | GO:0007468 | regulation of rhodopsin gene expression(GO:0007468) |
1.4 | 5.6 | GO:0043268 | positive regulation of potassium ion transport(GO:0043268) |
1.4 | 22.2 | GO:0086010 | membrane depolarization during action potential(GO:0086010) |
1.4 | 5.5 | GO:2001206 | positive regulation of osteoclast development(GO:2001206) |
1.4 | 1.4 | GO:0006517 | protein deglycosylation(GO:0006517) |
1.3 | 4.0 | GO:0030167 | proteoglycan catabolic process(GO:0030167) |
1.3 | 8.1 | GO:2000651 | positive regulation of sodium ion transmembrane transporter activity(GO:2000651) |
1.3 | 2.7 | GO:0071694 | protein localization to extracellular region(GO:0071692) maintenance of protein location in extracellular region(GO:0071694) |
1.3 | 1.3 | GO:2000172 | regulation of branching morphogenesis of a nerve(GO:2000172) |
1.3 | 4.0 | GO:1904017 | response to Thyroglobulin triiodothyronine(GO:1904016) cellular response to Thyroglobulin triiodothyronine(GO:1904017) |
1.3 | 14.7 | GO:0051966 | regulation of synaptic transmission, glutamatergic(GO:0051966) |
1.3 | 13.3 | GO:0009312 | oligosaccharide biosynthetic process(GO:0009312) |
1.3 | 6.6 | GO:0032020 | ISG15-protein conjugation(GO:0032020) |
1.3 | 2.7 | GO:1901420 | negative regulation of response to alcohol(GO:1901420) |
1.3 | 34.2 | GO:0021954 | central nervous system neuron development(GO:0021954) |
1.3 | 1.3 | GO:0014826 | vein smooth muscle contraction(GO:0014826) |
1.3 | 1.3 | GO:2000370 | positive regulation of clathrin-mediated endocytosis(GO:2000370) |
1.3 | 3.9 | GO:1903011 | negative regulation of bone development(GO:1903011) |
1.3 | 1.3 | GO:0021902 | commitment of neuronal cell to specific neuron type in forebrain(GO:0021902) |
1.3 | 5.1 | GO:0046102 | inosine metabolic process(GO:0046102) |
1.3 | 7.6 | GO:0051503 | adenine nucleotide transport(GO:0051503) |
1.3 | 35.5 | GO:0046839 | phospholipid dephosphorylation(GO:0046839) |
1.3 | 3.8 | GO:0060024 | rhythmic synaptic transmission(GO:0060024) |
1.3 | 5.0 | GO:0007621 | negative regulation of female receptivity(GO:0007621) |
1.3 | 1.3 | GO:0072199 | mesenchymal cell proliferation involved in ureter development(GO:0072198) regulation of mesenchymal cell proliferation involved in ureter development(GO:0072199) positive regulation of mesenchymal cell proliferation involved in ureter development(GO:2000729) |
1.3 | 1.3 | GO:1901187 | regulation of ephrin receptor signaling pathway(GO:1901187) |
1.2 | 6.2 | GO:0048664 | neuron fate determination(GO:0048664) |
1.2 | 3.7 | GO:0006597 | spermine biosynthetic process(GO:0006597) |
1.2 | 109.6 | GO:0071805 | potassium ion transmembrane transport(GO:0071805) |
1.2 | 1.2 | GO:0070428 | regulation of nucleotide-binding oligomerization domain containing 1 signaling pathway(GO:0070428) |
1.2 | 3.7 | GO:0042891 | antibiotic transport(GO:0042891) |
1.2 | 3.7 | GO:0060437 | lung growth(GO:0060437) |
1.2 | 4.9 | GO:0070345 | negative regulation of fat cell proliferation(GO:0070345) |
1.2 | 1.2 | GO:1903596 | regulation of gap junction assembly(GO:1903596) |
1.2 | 2.4 | GO:0046544 | development of secondary male sexual characteristics(GO:0046544) |
1.2 | 2.4 | GO:1902774 | late endosome to lysosome transport(GO:1902774) |
1.2 | 9.6 | GO:0010842 | retina layer formation(GO:0010842) |
1.2 | 2.4 | GO:0002692 | negative regulation of cellular extravasation(GO:0002692) |
1.2 | 16.6 | GO:0048488 | synaptic vesicle endocytosis(GO:0048488) |
1.2 | 1.2 | GO:0051562 | negative regulation of mitochondrial calcium ion concentration(GO:0051562) |
1.2 | 3.5 | GO:0001504 | neurotransmitter uptake(GO:0001504) |
1.2 | 2.3 | GO:0021873 | forebrain neuroblast division(GO:0021873) |
1.2 | 3.5 | GO:0090050 | positive regulation of cell migration involved in sprouting angiogenesis(GO:0090050) |
1.2 | 3.5 | GO:0090135 | actin filament branching(GO:0090135) |
1.2 | 8.2 | GO:2000270 | negative regulation of fibroblast apoptotic process(GO:2000270) |
1.2 | 7.0 | GO:0016339 | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0016339) |
1.1 | 3.4 | GO:1903336 | negative regulation of vacuolar transport(GO:1903336) |
1.1 | 7.9 | GO:0032957 | inositol trisphosphate metabolic process(GO:0032957) |
1.1 | 7.9 | GO:0016322 | neuron remodeling(GO:0016322) |
1.1 | 4.5 | GO:0006048 | UDP-N-acetylglucosamine biosynthetic process(GO:0006048) |
1.1 | 2.2 | GO:0055005 | ventricular cardiac myofibril assembly(GO:0055005) |
1.1 | 34.6 | GO:0050885 | neuromuscular process controlling balance(GO:0050885) |
1.1 | 2.2 | GO:1900449 | regulation of glutamate receptor signaling pathway(GO:1900449) |
1.1 | 7.8 | GO:0033683 | nucleotide-excision repair, DNA incision(GO:0033683) |
1.1 | 2.2 | GO:0006600 | creatine metabolic process(GO:0006600) |
1.1 | 3.3 | GO:0021563 | glossopharyngeal nerve development(GO:0021563) |
1.1 | 2.2 | GO:1904252 | negative regulation of bile acid biosynthetic process(GO:0070858) negative regulation of bile acid metabolic process(GO:1904252) |
1.1 | 1.1 | GO:0060174 | limb bud formation(GO:0060174) |
1.1 | 2.2 | GO:0019478 | D-amino acid catabolic process(GO:0019478) |
1.1 | 2.2 | GO:0099612 | protein localization to paranode region of axon(GO:0002175) protein localization to axon(GO:0099612) |
1.1 | 5.4 | GO:0051694 | pointed-end actin filament capping(GO:0051694) |
1.1 | 1.1 | GO:0030497 | fatty acid elongation(GO:0030497) |
1.1 | 3.2 | GO:0003419 | growth plate cartilage chondrocyte proliferation(GO:0003419) |
1.1 | 2.1 | GO:1903265 | positive regulation of tumor necrosis factor-mediated signaling pathway(GO:1903265) |
1.1 | 8.5 | GO:0051152 | positive regulation of smooth muscle cell differentiation(GO:0051152) |
1.1 | 4.2 | GO:0010917 | negative regulation of mitochondrial membrane potential(GO:0010917) |
1.1 | 2.1 | GO:0060452 | positive regulation of cardiac muscle contraction(GO:0060452) |
1.1 | 2.1 | GO:0001998 | angiotensin mediated vasoconstriction involved in regulation of systemic arterial blood pressure(GO:0001998) |
1.1 | 2.1 | GO:0006419 | alanyl-tRNA aminoacylation(GO:0006419) |
1.1 | 6.3 | GO:0018344 | protein geranylgeranylation(GO:0018344) |
1.0 | 7.3 | GO:0070050 | neuron cellular homeostasis(GO:0070050) |
1.0 | 2.1 | GO:0042940 | D-amino acid transport(GO:0042940) |
1.0 | 2.1 | GO:1901069 | guanosine-containing compound catabolic process(GO:1901069) |
1.0 | 3.1 | GO:0042723 | thiamine metabolic process(GO:0006772) thiamine-containing compound metabolic process(GO:0042723) |
1.0 | 2.1 | GO:0007158 | neuron cell-cell adhesion(GO:0007158) |
1.0 | 3.1 | GO:0010572 | positive regulation of platelet activation(GO:0010572) |
1.0 | 2.1 | GO:1902498 | regulation of protein autoubiquitination(GO:1902498) |
1.0 | 1.0 | GO:0060594 | mammary gland specification(GO:0060594) |
1.0 | 2.1 | GO:0070669 | response to interleukin-2(GO:0070669) |
1.0 | 3.1 | GO:0006393 | termination of mitochondrial transcription(GO:0006393) |
1.0 | 2.0 | GO:0045085 | negative regulation of interleukin-2 biosynthetic process(GO:0045085) |
1.0 | 5.1 | GO:0051096 | positive regulation of helicase activity(GO:0051096) |
1.0 | 5.1 | GO:0006642 | triglyceride mobilization(GO:0006642) |
1.0 | 3.0 | GO:0032025 | response to cobalt ion(GO:0032025) |
1.0 | 2.0 | GO:0042126 | nitrate metabolic process(GO:0042126) |
1.0 | 5.1 | GO:0032304 | negative regulation of icosanoid secretion(GO:0032304) |
1.0 | 1.0 | GO:0060278 | regulation of ovulation(GO:0060278) |
1.0 | 3.0 | GO:0055099 | response to high density lipoprotein particle(GO:0055099) |
1.0 | 5.0 | GO:0051151 | negative regulation of smooth muscle cell differentiation(GO:0051151) |
1.0 | 4.0 | GO:0048671 | negative regulation of collateral sprouting(GO:0048671) |
1.0 | 1.0 | GO:0061000 | negative regulation of dendritic spine development(GO:0061000) |
1.0 | 4.0 | GO:1900042 | positive regulation of interleukin-2 secretion(GO:1900042) |
1.0 | 1.0 | GO:0061043 | regulation of vascular wound healing(GO:0061043) |
1.0 | 2.0 | GO:0035983 | response to trichostatin A(GO:0035983) cellular response to trichostatin A(GO:0035984) |
1.0 | 1.9 | GO:0042360 | vitamin E metabolic process(GO:0042360) |
1.0 | 1.0 | GO:1901841 | regulation of high voltage-gated calcium channel activity(GO:1901841) |
1.0 | 1.0 | GO:0016078 | tRNA catabolic process(GO:0016078) |
0.9 | 8.5 | GO:0006122 | mitochondrial electron transport, ubiquinol to cytochrome c(GO:0006122) |
0.9 | 1.9 | GO:0018171 | peptidyl-cysteine oxidation(GO:0018171) |
0.9 | 8.5 | GO:0015816 | glycine transport(GO:0015816) |
0.9 | 2.8 | GO:1903626 | positive regulation of apoptotic DNA fragmentation(GO:1902512) positive regulation of DNA catabolic process(GO:1903626) |
0.9 | 3.7 | GO:0016082 | synaptic vesicle priming(GO:0016082) |
0.9 | 0.9 | GO:0008065 | establishment of blood-nerve barrier(GO:0008065) |
0.9 | 5.5 | GO:0001778 | plasma membrane repair(GO:0001778) |
0.9 | 0.9 | GO:0090526 | regulation of gluconeogenesis involved in cellular glucose homeostasis(GO:0090526) |
0.9 | 1.8 | GO:0046864 | retinol transport(GO:0034633) isoprenoid transport(GO:0046864) terpenoid transport(GO:0046865) |
0.9 | 2.7 | GO:0090206 | negative regulation of cholesterol biosynthetic process(GO:0045541) negative regulation of cholesterol metabolic process(GO:0090206) |
0.9 | 3.6 | GO:0002924 | negative regulation of humoral immune response mediated by circulating immunoglobulin(GO:0002924) |
0.9 | 2.7 | GO:0010637 | negative regulation of mitochondrial fusion(GO:0010637) |
0.9 | 0.9 | GO:0021979 | hypothalamus cell differentiation(GO:0021979) |
0.9 | 0.9 | GO:0061370 | testosterone biosynthetic process(GO:0061370) |
0.9 | 1.8 | GO:0009177 | deoxyribonucleoside monophosphate biosynthetic process(GO:0009157) pyrimidine deoxyribonucleoside monophosphate biosynthetic process(GO:0009177) |
0.9 | 3.6 | GO:0018103 | protein C-linked glycosylation(GO:0018103) peptidyl-tryptophan modification(GO:0018211) protein C-linked glycosylation via tryptophan(GO:0018317) protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan(GO:0018406) |
0.9 | 1.8 | GO:0019747 | regulation of isoprenoid metabolic process(GO:0019747) |
0.9 | 2.7 | GO:0036092 | phosphatidylinositol-3-phosphate biosynthetic process(GO:0036092) |
0.9 | 2.7 | GO:0036151 | phosphatidylcholine acyl-chain remodeling(GO:0036151) |
0.9 | 1.8 | GO:0034395 | regulation of transcription from RNA polymerase II promoter in response to iron(GO:0034395) |
0.9 | 5.3 | GO:0042135 | neurotransmitter catabolic process(GO:0042135) |
0.9 | 4.4 | GO:2000018 | regulation of male gonad development(GO:2000018) |
0.9 | 14.1 | GO:0007026 | negative regulation of microtubule depolymerization(GO:0007026) |
0.9 | 2.6 | GO:0021914 | negative regulation of smoothened signaling pathway involved in ventral spinal cord patterning(GO:0021914) |
0.9 | 3.5 | GO:0014744 | positive regulation of muscle adaptation(GO:0014744) |
0.9 | 3.5 | GO:0001302 | replicative cell aging(GO:0001302) |
0.9 | 0.9 | GO:1903069 | regulation of ER-associated ubiquitin-dependent protein catabolic process(GO:1903069) |
0.9 | 1.7 | GO:0009912 | auditory receptor cell fate commitment(GO:0009912) inner ear receptor cell fate commitment(GO:0060120) |
0.9 | 4.3 | GO:0031293 | membrane protein intracellular domain proteolysis(GO:0031293) |
0.9 | 2.6 | GO:1901873 | regulation of post-translational protein modification(GO:1901873) negative regulation of post-translational protein modification(GO:1901874) |
0.9 | 2.6 | GO:0090385 | phagosome-lysosome fusion(GO:0090385) |
0.9 | 0.9 | GO:0040034 | regulation of development, heterochronic(GO:0040034) |
0.9 | 0.9 | GO:0014012 | peripheral nervous system axon regeneration(GO:0014012) |
0.8 | 2.5 | GO:0046952 | ketone body catabolic process(GO:0046952) |
0.8 | 5.9 | GO:0035507 | regulation of myosin-light-chain-phosphatase activity(GO:0035507) |
0.8 | 1.7 | GO:0031296 | B cell costimulation(GO:0031296) |
0.8 | 2.5 | GO:0035860 | glial cell-derived neurotrophic factor receptor signaling pathway(GO:0035860) |
0.8 | 2.5 | GO:0018364 | peptidyl-glutamine methylation(GO:0018364) |
0.8 | 1.7 | GO:0009448 | gamma-aminobutyric acid metabolic process(GO:0009448) |
0.8 | 3.3 | GO:0006627 | protein processing involved in protein targeting to mitochondrion(GO:0006627) |
0.8 | 2.5 | GO:0030242 | pexophagy(GO:0030242) |
0.8 | 0.8 | GO:0008215 | spermine metabolic process(GO:0008215) |
0.8 | 3.3 | GO:0051725 | protein de-ADP-ribosylation(GO:0051725) |
0.8 | 3.3 | GO:0022417 | protein maturation by protein folding(GO:0022417) |
0.8 | 2.5 | GO:0043615 | astrocyte cell migration(GO:0043615) |
0.8 | 2.4 | GO:0002949 | tRNA threonylcarbamoyladenosine modification(GO:0002949) |
0.8 | 1.6 | GO:0015705 | iodide transport(GO:0015705) |
0.8 | 4.8 | GO:0060346 | bone trabecula formation(GO:0060346) |
0.8 | 3.2 | GO:0060017 | parathyroid gland development(GO:0060017) |
0.8 | 3.2 | GO:0051790 | short-chain fatty acid biosynthetic process(GO:0051790) |
0.8 | 3.2 | GO:1904294 | positive regulation of ERAD pathway(GO:1904294) |
0.8 | 2.4 | GO:0046477 | glycosylceramide catabolic process(GO:0046477) |
0.8 | 1.6 | GO:0030576 | Cajal body organization(GO:0030576) |
0.8 | 4.0 | GO:0046654 | tetrahydrofolate biosynthetic process(GO:0046654) |
0.8 | 0.8 | GO:0097049 | motor neuron apoptotic process(GO:0097049) |
0.8 | 0.8 | GO:0061209 | cell proliferation involved in mesonephros development(GO:0061209) |
0.8 | 4.7 | GO:0060736 | prostate gland growth(GO:0060736) |
0.8 | 2.3 | GO:0007220 | Notch receptor processing(GO:0007220) |
0.8 | 2.3 | GO:0060179 | male mating behavior(GO:0060179) |
0.8 | 21.6 | GO:0008333 | endosome to lysosome transport(GO:0008333) |
0.8 | 5.4 | GO:0006516 | glycoprotein catabolic process(GO:0006516) |
0.8 | 3.8 | GO:1903546 | protein localization to photoreceptor outer segment(GO:1903546) |
0.8 | 4.6 | GO:0009226 | nucleotide-sugar biosynthetic process(GO:0009226) |
0.8 | 0.8 | GO:0002424 | T cell mediated immune response to tumor cell(GO:0002424) regulation of T cell mediated immune response to tumor cell(GO:0002840) |
0.8 | 3.8 | GO:0098789 | pre-mRNA cleavage required for polyadenylation(GO:0098789) |
0.8 | 0.8 | GO:0051957 | positive regulation of amino acid transport(GO:0051957) |
0.8 | 1.5 | GO:0071599 | otic vesicle development(GO:0071599) |
0.8 | 1.5 | GO:0048014 | Tie signaling pathway(GO:0048014) |
0.8 | 2.3 | GO:0000389 | mRNA 3'-splice site recognition(GO:0000389) |
0.7 | 2.2 | GO:0050654 | chondroitin sulfate proteoglycan metabolic process(GO:0050654) |
0.7 | 5.2 | GO:0007342 | fusion of sperm to egg plasma membrane(GO:0007342) |
0.7 | 5.9 | GO:0006020 | inositol metabolic process(GO:0006020) |
0.7 | 0.7 | GO:0060052 | neurofilament cytoskeleton organization(GO:0060052) |
0.7 | 0.7 | GO:0061004 | pattern specification involved in kidney development(GO:0061004) renal system pattern specification(GO:0072048) |
0.7 | 2.9 | GO:0010640 | regulation of platelet-derived growth factor receptor signaling pathway(GO:0010640) |
0.7 | 2.2 | GO:1902268 | negative regulation of polyamine transmembrane transport(GO:1902268) |
0.7 | 2.2 | GO:0010961 | cellular magnesium ion homeostasis(GO:0010961) |
0.7 | 3.6 | GO:0021854 | hypothalamus development(GO:0021854) |
0.7 | 4.3 | GO:0015074 | DNA integration(GO:0015074) |
0.7 | 0.7 | GO:1905005 | regulation of epithelial to mesenchymal transition involved in endocardial cushion formation(GO:1905005) |
0.7 | 2.1 | GO:0006553 | lysine metabolic process(GO:0006553) |
0.7 | 2.8 | GO:0006432 | phenylalanyl-tRNA aminoacylation(GO:0006432) |
0.7 | 5.7 | GO:0060384 | innervation(GO:0060384) |
0.7 | 0.7 | GO:2000721 | positive regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation(GO:2000721) |
0.7 | 8.5 | GO:0007416 | synapse assembly(GO:0007416) |
0.7 | 7.8 | GO:0051703 | social behavior(GO:0035176) intraspecies interaction between organisms(GO:0051703) |
0.7 | 0.7 | GO:0070305 | response to cGMP(GO:0070305) cellular response to cGMP(GO:0071321) |
0.7 | 2.1 | GO:0071447 | cellular response to hydroperoxide(GO:0071447) |
0.7 | 0.7 | GO:0035934 | corticosterone secretion(GO:0035934) regulation of corticosterone secretion(GO:2000852) |
0.7 | 3.5 | GO:0051045 | negative regulation of membrane protein ectodomain proteolysis(GO:0051045) |
0.7 | 2.8 | GO:1900016 | negative regulation of cytokine production involved in inflammatory response(GO:1900016) |
0.7 | 0.7 | GO:0072174 | metanephric tubule formation(GO:0072174) |
0.7 | 2.8 | GO:0034239 | regulation of macrophage fusion(GO:0034239) |
0.7 | 5.6 | GO:0032410 | negative regulation of transporter activity(GO:0032410) |
0.7 | 1.4 | GO:0044340 | canonical Wnt signaling pathway involved in regulation of cell proliferation(GO:0044340) |
0.7 | 2.1 | GO:0044860 | protein localization to plasma membrane raft(GO:0044860) |
0.7 | 2.8 | GO:0090331 | negative regulation of platelet aggregation(GO:0090331) |
0.7 | 2.1 | GO:0045657 | positive regulation of monocyte differentiation(GO:0045657) |
0.7 | 3.5 | GO:0014824 | artery smooth muscle contraction(GO:0014824) |
0.7 | 1.4 | GO:0033566 | gamma-tubulin complex localization(GO:0033566) |
0.7 | 2.1 | GO:0060751 | epithelial cell proliferation involved in mammary gland duct elongation(GO:0060750) branch elongation involved in mammary gland duct branching(GO:0060751) |
0.7 | 0.7 | GO:0060460 | left lung morphogenesis(GO:0060460) |
0.7 | 4.1 | GO:1900113 | negative regulation of histone H3-K9 trimethylation(GO:1900113) |
0.7 | 4.8 | GO:0051797 | regulation of hair follicle development(GO:0051797) |
0.7 | 1.4 | GO:0018197 | peptidyl-aspartic acid modification(GO:0018197) |
0.7 | 5.4 | GO:0035563 | positive regulation of chromatin binding(GO:0035563) |
0.7 | 2.7 | GO:0045002 | DNA double-strand break processing involved in repair via single-strand annealing(GO:0010792) double-strand break repair via single-strand annealing(GO:0045002) |
0.7 | 4.7 | GO:0060292 | long term synaptic depression(GO:0060292) |
0.7 | 0.7 | GO:0002430 | complement receptor mediated signaling pathway(GO:0002430) |
0.7 | 2.7 | GO:0035469 | determination of pancreatic left/right asymmetry(GO:0035469) determination of liver left/right asymmetry(GO:0071910) |
0.7 | 0.7 | GO:1904948 | midbrain dopaminergic neuron differentiation(GO:1904948) |
0.7 | 0.7 | GO:0048485 | sympathetic nervous system development(GO:0048485) |
0.7 | 0.7 | GO:0045658 | regulation of neutrophil differentiation(GO:0045658) |
0.7 | 2.0 | GO:0006677 | glycosylceramide metabolic process(GO:0006677) |
0.7 | 2.0 | GO:0035249 | synaptic transmission, glutamatergic(GO:0035249) |
0.6 | 0.6 | GO:0048840 | otolith morphogenesis(GO:0032474) otolith development(GO:0048840) |
0.6 | 3.2 | GO:0030647 | polyketide metabolic process(GO:0030638) aminoglycoside antibiotic metabolic process(GO:0030647) daunorubicin metabolic process(GO:0044597) doxorubicin metabolic process(GO:0044598) |
0.6 | 0.6 | GO:0090325 | regulation of locomotion involved in locomotory behavior(GO:0090325) |
0.6 | 1.3 | GO:0007215 | glutamate receptor signaling pathway(GO:0007215) |
0.6 | 2.6 | GO:0007221 | positive regulation of transcription of Notch receptor target(GO:0007221) |
0.6 | 1.9 | GO:0031118 | rRNA pseudouridine synthesis(GO:0031118) |
0.6 | 9.6 | GO:0010758 | regulation of macrophage chemotaxis(GO:0010758) |
0.6 | 2.6 | GO:0071542 | dopaminergic neuron differentiation(GO:0071542) |
0.6 | 6.4 | GO:0045056 | transcytosis(GO:0045056) |
0.6 | 11.5 | GO:0051443 | positive regulation of ubiquitin-protein transferase activity(GO:0051443) |
0.6 | 1.9 | GO:0060287 | epithelial cilium movement involved in determination of left/right asymmetry(GO:0060287) |
0.6 | 3.2 | GO:0006398 | mRNA 3'-end processing by stem-loop binding and cleavage(GO:0006398) |
0.6 | 1.3 | GO:0060648 | mammary gland bud morphogenesis(GO:0060648) |
0.6 | 1.3 | GO:1904706 | negative regulation of vascular smooth muscle cell proliferation(GO:1904706) |
0.6 | 1.3 | GO:0045991 | carbon catabolite regulation of transcription from RNA polymerase II promoter(GO:0000429) regulation of transcription from RNA polymerase II promoter by glucose(GO:0000430) positive regulation of transcription from RNA polymerase II promoter by glucose(GO:0000432) carbon catabolite activation of transcription from RNA polymerase II promoter(GO:0000436) carbon catabolite activation of transcription(GO:0045991) positive regulation of transcription by glucose(GO:0046016) |
0.6 | 6.3 | GO:0061462 | protein localization to lysosome(GO:0061462) |
0.6 | 2.5 | GO:0051697 | protein delipidation(GO:0051697) |
0.6 | 1.9 | GO:0045743 | positive regulation of fibroblast growth factor receptor signaling pathway(GO:0045743) |
0.6 | 1.9 | GO:2000409 | positive regulation of T cell extravasation(GO:2000409) |
0.6 | 1.2 | GO:0010459 | negative regulation of heart rate(GO:0010459) |
0.6 | 1.9 | GO:0031642 | negative regulation of myelination(GO:0031642) |
0.6 | 1.9 | GO:0050884 | neuromuscular process controlling posture(GO:0050884) |
0.6 | 1.2 | GO:0001828 | inner cell mass cellular morphogenesis(GO:0001828) |
0.6 | 2.4 | GO:0070986 | left/right axis specification(GO:0070986) |
0.6 | 1.2 | GO:0070253 | somatostatin secretion(GO:0070253) |
0.6 | 1.2 | GO:1903659 | regulation of complement-dependent cytotoxicity(GO:1903659) negative regulation of complement-dependent cytotoxicity(GO:1903660) |
0.6 | 1.2 | GO:0051791 | medium-chain fatty acid metabolic process(GO:0051791) |
0.6 | 4.2 | GO:0046784 | viral mRNA export from host cell nucleus(GO:0046784) |
0.6 | 1.2 | GO:2001280 | positive regulation of prostaglandin biosynthetic process(GO:0031394) positive regulation of unsaturated fatty acid biosynthetic process(GO:2001280) |
0.6 | 1.2 | GO:0035624 | receptor transactivation(GO:0035624) epidermal growth factor-activated receptor transactivation by G-protein coupled receptor signaling pathway(GO:0035625) |
0.6 | 2.4 | GO:0035902 | response to immobilization stress(GO:0035902) |
0.6 | 4.2 | GO:2001214 | positive regulation of vasculogenesis(GO:2001214) |
0.6 | 1.2 | GO:0014732 | skeletal muscle atrophy(GO:0014732) |
0.6 | 1.2 | GO:0009629 | response to gravity(GO:0009629) |
0.6 | 1.8 | GO:1903894 | regulation of IRE1-mediated unfolded protein response(GO:1903894) |
0.6 | 1.8 | GO:0015817 | histidine transport(GO:0015817) |
0.6 | 4.1 | GO:0002084 | protein depalmitoylation(GO:0002084) macromolecule depalmitoylation(GO:0098734) |
0.6 | 1.2 | GO:1900109 | regulation of histone H3-K9 dimethylation(GO:1900109) |
0.6 | 0.6 | GO:0034331 | cell junction maintenance(GO:0034331) |
0.6 | 1.7 | GO:2000847 | negative regulation of steroid hormone secretion(GO:2000832) negative regulation of corticosteroid hormone secretion(GO:2000847) negative regulation of glucocorticoid secretion(GO:2000850) |
0.6 | 0.6 | GO:0016188 | synaptic vesicle maturation(GO:0016188) |
0.6 | 1.7 | GO:0035021 | negative regulation of Rac protein signal transduction(GO:0035021) |
0.6 | 16.7 | GO:0006813 | potassium ion transport(GO:0006813) |
0.6 | 1.1 | GO:0046379 | extracellular polysaccharide biosynthetic process(GO:0045226) extracellular polysaccharide metabolic process(GO:0046379) |
0.6 | 1.7 | GO:0090310 | negative regulation of methylation-dependent chromatin silencing(GO:0090310) |
0.6 | 1.7 | GO:0000712 | resolution of meiotic recombination intermediates(GO:0000712) |
0.6 | 1.1 | GO:0002765 | immune response-inhibiting signal transduction(GO:0002765) immune response-inhibiting cell surface receptor signaling pathway(GO:0002767) |
0.6 | 1.7 | GO:0015812 | gamma-aminobutyric acid transport(GO:0015812) |
0.6 | 5.6 | GO:1903859 | regulation of dendrite extension(GO:1903859) positive regulation of dendrite extension(GO:1903861) |
0.6 | 1.7 | GO:0000393 | spliceosomal conformational changes to generate catalytic conformation(GO:0000393) |
0.6 | 2.2 | GO:0002584 | negative regulation of antigen processing and presentation of peptide antigen(GO:0002584) |
0.6 | 1.7 | GO:0036444 | calcium ion transmembrane import into mitochondrion(GO:0036444) |
0.5 | 3.3 | GO:0032725 | positive regulation of granulocyte macrophage colony-stimulating factor production(GO:0032725) |
0.5 | 7.7 | GO:0006613 | cotranslational protein targeting to membrane(GO:0006613) |
0.5 | 1.1 | GO:0060956 | endocardial cell differentiation(GO:0060956) |
0.5 | 2.2 | GO:1901029 | negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway(GO:1901029) |
0.5 | 1.1 | GO:0060339 | negative regulation of type I interferon-mediated signaling pathway(GO:0060339) |
0.5 | 1.6 | GO:0021756 | striatum development(GO:0021756) |
0.5 | 1.1 | GO:0046668 | regulation of retinal cell programmed cell death(GO:0046668) |
0.5 | 1.1 | GO:1901536 | regulation of DNA demethylation(GO:1901535) negative regulation of DNA demethylation(GO:1901536) |
0.5 | 2.1 | GO:0030311 | poly-N-acetyllactosamine metabolic process(GO:0030309) poly-N-acetyllactosamine biosynthetic process(GO:0030311) |
0.5 | 1.6 | GO:0046618 | drug export(GO:0046618) |
0.5 | 2.6 | GO:0006297 | nucleotide-excision repair, DNA gap filling(GO:0006297) |
0.5 | 2.1 | GO:0090043 | regulation of tubulin deacetylation(GO:0090043) |
0.5 | 3.6 | GO:0007135 | meiosis II(GO:0007135) |
0.5 | 4.1 | GO:0006957 | complement activation, alternative pathway(GO:0006957) |
0.5 | 2.6 | GO:0007625 | grooming behavior(GO:0007625) |
0.5 | 0.5 | GO:0007614 | short-term memory(GO:0007614) |
0.5 | 2.6 | GO:0006983 | ER overload response(GO:0006983) |
0.5 | 1.5 | GO:0003383 | apical constriction(GO:0003383) |
0.5 | 0.5 | GO:2000015 | regulation of determination of dorsal identity(GO:2000015) |
0.5 | 0.5 | GO:0060676 | ureteric bud formation(GO:0060676) |
0.5 | 5.4 | GO:1904874 | regulation of telomerase RNA localization to Cajal body(GO:1904872) positive regulation of telomerase RNA localization to Cajal body(GO:1904874) |
0.5 | 6.4 | GO:0001919 | regulation of receptor recycling(GO:0001919) |
0.5 | 0.5 | GO:0097476 | motor neuron migration(GO:0097475) spinal cord motor neuron migration(GO:0097476) |
0.5 | 1.0 | GO:0060467 | negative regulation of fertilization(GO:0060467) |
0.5 | 2.9 | GO:0031119 | tRNA pseudouridine synthesis(GO:0031119) |
0.5 | 2.4 | GO:0009125 | nucleoside monophosphate catabolic process(GO:0009125) |
0.5 | 1.0 | GO:0007089 | traversing start control point of mitotic cell cycle(GO:0007089) |
0.5 | 1.9 | GO:0032836 | glomerular basement membrane development(GO:0032836) |
0.5 | 2.9 | GO:0008300 | isoprenoid catabolic process(GO:0008300) |
0.5 | 1.4 | GO:0007638 | mechanosensory behavior(GO:0007638) |
0.5 | 1.9 | GO:0001955 | blood vessel maturation(GO:0001955) |
0.5 | 4.8 | GO:1902043 | positive regulation of extrinsic apoptotic signaling pathway via death domain receptors(GO:1902043) |
0.5 | 0.9 | GO:0006624 | vacuolar protein processing(GO:0006624) |
0.5 | 1.4 | GO:0033615 | mitochondrial proton-transporting ATP synthase complex assembly(GO:0033615) |
0.5 | 0.5 | GO:0060971 | embryonic heart tube left/right pattern formation(GO:0060971) |
0.5 | 0.9 | GO:1901491 | negative regulation of lymphangiogenesis(GO:1901491) |
0.5 | 2.8 | GO:0070849 | response to epidermal growth factor(GO:0070849) cellular response to epidermal growth factor stimulus(GO:0071364) |
0.5 | 3.2 | GO:0051131 | chaperone-mediated protein complex assembly(GO:0051131) |
0.5 | 6.0 | GO:0045747 | positive regulation of Notch signaling pathway(GO:0045747) |
0.5 | 2.3 | GO:0060907 | positive regulation of macrophage cytokine production(GO:0060907) |
0.5 | 0.5 | GO:0001827 | inner cell mass cell fate commitment(GO:0001827) |
0.5 | 1.4 | GO:0006382 | adenosine to inosine editing(GO:0006382) |
0.5 | 0.9 | GO:0044065 | regulation of respiratory system process(GO:0044065) |
0.5 | 1.4 | GO:0060266 | negative regulation of respiratory burst involved in inflammatory response(GO:0060266) |
0.5 | 1.4 | GO:0042473 | outer ear morphogenesis(GO:0042473) |
0.5 | 1.8 | GO:2000035 | regulation of stem cell division(GO:2000035) |
0.4 | 2.2 | GO:0006105 | succinate metabolic process(GO:0006105) |
0.4 | 0.9 | GO:0032532 | regulation of microvillus length(GO:0032532) |
0.4 | 2.2 | GO:0002862 | negative regulation of inflammatory response to antigenic stimulus(GO:0002862) |
0.4 | 0.9 | GO:0043116 | negative regulation of vascular permeability(GO:0043116) |
0.4 | 0.4 | GO:0072385 | minus-end-directed organelle transport along microtubule(GO:0072385) |
0.4 | 1.7 | GO:0031033 | myosin filament organization(GO:0031033) |
0.4 | 0.9 | GO:0015888 | thiamine transport(GO:0015888) |
0.4 | 1.7 | GO:0030174 | regulation of DNA-dependent DNA replication initiation(GO:0030174) |
0.4 | 0.9 | GO:0045162 | clustering of voltage-gated sodium channels(GO:0045162) |
0.4 | 0.9 | GO:0002331 | pre-B cell allelic exclusion(GO:0002331) |
0.4 | 0.8 | GO:2000609 | regulation of thyroid hormone generation(GO:2000609) |
0.4 | 1.7 | GO:0070126 | mitochondrial translational termination(GO:0070126) |
0.4 | 0.8 | GO:0001992 | regulation of systemic arterial blood pressure by vasopressin(GO:0001992) |
0.4 | 1.7 | GO:0071786 | endoplasmic reticulum tubular network organization(GO:0071786) |
0.4 | 2.1 | GO:0042256 | mature ribosome assembly(GO:0042256) |
0.4 | 1.2 | GO:1902626 | assembly of large subunit precursor of preribosome(GO:1902626) |
0.4 | 1.2 | GO:0042494 | detection of bacterial lipoprotein(GO:0042494) |
0.4 | 0.8 | GO:0034982 | mitochondrial protein processing(GO:0034982) |
0.4 | 0.4 | GO:0006059 | hexitol metabolic process(GO:0006059) |
0.4 | 0.8 | GO:1903998 | regulation of eating behavior(GO:1903998) negative regulation of eating behavior(GO:1903999) |
0.4 | 1.2 | GO:0019859 | pyrimidine nucleobase catabolic process(GO:0006208) thymine catabolic process(GO:0006210) thymine metabolic process(GO:0019859) |
0.4 | 0.8 | GO:1902071 | regulation of hypoxia-inducible factor-1alpha signaling pathway(GO:1902071) |
0.4 | 0.8 | GO:0061055 | myotome development(GO:0061055) |
0.4 | 0.4 | GO:0045054 | constitutive secretory pathway(GO:0045054) |
0.4 | 2.9 | GO:0033299 | secretion of lysosomal enzymes(GO:0033299) |
0.4 | 2.0 | GO:0019732 | antifungal humoral response(GO:0019732) |
0.4 | 6.4 | GO:0030488 | tRNA methylation(GO:0030488) |
0.4 | 1.2 | GO:2001012 | mesenchymal cell differentiation involved in kidney development(GO:0072161) mesenchymal cell differentiation involved in renal system development(GO:2001012) |
0.4 | 2.4 | GO:0036297 | interstrand cross-link repair(GO:0036297) |
0.4 | 2.8 | GO:1902018 | negative regulation of cilium assembly(GO:1902018) |
0.4 | 1.2 | GO:0051547 | regulation of keratinocyte migration(GO:0051547) positive regulation of keratinocyte migration(GO:0051549) |
0.4 | 3.2 | GO:0034498 | early endosome to Golgi transport(GO:0034498) |
0.4 | 0.8 | GO:0032066 | nucleolus to nucleoplasm transport(GO:0032066) |
0.4 | 0.4 | GO:1900157 | regulation of bone mineralization involved in bone maturation(GO:1900157) |
0.4 | 0.4 | GO:0045423 | granulocyte macrophage colony-stimulating factor biosynthetic process(GO:0042253) regulation of granulocyte macrophage colony-stimulating factor biosynthetic process(GO:0045423) |
0.4 | 0.8 | GO:0002604 | dendritic cell antigen processing and presentation(GO:0002468) regulation of dendritic cell antigen processing and presentation(GO:0002604) positive regulation of dendritic cell antigen processing and presentation(GO:0002606) |
0.4 | 0.8 | GO:0033206 | meiotic cytokinesis(GO:0033206) |
0.4 | 0.4 | GO:0048859 | formation of anatomical boundary(GO:0048859) |
0.4 | 0.4 | GO:2000619 | negative regulation of histone H4-K16 acetylation(GO:2000619) |
0.4 | 2.7 | GO:0060999 | positive regulation of dendritic spine development(GO:0060999) |
0.4 | 1.1 | GO:2000427 | positive regulation of apoptotic cell clearance(GO:2000427) |
0.4 | 1.1 | GO:0043928 | exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay(GO:0043928) |
0.4 | 1.1 | GO:0035092 | sperm chromatin condensation(GO:0035092) |
0.4 | 3.4 | GO:0045579 | positive regulation of B cell differentiation(GO:0045579) |
0.4 | 1.5 | GO:0035584 | calcium-mediated signaling using intracellular calcium source(GO:0035584) |
0.4 | 1.1 | GO:0014816 | skeletal muscle satellite cell differentiation(GO:0014816) |
0.4 | 3.0 | GO:0050962 | detection of light stimulus involved in visual perception(GO:0050908) detection of light stimulus involved in sensory perception(GO:0050962) |
0.4 | 3.3 | GO:0019226 | transmission of nerve impulse(GO:0019226) |
0.4 | 1.8 | GO:0035234 | ectopic germ cell programmed cell death(GO:0035234) |
0.4 | 1.1 | GO:0000733 | DNA strand renaturation(GO:0000733) |
0.4 | 1.5 | GO:0033762 | response to glucagon(GO:0033762) |
0.4 | 2.9 | GO:0060576 | intestinal epithelial cell development(GO:0060576) |
0.4 | 0.4 | GO:0033603 | positive regulation of dopamine secretion(GO:0033603) |
0.4 | 1.1 | GO:0008347 | glial cell migration(GO:0008347) |
0.4 | 2.9 | GO:0035428 | hexose transmembrane transport(GO:0035428) |
0.4 | 1.4 | GO:0042415 | norepinephrine metabolic process(GO:0042415) |
0.4 | 1.4 | GO:0042417 | dopamine metabolic process(GO:0042417) |
0.4 | 0.4 | GO:0019374 | galactolipid metabolic process(GO:0019374) |
0.4 | 1.4 | GO:0035385 | Roundabout signaling pathway(GO:0035385) |
0.3 | 0.7 | GO:0071896 | protein localization to adherens junction(GO:0071896) |
0.3 | 1.0 | GO:0070889 | platelet alpha granule organization(GO:0070889) |
0.3 | 2.1 | GO:0030889 | negative regulation of B cell proliferation(GO:0030889) |
0.3 | 0.3 | GO:0097154 | GABAergic neuron differentiation(GO:0097154) |
0.3 | 1.4 | GO:0018243 | protein O-linked glycosylation via threonine(GO:0018243) |
0.3 | 0.3 | GO:0035701 | hematopoietic stem cell migration(GO:0035701) |
0.3 | 2.4 | GO:2000786 | positive regulation of autophagosome assembly(GO:2000786) |
0.3 | 1.0 | GO:0060768 | epithelial cell proliferation involved in prostate gland development(GO:0060767) regulation of epithelial cell proliferation involved in prostate gland development(GO:0060768) negative regulation of epithelial cell proliferation involved in prostate gland development(GO:0060770) |
0.3 | 0.3 | GO:0006848 | pyruvate transport(GO:0006848) |
0.3 | 4.0 | GO:1904355 | positive regulation of telomere capping(GO:1904355) |
0.3 | 0.7 | GO:0001831 | trophectodermal cellular morphogenesis(GO:0001831) |
0.3 | 0.7 | GO:0072679 | thymocyte migration(GO:0072679) regulation of thymocyte migration(GO:2000410) positive regulation of thymocyte migration(GO:2000412) |
0.3 | 1.0 | GO:0015747 | urate transport(GO:0015747) |
0.3 | 1.3 | GO:0031666 | positive regulation of lipopolysaccharide-mediated signaling pathway(GO:0031666) |
0.3 | 5.6 | GO:0007271 | synaptic transmission, cholinergic(GO:0007271) |
0.3 | 1.9 | GO:0048169 | regulation of long-term neuronal synaptic plasticity(GO:0048169) |
0.3 | 0.6 | GO:1903225 | negative regulation of endodermal cell differentiation(GO:1903225) |
0.3 | 2.2 | GO:0006012 | galactose metabolic process(GO:0006012) |
0.3 | 1.0 | GO:0009130 | UMP biosynthetic process(GO:0006222) pyrimidine nucleoside monophosphate biosynthetic process(GO:0009130) pyrimidine ribonucleoside monophosphate metabolic process(GO:0009173) pyrimidine ribonucleoside monophosphate biosynthetic process(GO:0009174) UMP metabolic process(GO:0046049) |
0.3 | 0.6 | GO:0070102 | interleukin-6-mediated signaling pathway(GO:0070102) |
0.3 | 0.6 | GO:0021523 | somatic motor neuron differentiation(GO:0021523) |
0.3 | 1.3 | GO:0046826 | negative regulation of protein export from nucleus(GO:0046826) |
0.3 | 0.3 | GO:0008611 | ether lipid biosynthetic process(GO:0008611) glycerol ether biosynthetic process(GO:0046504) cellular lipid biosynthetic process(GO:0097384) ether biosynthetic process(GO:1901503) |
0.3 | 0.3 | GO:0086066 | atrial cardiac muscle cell action potential(GO:0086014) atrial cardiac muscle cell to AV node cell signaling(GO:0086026) atrial cardiac muscle cell to AV node cell communication(GO:0086066) |
0.3 | 0.3 | GO:0090191 | negative regulation of branching involved in ureteric bud morphogenesis(GO:0090191) |
0.3 | 0.9 | GO:0070562 | regulation of vitamin D receptor signaling pathway(GO:0070562) |
0.3 | 22.8 | GO:0007626 | locomotory behavior(GO:0007626) |
0.3 | 0.9 | GO:0016264 | gap junction assembly(GO:0016264) |
0.3 | 1.2 | GO:2000095 | regulation of Wnt signaling pathway, planar cell polarity pathway(GO:2000095) |
0.3 | 4.3 | GO:0048873 | homeostasis of number of cells within a tissue(GO:0048873) |
0.3 | 2.2 | GO:0000338 | protein deneddylation(GO:0000338) cullin deneddylation(GO:0010388) |
0.3 | 0.3 | GO:1990144 | intrinsic apoptotic signaling pathway in response to hypoxia(GO:1990144) |
0.3 | 1.5 | GO:0007096 | regulation of exit from mitosis(GO:0007096) |
0.3 | 0.3 | GO:0009181 | purine nucleoside diphosphate catabolic process(GO:0009137) purine ribonucleoside diphosphate catabolic process(GO:0009181) |
0.3 | 0.9 | GO:2000327 | regulation of ligand-dependent nuclear receptor transcription coactivator activity(GO:2000325) positive regulation of ligand-dependent nuclear receptor transcription coactivator activity(GO:2000327) |
0.3 | 2.4 | GO:0048668 | collateral sprouting(GO:0048668) |
0.3 | 0.3 | GO:0071639 | positive regulation of monocyte chemotactic protein-1 production(GO:0071639) |
0.3 | 17.5 | GO:0001764 | neuron migration(GO:0001764) |
0.3 | 4.5 | GO:0006491 | N-glycan processing(GO:0006491) |
0.3 | 0.9 | GO:0046167 | glycerol-3-phosphate biosynthetic process(GO:0046167) |
0.3 | 0.9 | GO:0032596 | protein transport into membrane raft(GO:0032596) |
0.3 | 1.2 | GO:0060158 | phospholipase C-activating dopamine receptor signaling pathway(GO:0060158) |
0.3 | 0.6 | GO:0014707 | branchiomeric skeletal muscle development(GO:0014707) |
0.3 | 5.5 | GO:0034605 | cellular response to heat(GO:0034605) |
0.3 | 0.9 | GO:0090261 | positive regulation of inclusion body assembly(GO:0090261) |
0.3 | 2.3 | GO:0042984 | amyloid precursor protein biosynthetic process(GO:0042983) regulation of amyloid precursor protein biosynthetic process(GO:0042984) |
0.3 | 4.0 | GO:0048026 | positive regulation of mRNA splicing, via spliceosome(GO:0048026) |
0.3 | 0.6 | GO:0050805 | negative regulation of synaptic transmission(GO:0050805) |
0.3 | 2.6 | GO:0032515 | negative regulation of phosphoprotein phosphatase activity(GO:0032515) |
0.3 | 0.6 | GO:0097112 | gamma-aminobutyric acid receptor clustering(GO:0097112) |
0.3 | 0.3 | GO:0048294 | negative regulation of isotype switching to IgE isotypes(GO:0048294) |
0.3 | 0.6 | GO:0035747 | natural killer cell chemotaxis(GO:0035747) regulation of natural killer cell chemotaxis(GO:2000501) positive regulation of natural killer cell chemotaxis(GO:2000503) |
0.3 | 1.7 | GO:0046146 | tetrahydrobiopterin metabolic process(GO:0046146) |
0.3 | 2.2 | GO:0032401 | establishment of melanosome localization(GO:0032401) |
0.3 | 0.6 | GO:1904181 | positive regulation of membrane depolarization(GO:1904181) |
0.3 | 0.3 | GO:0002322 | B cell proliferation involved in immune response(GO:0002322) |
0.3 | 0.6 | GO:0045585 | regulation of cytotoxic T cell differentiation(GO:0045583) positive regulation of cytotoxic T cell differentiation(GO:0045585) |
0.3 | 0.3 | GO:1900040 | regulation of interleukin-2 secretion(GO:1900040) |
0.3 | 0.5 | GO:0010966 | regulation of phosphate transport(GO:0010966) |
0.3 | 1.6 | GO:2000008 | regulation of protein localization to cell surface(GO:2000008) |
0.3 | 1.3 | GO:0006528 | asparagine metabolic process(GO:0006528) |
0.3 | 0.5 | GO:1903232 | melanosome assembly(GO:1903232) |
0.3 | 0.5 | GO:0014866 | skeletal myofibril assembly(GO:0014866) |
0.3 | 0.8 | GO:0006013 | mannose metabolic process(GO:0006013) |
0.3 | 1.3 | GO:0002052 | positive regulation of neuroblast proliferation(GO:0002052) |
0.3 | 6.1 | GO:0046847 | filopodium assembly(GO:0046847) |
0.3 | 2.8 | GO:0043496 | regulation of protein homodimerization activity(GO:0043496) |
0.2 | 3.7 | GO:0046579 | positive regulation of Ras protein signal transduction(GO:0046579) |
0.2 | 2.7 | GO:0044458 | motile cilium assembly(GO:0044458) |
0.2 | 4.9 | GO:0031110 | regulation of microtubule polymerization or depolymerization(GO:0031110) |
0.2 | 3.2 | GO:0090218 | positive regulation of lipid kinase activity(GO:0090218) |
0.2 | 0.5 | GO:0035964 | COPI-coated vesicle budding(GO:0035964) |
0.2 | 1.0 | GO:0006598 | polyamine catabolic process(GO:0006598) |
0.2 | 1.4 | GO:0061732 | mitochondrial acetyl-CoA biosynthetic process from pyruvate(GO:0061732) |
0.2 | 1.2 | GO:0045198 | establishment of epithelial cell apical/basal polarity(GO:0045198) |
0.2 | 1.6 | GO:0002710 | negative regulation of T cell mediated immunity(GO:0002710) |
0.2 | 1.2 | GO:1904262 | negative regulation of TORC1 signaling(GO:1904262) |
0.2 | 4.6 | GO:0000002 | mitochondrial genome maintenance(GO:0000002) |
0.2 | 0.7 | GO:0015959 | diadenosine polyphosphate metabolic process(GO:0015959) |
0.2 | 0.9 | GO:0035020 | regulation of Rac protein signal transduction(GO:0035020) |
0.2 | 0.2 | GO:0006551 | leucine metabolic process(GO:0006551) |
0.2 | 0.4 | GO:0090360 | platelet-derived growth factor production(GO:0090360) regulation of platelet-derived growth factor production(GO:0090361) |
0.2 | 11.4 | GO:0050954 | sensory perception of mechanical stimulus(GO:0050954) |
0.2 | 0.9 | GO:0007210 | serotonin receptor signaling pathway(GO:0007210) |
0.2 | 0.7 | GO:0006931 | substrate-dependent cell migration, cell attachment to substrate(GO:0006931) |
0.2 | 0.2 | GO:0060618 | nipple development(GO:0060618) |
0.2 | 0.6 | GO:0006564 | L-serine biosynthetic process(GO:0006564) |
0.2 | 0.6 | GO:0035822 | meiotic gene conversion(GO:0006311) gene conversion(GO:0035822) |
0.2 | 0.4 | GO:0048753 | pigment granule organization(GO:0048753) |
0.2 | 2.3 | GO:0000920 | cell separation after cytokinesis(GO:0000920) |
0.2 | 0.6 | GO:0006546 | glycine catabolic process(GO:0006546) glycine decarboxylation via glycine cleavage system(GO:0019464) |
0.2 | 0.4 | GO:0048808 | male genitalia morphogenesis(GO:0048808) male anatomical structure morphogenesis(GO:0090598) |
0.2 | 1.3 | GO:0010744 | positive regulation of macrophage derived foam cell differentiation(GO:0010744) |
0.2 | 0.6 | GO:0035962 | response to interleukin-13(GO:0035962) cellular response to interleukin-13(GO:0035963) |
0.2 | 0.2 | GO:0070973 | protein localization to endoplasmic reticulum exit site(GO:0070973) |
0.2 | 0.2 | GO:0098528 | skeletal muscle fiber differentiation(GO:0098528) |
0.2 | 0.2 | GO:0003219 | cardiac right ventricle formation(GO:0003219) |
0.2 | 0.2 | GO:0002093 | auditory receptor cell morphogenesis(GO:0002093) |
0.2 | 0.2 | GO:0002378 | immunoglobulin biosynthetic process(GO:0002378) |
0.2 | 0.2 | GO:0010728 | regulation of hydrogen peroxide biosynthetic process(GO:0010728) |
0.2 | 0.4 | GO:0009106 | lipoate metabolic process(GO:0009106) |
0.2 | 0.2 | GO:0001560 | regulation of cell growth by extracellular stimulus(GO:0001560) |
0.2 | 2.5 | GO:0006541 | glutamine metabolic process(GO:0006541) |
0.2 | 0.2 | GO:0090239 | regulation of histone H4 acetylation(GO:0090239) |
0.2 | 7.8 | GO:0030490 | maturation of SSU-rRNA(GO:0030490) |
0.2 | 0.4 | GO:0014878 | response to electrical stimulus involved in regulation of muscle adaptation(GO:0014878) |
0.2 | 4.4 | GO:0006493 | protein O-linked glycosylation(GO:0006493) |
0.2 | 0.4 | GO:0045650 | negative regulation of macrophage differentiation(GO:0045650) |
0.2 | 1.3 | GO:0042790 | transcription of nuclear large rRNA transcript from RNA polymerase I promoter(GO:0042790) |
0.2 | 0.4 | GO:1902047 | polyamine transmembrane transport(GO:1902047) regulation of polyamine transmembrane transport(GO:1902267) |
0.2 | 0.4 | GO:0006651 | diacylglycerol biosynthetic process(GO:0006651) |
0.2 | 1.3 | GO:0007252 | I-kappaB phosphorylation(GO:0007252) |
0.2 | 0.4 | GO:0060830 | ciliary receptor clustering involved in smoothened signaling pathway(GO:0060830) |
0.2 | 0.9 | GO:0001508 | action potential(GO:0001508) |
0.2 | 4.6 | GO:0043252 | sodium-independent organic anion transport(GO:0043252) |
0.2 | 0.2 | GO:0003330 | regulation of extracellular matrix constituent secretion(GO:0003330) positive regulation of extracellular matrix constituent secretion(GO:0003331) |
0.2 | 0.3 | GO:0048254 | snoRNA localization(GO:0048254) |
0.2 | 0.5 | GO:0035425 | autocrine signaling(GO:0035425) |
0.2 | 0.3 | GO:0060011 | Sertoli cell proliferation(GO:0060011) |
0.2 | 0.5 | GO:0034310 | primary alcohol catabolic process(GO:0034310) |
0.2 | 0.5 | GO:1900095 | regulation of dosage compensation by inactivation of X chromosome(GO:1900095) |
0.2 | 1.0 | GO:0034453 | microtubule anchoring(GO:0034453) |
0.2 | 0.2 | GO:2001201 | transforming growth factor-beta secretion(GO:0038044) regulation of transforming growth factor-beta secretion(GO:2001201) |
0.2 | 0.5 | GO:0006363 | termination of RNA polymerase I transcription(GO:0006363) |
0.2 | 0.5 | GO:0048743 | positive regulation of skeletal muscle fiber development(GO:0048743) |
0.2 | 1.2 | GO:0034315 | regulation of Arp2/3 complex-mediated actin nucleation(GO:0034315) |
0.2 | 0.9 | GO:0032525 | somite rostral/caudal axis specification(GO:0032525) |
0.2 | 0.9 | GO:0046116 | queuosine biosynthetic process(GO:0008616) queuosine metabolic process(GO:0046116) |
0.2 | 0.3 | GO:0035188 | blastocyst hatching(GO:0001835) hatching(GO:0035188) organism emergence from protective structure(GO:0071684) |
0.2 | 0.3 | GO:0036123 | histone H3-K9 dimethylation(GO:0036123) |
0.2 | 1.2 | GO:0002566 | somatic diversification of immune receptors via somatic mutation(GO:0002566) somatic hypermutation of immunoglobulin genes(GO:0016446) |
0.1 | 0.6 | GO:1900121 | negative regulation of receptor binding(GO:1900121) |
0.1 | 0.7 | GO:0034398 | telomere tethering at nuclear periphery(GO:0034398) |
0.1 | 0.1 | GO:0036476 | neuron death in response to hydrogen peroxide(GO:0036476) regulation of hydrogen peroxide-induced neuron death(GO:1903207) negative regulation of hydrogen peroxide-induced neuron death(GO:1903208) |
0.1 | 0.3 | GO:0045607 | regulation of auditory receptor cell differentiation(GO:0045607) regulation of mechanoreceptor differentiation(GO:0045631) regulation of inner ear receptor cell differentiation(GO:2000980) |
0.1 | 0.1 | GO:0051660 | establishment of centrosome localization(GO:0051660) |
0.1 | 0.7 | GO:1901538 | DNA methylation involved in embryo development(GO:0043045) changes to DNA methylation involved in embryo development(GO:1901538) |
0.1 | 0.1 | GO:1905048 | regulation of metallopeptidase activity(GO:1905048) |
0.1 | 0.1 | GO:0014835 | myoblast differentiation involved in skeletal muscle regeneration(GO:0014835) |
0.1 | 0.1 | GO:0010387 | COP9 signalosome assembly(GO:0010387) |
0.1 | 1.0 | GO:0060294 | cilium movement involved in cell motility(GO:0060294) |
0.1 | 17.4 | GO:0007409 | axonogenesis(GO:0007409) |
0.1 | 1.2 | GO:0018298 | protein-chromophore linkage(GO:0018298) |
0.1 | 1.1 | GO:0042487 | regulation of odontogenesis of dentin-containing tooth(GO:0042487) |
0.1 | 1.1 | GO:0061377 | mammary gland alveolus development(GO:0060749) mammary gland lobule development(GO:0061377) |
0.1 | 0.5 | GO:0046602 | regulation of mitotic centrosome separation(GO:0046602) |
0.1 | 0.6 | GO:0009235 | cobalamin metabolic process(GO:0009235) |
0.1 | 0.1 | GO:0061470 | T follicular helper cell differentiation(GO:0061470) |
0.1 | 0.1 | GO:0021794 | thalamus development(GO:0021794) |
0.1 | 0.1 | GO:0045409 | negative regulation of interleukin-6 biosynthetic process(GO:0045409) |
0.1 | 2.1 | GO:0007340 | acrosome reaction(GO:0007340) |
0.1 | 0.4 | GO:1903624 | regulation of apoptotic DNA fragmentation(GO:1902510) regulation of DNA catabolic process(GO:1903624) |
0.1 | 0.1 | GO:0048550 | negative regulation of pinocytosis(GO:0048550) |
0.1 | 0.6 | GO:0006307 | DNA dealkylation involved in DNA repair(GO:0006307) |
0.1 | 0.5 | GO:1902571 | regulation of serine-type endopeptidase activity(GO:1900003) negative regulation of serine-type endopeptidase activity(GO:1900004) regulation of serine-type peptidase activity(GO:1902571) negative regulation of serine-type peptidase activity(GO:1902572) |
0.1 | 0.6 | GO:2000060 | positive regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:2000060) |
0.1 | 0.2 | GO:0043988 | histone H3-S28 phosphorylation(GO:0043988) |
0.1 | 0.2 | GO:0021984 | adenohypophysis development(GO:0021984) |
0.1 | 0.1 | GO:0060665 | regulation of branching involved in salivary gland morphogenesis by mesenchymal-epithelial signaling(GO:0060665) |
0.1 | 0.1 | GO:0070662 | mast cell proliferation(GO:0070662) regulation of mast cell proliferation(GO:0070666) positive regulation of mast cell proliferation(GO:0070668) |
0.1 | 0.7 | GO:0070269 | pyroptosis(GO:0070269) |
0.1 | 0.2 | GO:0071034 | CUT catabolic process(GO:0071034) CUT metabolic process(GO:0071043) |
0.1 | 0.2 | GO:0038165 | oncostatin-M-mediated signaling pathway(GO:0038165) |
0.1 | 0.9 | GO:0006103 | 2-oxoglutarate metabolic process(GO:0006103) |
0.1 | 0.8 | GO:0007289 | spermatid nucleus differentiation(GO:0007289) |
0.1 | 0.2 | GO:0070920 | regulation of production of small RNA involved in gene silencing by RNA(GO:0070920) |
0.1 | 0.6 | GO:0043651 | linoleic acid metabolic process(GO:0043651) |
0.1 | 0.2 | GO:1902093 | positive regulation of sperm motility(GO:1902093) |
0.1 | 0.1 | GO:0050655 | dermatan sulfate proteoglycan metabolic process(GO:0050655) |
0.1 | 0.1 | GO:2000402 | negative regulation of lymphocyte migration(GO:2000402) |
0.1 | 0.8 | GO:0001867 | complement activation, lectin pathway(GO:0001867) |
0.1 | 0.3 | GO:0045416 | positive regulation of interleukin-8 biosynthetic process(GO:0045416) |
0.1 | 3.3 | GO:0010923 | negative regulation of phosphatase activity(GO:0010923) |
0.1 | 1.4 | GO:0021987 | cerebral cortex development(GO:0021987) |
0.1 | 0.1 | GO:0033505 | floor plate morphogenesis(GO:0033505) |
0.1 | 0.2 | GO:0002540 | leukotriene production involved in inflammatory response(GO:0002540) |
0.1 | 0.6 | GO:0098856 | intestinal cholesterol absorption(GO:0030299) intestinal lipid absorption(GO:0098856) |
0.1 | 0.1 | GO:0032225 | regulation of synaptic transmission, dopaminergic(GO:0032225) |
0.1 | 0.1 | GO:0042538 | hyperosmotic salinity response(GO:0042538) |
0.1 | 0.1 | GO:0090383 | phagosome acidification(GO:0090383) |
0.1 | 0.2 | GO:0042276 | error-prone translesion synthesis(GO:0042276) |
0.1 | 0.1 | GO:0070460 | thyroid-stimulating hormone secretion(GO:0070460) |
0.1 | 0.1 | GO:0048341 | paraxial mesoderm formation(GO:0048341) |
0.1 | 0.4 | GO:0043249 | erythrocyte maturation(GO:0043249) |
0.1 | 0.3 | GO:0001710 | mesodermal cell fate commitment(GO:0001710) |
0.1 | 0.4 | GO:0006268 | DNA unwinding involved in DNA replication(GO:0006268) |
0.1 | 0.5 | GO:0000459 | exonucleolytic trimming involved in rRNA processing(GO:0000459) exonucleolytic trimming to generate mature 3'-end of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000467) |
0.1 | 0.1 | GO:0010940 | positive regulation of necrotic cell death(GO:0010940) |
0.1 | 0.2 | GO:0017121 | phospholipid scrambling(GO:0017121) |
0.0 | 0.0 | GO:0097029 | mature conventional dendritic cell differentiation(GO:0097029) |
0.0 | 0.2 | GO:0042796 | snRNA transcription from RNA polymerase III promoter(GO:0042796) |
0.0 | 0.0 | GO:0002370 | natural killer cell cytokine production(GO:0002370) regulation of natural killer cell cytokine production(GO:0002727) |
0.0 | 0.2 | GO:1903301 | positive regulation of glucokinase activity(GO:0033133) positive regulation of hexokinase activity(GO:1903301) |
0.0 | 0.3 | GO:0007019 | microtubule depolymerization(GO:0007019) |
0.0 | 0.0 | GO:0032914 | positive regulation of transforming growth factor beta1 production(GO:0032914) |
0.0 | 0.6 | GO:0010257 | NADH dehydrogenase complex assembly(GO:0010257) mitochondrial respiratory chain complex I assembly(GO:0032981) mitochondrial respiratory chain complex I biogenesis(GO:0097031) |
0.0 | 0.3 | GO:0035067 | negative regulation of histone acetylation(GO:0035067) |
0.0 | 0.0 | GO:0010644 | cell communication by electrical coupling(GO:0010644) |
0.0 | 0.1 | GO:0051025 | negative regulation of immunoglobulin secretion(GO:0051025) |
0.0 | 0.1 | GO:0000491 | small nucleolar ribonucleoprotein complex assembly(GO:0000491) box C/D snoRNP assembly(GO:0000492) |
0.0 | 0.4 | GO:0008210 | estrogen metabolic process(GO:0008210) |
0.0 | 0.0 | GO:0002638 | negative regulation of immunoglobulin production(GO:0002638) |
0.0 | 0.1 | GO:0060012 | synaptic transmission, glycinergic(GO:0060012) |
0.0 | 0.0 | GO:0071864 | positive regulation of cell proliferation in bone marrow(GO:0071864) |
0.0 | 0.1 | GO:0010446 | response to alkaline pH(GO:0010446) |
0.0 | 0.1 | GO:0072540 | T-helper 17 cell lineage commitment(GO:0072540) |
0.0 | 1.0 | GO:0050911 | detection of chemical stimulus involved in sensory perception of smell(GO:0050911) |
0.0 | 0.1 | GO:0048311 | mitochondrion distribution(GO:0048311) |
0.0 | 0.1 | GO:0007000 | nucleolus organization(GO:0007000) |
0.0 | 0.0 | GO:0003157 | endocardium development(GO:0003157) |
0.0 | 0.0 | GO:0090158 | endoplasmic reticulum membrane organization(GO:0090158) |
0.0 | 0.0 | GO:0060729 | intestinal epithelial structure maintenance(GO:0060729) |
0.0 | 0.1 | GO:0030431 | sleep(GO:0030431) |
0.0 | 0.1 | GO:0042438 | melanin biosynthetic process(GO:0042438) |
0.0 | 0.1 | GO:0016926 | protein desumoylation(GO:0016926) |
0.0 | 1.3 | GO:0019236 | response to pheromone(GO:0019236) |
0.0 | 0.0 | GO:0015766 | disaccharide transport(GO:0015766) sucrose transport(GO:0015770) oligosaccharide transport(GO:0015772) |
0.0 | 0.4 | GO:0006836 | neurotransmitter transport(GO:0006836) |
0.0 | 0.0 | GO:0003356 | regulation of cilium beat frequency(GO:0003356) |
0.0 | 0.0 | GO:0006072 | glycerol-3-phosphate metabolic process(GO:0006072) |
0.0 | 0.0 | GO:0044375 | regulation of peroxisome size(GO:0044375) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
9.3 | 28.0 | GO:0038037 | G-protein coupled receptor dimeric complex(GO:0038037) G-protein coupled receptor complex(GO:0097648) |
7.4 | 7.4 | GO:0008328 | ionotropic glutamate receptor complex(GO:0008328) neurotransmitter receptor complex(GO:0098878) |
6.3 | 43.9 | GO:0030285 | integral component of synaptic vesicle membrane(GO:0030285) intrinsic component of synaptic vesicle membrane(GO:0098563) |
5.4 | 27.1 | GO:0032983 | kainate selective glutamate receptor complex(GO:0032983) |
5.1 | 20.4 | GO:1990696 | USH2 complex(GO:1990696) |
4.9 | 48.8 | GO:0044224 | juxtaparanode region of axon(GO:0044224) |
4.7 | 83.9 | GO:0060077 | inhibitory synapse(GO:0060077) |
4.5 | 13.4 | GO:0070110 | ciliary neurotrophic factor receptor complex(GO:0070110) |
4.3 | 51.5 | GO:0017146 | NMDA selective glutamate receptor complex(GO:0017146) |
4.3 | 4.3 | GO:0070033 | synaptobrevin 2-SNAP-25-syntaxin-1a-complexin II complex(GO:0070033) |
4.3 | 17.1 | GO:0070032 | synaptobrevin 2-SNAP-25-syntaxin-1a-complexin I complex(GO:0070032) |
4.3 | 12.8 | GO:0044322 | endoplasmic reticulum quality control compartment(GO:0044322) |
4.3 | 4.3 | GO:0030121 | AP-1 adaptor complex(GO:0030121) |
4.3 | 12.8 | GO:1990812 | growth cone filopodium(GO:1990812) |
4.2 | 25.2 | GO:0043083 | synaptic cleft(GO:0043083) |
4.2 | 58.6 | GO:0030673 | axolemma(GO:0030673) |
4.1 | 12.4 | GO:0072534 | perineuronal net(GO:0072534) |
4.1 | 16.3 | GO:0044308 | axonal spine(GO:0044308) |
3.9 | 90.6 | GO:0048786 | presynaptic active zone(GO:0048786) |
3.9 | 46.3 | GO:0043194 | axon initial segment(GO:0043194) |
3.8 | 99.9 | GO:0032281 | AMPA glutamate receptor complex(GO:0032281) |
3.4 | 6.9 | GO:0097025 | MPP7-DLG1-LIN7 complex(GO:0097025) |
3.4 | 13.6 | GO:0044326 | dendritic spine neck(GO:0044326) |
3.4 | 97.8 | GO:0005790 | smooth endoplasmic reticulum(GO:0005790) |
3.3 | 9.8 | GO:0044294 | dendritic growth cone(GO:0044294) |
3.2 | 3.2 | GO:0005742 | mitochondrial outer membrane translocase complex(GO:0005742) |
3.1 | 9.4 | GO:0005853 | eukaryotic translation elongation factor 1 complex(GO:0005853) |
3.1 | 91.9 | GO:0042734 | presynaptic membrane(GO:0042734) |
3.0 | 14.8 | GO:0070695 | FHF complex(GO:0070695) |
2.9 | 11.6 | GO:0017071 | intracellular cyclic nucleotide activated cation channel complex(GO:0017071) |
2.7 | 11.0 | GO:0008274 | gamma-tubulin large complex(GO:0000931) gamma-tubulin ring complex(GO:0008274) |
2.7 | 8.1 | GO:0043511 | inhibin complex(GO:0043511) |
2.6 | 17.9 | GO:0036056 | filtration diaphragm(GO:0036056) slit diaphragm(GO:0036057) |
2.5 | 12.6 | GO:1990454 | L-type voltage-gated calcium channel complex(GO:1990454) |
2.5 | 17.5 | GO:0032584 | growth cone membrane(GO:0032584) |
2.4 | 131.0 | GO:0008076 | voltage-gated potassium channel complex(GO:0008076) |
2.4 | 18.9 | GO:0035253 | ciliary rootlet(GO:0035253) |
2.2 | 8.8 | GO:0044300 | cerebellar mossy fiber(GO:0044300) |
2.1 | 29.7 | GO:0097440 | apical dendrite(GO:0097440) |
2.1 | 6.4 | GO:0005899 | insulin receptor complex(GO:0005899) |
2.1 | 53.0 | GO:0005891 | voltage-gated calcium channel complex(GO:0005891) |
2.0 | 26.5 | GO:0030877 | beta-catenin destruction complex(GO:0030877) |
2.0 | 12.1 | GO:0016012 | sarcoglycan complex(GO:0016012) |
2.0 | 10.0 | GO:0045098 | type III intermediate filament(GO:0045098) |
2.0 | 31.7 | GO:0032809 | neuronal cell body membrane(GO:0032809) |
2.0 | 9.9 | GO:0071598 | neuronal ribonucleoprotein granule(GO:0071598) |
1.9 | 5.8 | GO:0071008 | U2-type post-mRNA release spliceosomal complex(GO:0071008) |
1.8 | 12.8 | GO:0043198 | dendritic shaft(GO:0043198) |
1.7 | 22.5 | GO:0031045 | dense core granule(GO:0031045) |
1.7 | 6.9 | GO:0005968 | Rab-protein geranylgeranyltransferase complex(GO:0005968) |
1.7 | 13.5 | GO:0042788 | polysomal ribosome(GO:0042788) |
1.7 | 243.9 | GO:0045211 | postsynaptic membrane(GO:0045211) |
1.7 | 6.7 | GO:1990716 | axonemal central apparatus(GO:1990716) |
1.7 | 23.5 | GO:0034704 | calcium channel complex(GO:0034704) |
1.5 | 3.0 | GO:0016533 | cyclin-dependent protein kinase 5 holoenzyme complex(GO:0016533) |
1.5 | 3.0 | GO:0005608 | laminin-3 complex(GO:0005608) |
1.5 | 4.5 | GO:0000110 | nucleotide-excision repair factor 1 complex(GO:0000110) |
1.5 | 160.0 | GO:0060076 | excitatory synapse(GO:0060076) |
1.5 | 1.5 | GO:0043219 | lateral loop(GO:0043219) |
1.5 | 5.9 | GO:0031466 | Cul5-RING ubiquitin ligase complex(GO:0031466) |
1.5 | 2.9 | GO:0033648 | host intracellular organelle(GO:0033647) host intracellular membrane-bounded organelle(GO:0033648) |
1.5 | 5.8 | GO:0033269 | internode region of axon(GO:0033269) |
1.4 | 14.4 | GO:0001518 | voltage-gated sodium channel complex(GO:0001518) |
1.4 | 5.4 | GO:0000220 | vacuolar proton-transporting V-type ATPase, V0 domain(GO:0000220) |
1.3 | 8.0 | GO:0005915 | zonula adherens(GO:0005915) |
1.3 | 3.9 | GO:0031233 | intrinsic component of external side of plasma membrane(GO:0031233) |
1.3 | 2.6 | GO:0002193 | MAML1-RBP-Jkappa- ICN1 complex(GO:0002193) |
1.3 | 9.0 | GO:0032590 | dendrite membrane(GO:0032590) |
1.3 | 17.8 | GO:0044295 | axonal growth cone(GO:0044295) |
1.2 | 1.2 | GO:0044316 | cone cell pedicle(GO:0044316) |
1.2 | 9.7 | GO:0045275 | mitochondrial respiratory chain complex III(GO:0005750) respiratory chain complex III(GO:0045275) |
1.2 | 4.8 | GO:0031313 | extrinsic component of endosome membrane(GO:0031313) |
1.1 | 3.4 | GO:0000814 | ESCRT II complex(GO:0000814) |
1.1 | 3.4 | GO:0017133 | mitochondrial electron transfer flavoprotein complex(GO:0017133) electron transfer flavoprotein complex(GO:0045251) |
1.1 | 3.4 | GO:0097427 | microtubule bundle(GO:0097427) |
1.1 | 16.4 | GO:0032588 | trans-Golgi network membrane(GO:0032588) |
1.1 | 1.1 | GO:0014701 | junctional sarcoplasmic reticulum membrane(GO:0014701) |
1.1 | 4.3 | GO:0098984 | neuron to neuron synapse(GO:0098984) |
1.1 | 7.4 | GO:0070419 | nonhomologous end joining complex(GO:0070419) |
1.0 | 2.1 | GO:0000322 | storage vacuole(GO:0000322) |
1.0 | 83.1 | GO:0008021 | synaptic vesicle(GO:0008021) |
1.0 | 3.0 | GO:0033010 | paranodal junction(GO:0033010) |
0.9 | 2.8 | GO:0071001 | U4/U6 snRNP(GO:0071001) |
0.9 | 0.9 | GO:0070522 | ERCC4-ERCC1 complex(GO:0070522) |
0.9 | 3.6 | GO:0070876 | SOSS complex(GO:0070876) |
0.9 | 9.9 | GO:0042555 | MCM complex(GO:0042555) |
0.9 | 56.3 | GO:0030427 | site of polarized growth(GO:0030427) |
0.9 | 4.4 | GO:0005579 | membrane attack complex(GO:0005579) |
0.9 | 2.6 | GO:0005955 | calcineurin complex(GO:0005955) |
0.8 | 1.7 | GO:0070044 | synaptobrevin 2-SNAP-25-syntaxin-1a complex(GO:0070044) |
0.8 | 1.7 | GO:0042827 | platelet dense granule(GO:0042827) |
0.8 | 193.6 | GO:0045202 | synapse(GO:0045202) |
0.8 | 13.7 | GO:0030904 | retromer complex(GO:0030904) |
0.8 | 1.6 | GO:0005818 | aster(GO:0005818) |
0.8 | 0.8 | GO:0060053 | neurofilament cytoskeleton(GO:0060053) |
0.8 | 46.7 | GO:0031463 | Cul3-RING ubiquitin ligase complex(GO:0031463) |
0.7 | 4.5 | GO:0000347 | THO complex(GO:0000347) THO complex part of transcription export complex(GO:0000445) |
0.7 | 6.7 | GO:0000137 | Golgi cis cisterna(GO:0000137) |
0.7 | 3.0 | GO:0070545 | PeBoW complex(GO:0070545) |
0.7 | 0.7 | GO:0005883 | neurofilament(GO:0005883) |
0.7 | 1.5 | GO:1902710 | GABA receptor complex(GO:1902710) GABA-A receptor complex(GO:1902711) |
0.7 | 1.5 | GO:0090498 | extrinsic component of Golgi membrane(GO:0090498) |
0.7 | 2.2 | GO:0036396 | MIS complex(GO:0036396) |
0.7 | 8.7 | GO:0032580 | Golgi cisterna membrane(GO:0032580) |
0.7 | 2.9 | GO:0031201 | SNARE complex(GO:0031201) |
0.7 | 3.6 | GO:0031428 | box C/D snoRNP complex(GO:0031428) |
0.7 | 2.8 | GO:0030127 | COPII vesicle coat(GO:0030127) |
0.7 | 92.3 | GO:0031225 | anchored component of membrane(GO:0031225) |
0.7 | 2.7 | GO:0043202 | lysosomal lumen(GO:0043202) |
0.7 | 2.0 | GO:0032437 | cuticular plate(GO:0032437) |
0.6 | 4.5 | GO:0033180 | proton-transporting V-type ATPase, V1 domain(GO:0033180) |
0.6 | 1.9 | GO:0090661 | box H/ACA telomerase RNP complex(GO:0090661) |
0.6 | 7.6 | GO:0031597 | cytosolic proteasome complex(GO:0031597) |
0.6 | 7.2 | GO:0005732 | small nucleolar ribonucleoprotein complex(GO:0005732) |
0.6 | 3.0 | GO:0046696 | lipopolysaccharide receptor complex(GO:0046696) |
0.6 | 17.0 | GO:0005921 | gap junction(GO:0005921) |
0.6 | 5.2 | GO:0000124 | SAGA complex(GO:0000124) |
0.6 | 3.9 | GO:0030681 | nucleolar ribonuclease P complex(GO:0005655) ribonuclease P complex(GO:0030677) multimeric ribonuclease P complex(GO:0030681) |
0.6 | 0.6 | GO:0098573 | intrinsic component of mitochondrial membrane(GO:0098573) |
0.5 | 1.1 | GO:0033186 | CAF-1 complex(GO:0033186) |
0.5 | 2.2 | GO:0032777 | Piccolo NuA4 histone acetyltransferase complex(GO:0032777) |
0.5 | 3.8 | GO:0016272 | prefoldin complex(GO:0016272) |
0.5 | 0.5 | GO:0097487 | multivesicular body, internal vesicle(GO:0097487) |
0.5 | 3.2 | GO:0071204 | histone pre-mRNA 3'end processing complex(GO:0071204) |
0.5 | 6.6 | GO:0060293 | P granule(GO:0043186) pole plasm(GO:0045495) germ plasm(GO:0060293) |
0.5 | 5.1 | GO:0030867 | rough endoplasmic reticulum membrane(GO:0030867) |
0.5 | 2.4 | GO:0031258 | lamellipodium membrane(GO:0031258) |
0.5 | 1.5 | GO:0005610 | laminin-5 complex(GO:0005610) |
0.5 | 0.9 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
0.5 | 0.9 | GO:0044614 | nuclear pore cytoplasmic filaments(GO:0044614) |
0.5 | 3.8 | GO:0005687 | U4 snRNP(GO:0005687) |
0.5 | 1.4 | GO:0009331 | glycerol-3-phosphate dehydrogenase complex(GO:0009331) |
0.4 | 1.3 | GO:0005594 | collagen type IX trimer(GO:0005594) |
0.4 | 4.5 | GO:0031512 | motile primary cilium(GO:0031512) |
0.4 | 1.3 | GO:0042719 | mitochondrial intermembrane space protein transporter complex(GO:0042719) |
0.4 | 2.2 | GO:0000120 | RNA polymerase I transcription factor complex(GO:0000120) |
0.4 | 1.8 | GO:0016589 | NURF complex(GO:0016589) |
0.4 | 3.9 | GO:0030134 | ER to Golgi transport vesicle(GO:0030134) |
0.4 | 2.5 | GO:0035032 | phosphatidylinositol 3-kinase complex, class III(GO:0035032) |
0.4 | 2.1 | GO:0097433 | dense body(GO:0097433) |
0.4 | 1.7 | GO:0030314 | junctional membrane complex(GO:0030314) |
0.4 | 1.6 | GO:0097169 | AIM2 inflammasome complex(GO:0097169) |
0.4 | 1.6 | GO:0008290 | F-actin capping protein complex(GO:0008290) |
0.4 | 4.1 | GO:0005675 | holo TFIIH complex(GO:0005675) |
0.4 | 5.1 | GO:0000800 | lateral element(GO:0000800) |
0.3 | 1.4 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
0.3 | 2.0 | GO:0001674 | female germ cell nucleus(GO:0001674) |
0.3 | 0.3 | GO:0044298 | cell body membrane(GO:0044298) |
0.3 | 3.7 | GO:0005697 | telomerase holoenzyme complex(GO:0005697) |
0.3 | 2.4 | GO:0070187 | telosome(GO:0070187) |
0.3 | 3.7 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
0.3 | 0.7 | GO:0005892 | acetylcholine-gated channel complex(GO:0005892) |
0.3 | 4.9 | GO:0005614 | interstitial matrix(GO:0005614) |
0.3 | 2.9 | GO:0000813 | ESCRT I complex(GO:0000813) |
0.3 | 99.8 | GO:0036477 | somatodendritic compartment(GO:0036477) |
0.3 | 0.9 | GO:1990393 | 3M complex(GO:1990393) |
0.3 | 1.2 | GO:0097209 | epidermal lamellar body(GO:0097209) |
0.3 | 0.9 | GO:1990075 | periciliary membrane compartment(GO:1990075) |
0.3 | 0.8 | GO:0033017 | sarcoplasmic reticulum membrane(GO:0033017) |
0.3 | 1.7 | GO:0030008 | TRAPP complex(GO:0030008) |
0.3 | 1.7 | GO:0030062 | mitochondrial tricarboxylic acid cycle enzyme complex(GO:0030062) |
0.3 | 4.9 | GO:0016581 | NuRD complex(GO:0016581) CHD-type complex(GO:0090545) |
0.3 | 3.0 | GO:0005847 | mRNA cleavage and polyadenylation specificity factor complex(GO:0005847) |
0.3 | 1.1 | GO:0033116 | endoplasmic reticulum-Golgi intermediate compartment membrane(GO:0033116) |
0.3 | 2.5 | GO:0072546 | ER membrane protein complex(GO:0072546) |
0.2 | 4.4 | GO:0005689 | U12-type spliceosomal complex(GO:0005689) |
0.2 | 1.2 | GO:0097038 | perinuclear endoplasmic reticulum(GO:0097038) |
0.2 | 0.9 | GO:0031262 | Ndc80 complex(GO:0031262) |
0.2 | 3.8 | GO:0001917 | photoreceptor inner segment(GO:0001917) |
0.2 | 0.7 | GO:1990851 | Wnt-Frizzled-LRP5/6 complex(GO:1990851) |
0.2 | 0.9 | GO:0000346 | transcription export complex(GO:0000346) |
0.2 | 5.6 | GO:0032040 | small-subunit processome(GO:0032040) |
0.2 | 0.7 | GO:0043159 | acrosomal matrix(GO:0043159) |
0.2 | 5.4 | GO:0008180 | COP9 signalosome(GO:0008180) |
0.2 | 7.1 | GO:0005776 | autophagosome(GO:0005776) |
0.2 | 0.6 | GO:0016942 | insulin-like growth factor binding protein complex(GO:0016942) growth factor complex(GO:0036454) insulin-like growth factor ternary complex(GO:0042567) |
0.2 | 1.0 | GO:0031264 | death-inducing signaling complex(GO:0031264) |
0.2 | 0.6 | GO:0097524 | sperm plasma membrane(GO:0097524) |
0.2 | 4.3 | GO:0005801 | cis-Golgi network(GO:0005801) |
0.2 | 0.5 | GO:0005863 | striated muscle myosin thick filament(GO:0005863) |
0.2 | 0.5 | GO:0071817 | MMXD complex(GO:0071817) |
0.2 | 3.3 | GO:0034451 | centriolar satellite(GO:0034451) |
0.2 | 1.3 | GO:0036157 | outer dynein arm(GO:0036157) |
0.2 | 0.2 | GO:0019815 | B cell receptor complex(GO:0019815) |
0.2 | 1.5 | GO:0005798 | Golgi-associated vesicle(GO:0005798) |
0.1 | 0.7 | GO:0000805 | X chromosome(GO:0000805) |
0.1 | 2.1 | GO:0005779 | integral component of peroxisomal membrane(GO:0005779) |
0.1 | 0.4 | GO:0000942 | condensed nuclear chromosome outer kinetochore(GO:0000942) |
0.1 | 0.1 | GO:0045293 | mRNA editing complex(GO:0045293) |
0.1 | 0.7 | GO:0033177 | proton-transporting two-sector ATPase complex, proton-transporting domain(GO:0033177) |
0.1 | 0.4 | GO:0035355 | Toll-like receptor 2-Toll-like receptor 6 protein complex(GO:0035355) |
0.1 | 0.8 | GO:0045239 | tricarboxylic acid cycle enzyme complex(GO:0045239) |
0.1 | 0.9 | GO:0097386 | glial cell projection(GO:0097386) |
0.1 | 0.8 | GO:0008385 | IkappaB kinase complex(GO:0008385) |
0.1 | 5.0 | GO:0005747 | mitochondrial respiratory chain complex I(GO:0005747) NADH dehydrogenase complex(GO:0030964) respiratory chain complex I(GO:0045271) |
0.1 | 0.6 | GO:0071986 | Ragulator complex(GO:0071986) |
0.1 | 0.1 | GO:0044393 | microspike(GO:0044393) |
0.1 | 1.0 | GO:0000930 | gamma-tubulin complex(GO:0000930) |
0.1 | 0.2 | GO:0000015 | phosphopyruvate hydratase complex(GO:0000015) |
0.1 | 0.3 | GO:0033179 | proton-transporting V-type ATPase, V0 domain(GO:0033179) |
0.1 | 4.7 | GO:0019005 | SCF ubiquitin ligase complex(GO:0019005) |
0.1 | 0.5 | GO:0005890 | sodium:potassium-exchanging ATPase complex(GO:0005890) |
0.1 | 0.3 | GO:0070552 | BRISC complex(GO:0070552) |
0.1 | 0.3 | GO:0042622 | photoreceptor outer segment membrane(GO:0042622) |
0.1 | 0.6 | GO:0070847 | core mediator complex(GO:0070847) |
0.1 | 0.3 | GO:0030485 | smooth muscle contractile fiber(GO:0030485) |
0.1 | 0.9 | GO:0046581 | intercellular canaliculus(GO:0046581) |
0.1 | 0.8 | GO:0019773 | proteasome core complex, alpha-subunit complex(GO:0019773) |
0.1 | 0.8 | GO:0005832 | chaperonin-containing T-complex(GO:0005832) |
0.1 | 0.8 | GO:0036452 | ESCRT complex(GO:0036452) |
0.1 | 1.4 | GO:0002080 | acrosomal membrane(GO:0002080) |
0.1 | 0.2 | GO:0045009 | melanosome membrane(GO:0033162) chitosome(GO:0045009) |
0.1 | 0.2 | GO:1990316 | ATG1/ULK1 kinase complex(GO:1990316) |
0.1 | 5.2 | GO:0030424 | axon(GO:0030424) |
0.1 | 0.1 | GO:0072558 | NLRP1 inflammasome complex(GO:0072558) |
0.1 | 2.3 | GO:0005720 | nuclear heterochromatin(GO:0005720) |
0.1 | 1.9 | GO:0030660 | Golgi-associated vesicle membrane(GO:0030660) |
0.1 | 0.1 | GO:0034715 | pICln-Sm protein complex(GO:0034715) |
0.1 | 0.5 | GO:0035371 | microtubule plus-end(GO:0035371) |
0.0 | 218.2 | GO:0016021 | integral component of membrane(GO:0016021) |
0.0 | 0.1 | GO:0044611 | nuclear pore inner ring(GO:0044611) |
0.0 | 1.9 | GO:0001669 | acrosomal vesicle(GO:0001669) |
0.0 | 0.2 | GO:0001520 | outer dense fiber(GO:0001520) |
0.0 | 0.4 | GO:0000314 | organellar small ribosomal subunit(GO:0000314) mitochondrial small ribosomal subunit(GO:0005763) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
10.1 | 30.4 | GO:0005519 | cytoskeletal regulatory protein binding(GO:0005519) |
10.1 | 20.2 | GO:0031697 | beta-1 adrenergic receptor binding(GO:0031697) |
10.1 | 30.2 | GO:0030160 | GKAP/Homer scaffold activity(GO:0030160) |
9.4 | 28.1 | GO:0004965 | G-protein coupled GABA receptor activity(GO:0004965) |
8.5 | 42.5 | GO:0044323 | retinoic acid-responsive element binding(GO:0044323) |
8.4 | 33.6 | GO:0032051 | clathrin light chain binding(GO:0032051) |
8.3 | 33.1 | GO:0004971 | AMPA glutamate receptor activity(GO:0004971) |
7.8 | 15.5 | GO:0043125 | ErbB-3 class receptor binding(GO:0043125) |
7.8 | 23.3 | GO:0097109 | neuroligin family protein binding(GO:0097109) |
7.2 | 21.5 | GO:0015018 | galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase activity(GO:0015018) |
6.8 | 20.4 | GO:0005176 | ErbB-2 class receptor binding(GO:0005176) |
6.7 | 20.2 | GO:0048101 | calcium- and calmodulin-regulated 3',5'-cyclic-GMP phosphodiesterase activity(GO:0048101) |
6.6 | 26.6 | GO:0005030 | neurotrophin receptor activity(GO:0005030) |
6.4 | 19.3 | GO:0004471 | malic enzyme activity(GO:0004470) malate dehydrogenase (decarboxylating) (NAD+) activity(GO:0004471) |
6.3 | 31.3 | GO:0004826 | phenylalanine-tRNA ligase activity(GO:0004826) |
6.1 | 18.3 | GO:0034040 | lipid-transporting ATPase activity(GO:0034040) |
5.9 | 29.5 | GO:0003828 | alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity(GO:0003828) |
5.8 | 23.1 | GO:0015277 | kainate selective glutamate receptor activity(GO:0015277) |
5.7 | 40.2 | GO:0102338 | fatty acid elongase activity(GO:0009922) 3-oxo-arachidoyl-CoA synthase activity(GO:0102336) 3-oxo-cerotoyl-CoA synthase activity(GO:0102337) 3-oxo-lignoceronyl-CoA synthase activity(GO:0102338) |
5.3 | 15.9 | GO:0048763 | calcium-induced calcium release activity(GO:0048763) |
5.2 | 21.0 | GO:0016286 | small conductance calcium-activated potassium channel activity(GO:0016286) |
4.9 | 19.7 | GO:0015467 | G-protein activated inward rectifier potassium channel activity(GO:0015467) |
4.9 | 29.3 | GO:0001640 | adenylate cyclase inhibiting G-protein coupled glutamate receptor activity(GO:0001640) |
4.9 | 14.6 | GO:0004351 | glutamate decarboxylase activity(GO:0004351) |
4.8 | 9.6 | GO:0098988 | G-protein coupled glutamate receptor activity(GO:0098988) |
4.8 | 19.1 | GO:0004897 | ciliary neurotrophic factor receptor activity(GO:0004897) |
4.5 | 13.6 | GO:0008332 | low voltage-gated calcium channel activity(GO:0008332) |
4.5 | 31.6 | GO:0050291 | sphingosine N-acyltransferase activity(GO:0050291) |
4.5 | 22.4 | GO:0030550 | acetylcholine receptor inhibitor activity(GO:0030550) |
4.4 | 30.8 | GO:0003680 | AT DNA binding(GO:0003680) |
4.4 | 17.6 | GO:0035727 | lysophosphatidic acid binding(GO:0035727) |
4.4 | 48.3 | GO:0005234 | extracellular-glutamate-gated ion channel activity(GO:0005234) |
4.3 | 8.5 | GO:0045503 | dynein light chain binding(GO:0045503) |
4.2 | 21.1 | GO:0005005 | transmembrane-ephrin receptor activity(GO:0005005) |
4.1 | 20.6 | GO:0005004 | GPI-linked ephrin receptor activity(GO:0005004) |
4.1 | 20.3 | GO:0086080 | protein binding involved in heterotypic cell-cell adhesion(GO:0086080) |
4.0 | 11.9 | GO:0008503 | benzodiazepine receptor activity(GO:0008503) |
3.8 | 26.5 | GO:0005283 | sodium:amino acid symporter activity(GO:0005283) |
3.7 | 11.2 | GO:0042296 | ISG15 transferase activity(GO:0042296) |
3.6 | 10.7 | GO:0050833 | pyruvate transmembrane transporter activity(GO:0050833) |
3.5 | 14.2 | GO:0031694 | alpha-2A adrenergic receptor binding(GO:0031694) |
3.4 | 17.1 | GO:0015185 | gamma-aminobutyric acid transmembrane transporter activity(GO:0015185) |
3.3 | 13.3 | GO:0001602 | pancreatic polypeptide receptor activity(GO:0001602) |
3.3 | 23.0 | GO:0005237 | inhibitory extracellular ligand-gated ion channel activity(GO:0005237) |
3.3 | 13.1 | GO:0008499 | UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity(GO:0008499) |
3.2 | 3.2 | GO:0038191 | neuropilin binding(GO:0038191) |
3.2 | 25.5 | GO:0031957 | very long-chain fatty acid-CoA ligase activity(GO:0031957) |
3.1 | 9.3 | GO:0005250 | A-type (transient outward) potassium channel activity(GO:0005250) |
3.1 | 9.3 | GO:0030297 | transmembrane receptor protein tyrosine kinase activator activity(GO:0030297) |
3.1 | 15.4 | GO:0000268 | peroxisome targeting sequence binding(GO:0000268) |
3.0 | 12.0 | GO:0097001 | ceramide binding(GO:0097001) |
3.0 | 17.9 | GO:0022835 | transmitter-gated ion channel activity(GO:0022824) transmitter-gated channel activity(GO:0022835) |
2.9 | 8.8 | GO:1990430 | extracellular matrix protein binding(GO:1990430) |
2.9 | 58.3 | GO:0017075 | syntaxin-1 binding(GO:0017075) |
2.8 | 19.9 | GO:0005167 | neurotrophin TRK receptor binding(GO:0005167) |
2.8 | 8.4 | GO:0015137 | citrate transmembrane transporter activity(GO:0015137) tricarboxylic acid transmembrane transporter activity(GO:0015142) |
2.8 | 5.6 | GO:0035373 | chondroitin sulfate proteoglycan binding(GO:0035373) |
2.8 | 30.6 | GO:0008331 | high voltage-gated calcium channel activity(GO:0008331) |
2.8 | 8.3 | GO:0019797 | procollagen-proline 3-dioxygenase activity(GO:0019797) |
2.7 | 16.5 | GO:0004385 | guanylate kinase activity(GO:0004385) |
2.7 | 8.0 | GO:0050145 | nucleoside phosphate kinase activity(GO:0050145) |
2.7 | 8.0 | GO:0030144 | alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase activity(GO:0030144) |
2.6 | 84.6 | GO:0005251 | delayed rectifier potassium channel activity(GO:0005251) |
2.6 | 13.0 | GO:0008294 | calcium- and calmodulin-responsive adenylate cyclase activity(GO:0008294) |
2.6 | 13.0 | GO:0019871 | sodium channel inhibitor activity(GO:0019871) |
2.6 | 5.1 | GO:0086008 | voltage-gated potassium channel activity involved in cardiac muscle cell action potential repolarization(GO:0086008) |
2.5 | 5.0 | GO:0097016 | L27 domain binding(GO:0097016) |
2.5 | 19.8 | GO:0051011 | microtubule minus-end binding(GO:0051011) |
2.5 | 12.3 | GO:0003958 | NADPH-hemoprotein reductase activity(GO:0003958) |
2.4 | 31.6 | GO:0004690 | cyclic nucleotide-dependent protein kinase activity(GO:0004690) |
2.4 | 7.3 | GO:0050508 | glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity(GO:0050508) |
2.4 | 7.2 | GO:0030158 | protein xylosyltransferase activity(GO:0030158) |
2.4 | 7.2 | GO:0030899 | calcium-dependent ATPase activity(GO:0030899) |
2.4 | 7.1 | GO:0000309 | nicotinamide-nucleotide adenylyltransferase activity(GO:0000309) nicotinate-nucleotide adenylyltransferase activity(GO:0004515) |
2.3 | 4.6 | GO:0072542 | protein phosphatase activator activity(GO:0072542) |
2.3 | 22.6 | GO:0015172 | acidic amino acid transmembrane transporter activity(GO:0015172) |
2.2 | 13.4 | GO:0034190 | apolipoprotein receptor binding(GO:0034190) |
2.2 | 22.4 | GO:0042577 | lipid phosphatase activity(GO:0042577) |
2.2 | 8.9 | GO:0034056 | estrogen response element binding(GO:0034056) |
2.2 | 10.8 | GO:0005432 | calcium:sodium antiporter activity(GO:0005432) |
2.2 | 8.7 | GO:0046923 | ER retention sequence binding(GO:0046923) |
2.2 | 15.1 | GO:0031821 | G-protein coupled serotonin receptor binding(GO:0031821) |
2.1 | 2.1 | GO:0004924 | oncostatin-M receptor activity(GO:0004924) |
2.1 | 4.2 | GO:0043423 | 3-phosphoinositide-dependent protein kinase binding(GO:0043423) |
2.1 | 4.2 | GO:0004938 | alpha2-adrenergic receptor activity(GO:0004938) |
2.1 | 16.6 | GO:0008599 | protein phosphatase type 1 regulator activity(GO:0008599) |
2.0 | 10.2 | GO:0042609 | CD4 receptor binding(GO:0042609) |
2.0 | 2.0 | GO:0005219 | ryanodine-sensitive calcium-release channel activity(GO:0005219) |
2.0 | 46.5 | GO:0043395 | heparan sulfate proteoglycan binding(GO:0043395) |
2.0 | 25.8 | GO:0050811 | GABA receptor binding(GO:0050811) |
2.0 | 7.9 | GO:1904288 | BAT3 complex binding(GO:1904288) |
2.0 | 11.9 | GO:0005225 | volume-sensitive anion channel activity(GO:0005225) |
2.0 | 5.9 | GO:0000155 | phosphorelay sensor kinase activity(GO:0000155) |
1.9 | 5.8 | GO:0004705 | JUN kinase activity(GO:0004705) SAP kinase activity(GO:0016909) |
1.9 | 34.6 | GO:0005248 | voltage-gated sodium channel activity(GO:0005248) voltage-gated ion channel activity involved in regulation of postsynaptic membrane potential(GO:1905030) |
1.9 | 7.7 | GO:0008273 | calcium, potassium:sodium antiporter activity(GO:0008273) |
1.9 | 5.7 | GO:0072345 | NAADP-sensitive calcium-release channel activity(GO:0072345) |
1.9 | 15.1 | GO:0005068 | transmembrane receptor protein tyrosine kinase adaptor activity(GO:0005068) |
1.9 | 5.6 | GO:0031802 | type 5 metabotropic glutamate receptor binding(GO:0031802) |
1.8 | 7.4 | GO:0030229 | very-low-density lipoprotein particle receptor activity(GO:0030229) |
1.8 | 7.3 | GO:0102345 | 3-hydroxy-behenoyl-CoA dehydratase activity(GO:0102344) 3-hydroxy-lignoceroyl-CoA dehydratase activity(GO:0102345) |
1.8 | 5.5 | GO:0004719 | protein-L-isoaspartate (D-aspartate) O-methyltransferase activity(GO:0004719) |
1.8 | 10.9 | GO:0035312 | 5'-3' exodeoxyribonuclease activity(GO:0035312) |
1.8 | 8.9 | GO:0004994 | somatostatin receptor activity(GO:0004994) |
1.7 | 22.7 | GO:0004993 | G-protein coupled serotonin receptor activity(GO:0004993) serotonin receptor activity(GO:0099589) |
1.7 | 7.0 | GO:0048403 | brain-derived neurotrophic factor binding(GO:0048403) |
1.7 | 53.9 | GO:0015459 | potassium channel regulator activity(GO:0015459) |
1.7 | 38.0 | GO:0005245 | voltage-gated calcium channel activity(GO:0005245) |
1.7 | 5.1 | GO:0047192 | 1-alkylglycerophosphocholine O-acetyltransferase activity(GO:0047192) |
1.7 | 1.7 | GO:0004367 | glycerol-3-phosphate dehydrogenase [NAD+] activity(GO:0004367) |
1.7 | 18.6 | GO:0004707 | MAP kinase activity(GO:0004707) |
1.7 | 46.8 | GO:0001540 | beta-amyloid binding(GO:0001540) |
1.7 | 6.7 | GO:0016715 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced ascorbate as one donor, and incorporation of one atom of oxygen(GO:0016715) |
1.7 | 21.6 | GO:0005337 | nucleoside transmembrane transporter activity(GO:0005337) |
1.7 | 6.6 | GO:0004985 | opioid receptor activity(GO:0004985) |
1.6 | 6.5 | GO:0015016 | [heparan sulfate]-glucosamine N-sulfotransferase activity(GO:0015016) |
1.6 | 6.3 | GO:0004969 | histamine receptor activity(GO:0004969) |
1.6 | 3.2 | GO:0005001 | transmembrane receptor protein tyrosine phosphatase activity(GO:0005001) |
1.6 | 14.1 | GO:0004438 | phosphatidylinositol-3-phosphatase activity(GO:0004438) |
1.5 | 3.1 | GO:0004027 | alcohol sulfotransferase activity(GO:0004027) |
1.5 | 6.1 | GO:0038064 | collagen receptor activity(GO:0038064) |
1.5 | 19.7 | GO:0005242 | inward rectifier potassium channel activity(GO:0005242) |
1.5 | 38.6 | GO:0005104 | fibroblast growth factor receptor binding(GO:0005104) |
1.5 | 8.9 | GO:0008517 | folic acid transporter activity(GO:0008517) |
1.4 | 7.2 | GO:0008179 | adenylate cyclase binding(GO:0008179) |
1.4 | 5.8 | GO:0005042 | netrin receptor activity(GO:0005042) |
1.4 | 11.3 | GO:0030955 | potassium ion binding(GO:0030955) |
1.4 | 4.2 | GO:0047184 | 1-acylglycerophosphocholine O-acyltransferase activity(GO:0047184) |
1.4 | 2.8 | GO:0050816 | phosphothreonine binding(GO:0050816) |
1.4 | 15.1 | GO:0042043 | neurexin family protein binding(GO:0042043) |
1.4 | 25.8 | GO:0045499 | chemorepellent activity(GO:0045499) |
1.3 | 4.0 | GO:0031748 | D1 dopamine receptor binding(GO:0031748) |
1.3 | 4.0 | GO:0089720 | caspase binding(GO:0089720) |
1.3 | 27.8 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
1.3 | 54.2 | GO:0034483 | heparan sulfate sulfotransferase activity(GO:0034483) |
1.3 | 19.2 | GO:0016805 | dipeptidase activity(GO:0016805) |
1.3 | 69.2 | GO:0046921 | alpha-(1->6)-fucosyltransferase activity(GO:0046921) |
1.3 | 8.9 | GO:0001849 | complement component C1q binding(GO:0001849) |
1.3 | 16.4 | GO:0030676 | Rac guanyl-nucleotide exchange factor activity(GO:0030676) |
1.3 | 2.5 | GO:0032564 | dATP binding(GO:0032564) |
1.2 | 2.5 | GO:0002046 | opsin binding(GO:0002046) |
1.2 | 2.5 | GO:1901611 | phosphatidylglycerol binding(GO:1901611) cardiolipin binding(GO:1901612) |
1.2 | 3.7 | GO:0042895 | antibiotic transporter activity(GO:0042895) |
1.2 | 4.9 | GO:0004065 | arylsulfatase activity(GO:0004065) |
1.2 | 17.0 | GO:0005545 | 1-phosphatidylinositol binding(GO:0005545) |
1.2 | 10.8 | GO:0001206 | transcriptional repressor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001206) |
1.2 | 10.8 | GO:0070679 | inositol 1,4,5 trisphosphate binding(GO:0070679) |
1.2 | 4.8 | GO:0035612 | AP-2 adaptor complex binding(GO:0035612) |
1.2 | 13.1 | GO:0004865 | protein serine/threonine phosphatase inhibitor activity(GO:0004865) |
1.2 | 3.6 | GO:0016149 | translation release factor activity, codon specific(GO:0016149) |
1.2 | 2.4 | GO:0019211 | phosphatase activator activity(GO:0019211) |
1.2 | 2.3 | GO:0051425 | PTB domain binding(GO:0051425) |
1.2 | 13.9 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
1.2 | 3.5 | GO:0005148 | prolactin receptor binding(GO:0005148) |
1.2 | 11.6 | GO:0022821 | sodium:proton antiporter activity(GO:0015385) potassium:proton antiporter activity(GO:0015386) potassium ion antiporter activity(GO:0022821) |
1.2 | 4.6 | GO:0004839 | ubiquitin activating enzyme activity(GO:0004839) |
1.1 | 3.4 | GO:0004731 | purine-nucleoside phosphorylase activity(GO:0004731) |
1.1 | 7.9 | GO:0002151 | G-quadruplex RNA binding(GO:0002151) |
1.1 | 13.4 | GO:0008601 | protein phosphatase type 2A regulator activity(GO:0008601) |
1.1 | 12.2 | GO:0048018 | receptor agonist activity(GO:0048018) |
1.1 | 6.6 | GO:0050998 | nitric-oxide synthase binding(GO:0050998) |
1.1 | 9.9 | GO:0016920 | pyroglutamyl-peptidase activity(GO:0016920) |
1.1 | 3.2 | GO:0008046 | axon guidance receptor activity(GO:0008046) |
1.1 | 7.5 | GO:0034711 | inhibin binding(GO:0034711) |
1.1 | 3.2 | GO:0004937 | alpha1-adrenergic receptor activity(GO:0004937) |
1.1 | 11.6 | GO:0008574 | ATP-dependent microtubule motor activity, plus-end-directed(GO:0008574) |
1.0 | 22.9 | GO:0052715 | calmodulin-dependent cyclic-nucleotide phosphodiesterase activity(GO:0004117) cGMP-stimulated cyclic-nucleotide phosphodiesterase activity(GO:0004118) cGMP-inhibited cyclic-nucleotide phosphodiesterase activity(GO:0004119) photoreceptor cyclic-nucleotide phosphodiesterase activity(GO:0004120) 7,8-dihydro-D-neopterin 2',3'-cyclic phosphate phosphodiesterase activity(GO:0044688) inositol phosphosphingolipid phospholipase activity(GO:0052712) inositol phosphorylceramide phospholipase activity(GO:0052713) mannosyl-inositol phosphorylceramide phospholipase activity(GO:0052714) mannosyl-diinositol phosphorylceramide phospholipase activity(GO:0052715) |
1.0 | 3.1 | GO:0016823 | hydrolase activity, acting on acid carbon-carbon bonds(GO:0016822) hydrolase activity, acting on acid carbon-carbon bonds, in ketonic substances(GO:0016823) |
1.0 | 4.1 | GO:0098634 | protein binding involved in cell-matrix adhesion(GO:0098634) |
1.0 | 9.2 | GO:0001091 | RNA polymerase II basal transcription factor binding(GO:0001091) |
1.0 | 5.1 | GO:1990254 | keratin filament binding(GO:1990254) |
1.0 | 6.1 | GO:0031995 | insulin-like growth factor II binding(GO:0031995) |
1.0 | 5.0 | GO:0016901 | oxidoreductase activity, acting on the CH-OH group of donors, quinone or similar compound as acceptor(GO:0016901) |
1.0 | 1.0 | GO:0031544 | peptidyl-proline 3-dioxygenase activity(GO:0031544) |
1.0 | 5.9 | GO:0070191 | methionine-R-sulfoxide reductase activity(GO:0070191) |
1.0 | 9.7 | GO:0003993 | acid phosphatase activity(GO:0003993) |
1.0 | 24.3 | GO:0050699 | WW domain binding(GO:0050699) |
1.0 | 11.7 | GO:0008146 | sulfotransferase activity(GO:0008146) |
1.0 | 1.9 | GO:0055131 | C3HC4-type RING finger domain binding(GO:0055131) |
0.9 | 3.8 | GO:0005025 | transforming growth factor beta receptor activity, type I(GO:0005025) |
0.9 | 11.3 | GO:0005272 | sodium channel activity(GO:0005272) |
0.9 | 0.9 | GO:0017108 | 5'-flap endonuclease activity(GO:0017108) |
0.9 | 3.7 | GO:0033192 | calmodulin-dependent protein phosphatase activity(GO:0033192) |
0.9 | 10.2 | GO:0080025 | phosphatidylinositol-3,5-bisphosphate binding(GO:0080025) |
0.9 | 1.9 | GO:0042281 | dolichyl pyrophosphate Man9GlcNAc2 alpha-1,3-glucosyltransferase activity(GO:0042281) |
0.9 | 18.6 | GO:0003785 | actin monomer binding(GO:0003785) |
0.9 | 2.8 | GO:0016520 | growth hormone-releasing hormone receptor activity(GO:0016520) |
0.9 | 2.8 | GO:0004739 | pyruvate dehydrogenase (acetyl-transferring) activity(GO:0004739) |
0.9 | 7.3 | GO:0000900 | translation repressor activity, nucleic acid binding(GO:0000900) |
0.9 | 0.9 | GO:0001601 | peptide YY receptor activity(GO:0001601) |
0.9 | 2.7 | GO:0019153 | protein-disulfide reductase (glutathione) activity(GO:0019153) |
0.9 | 4.5 | GO:0008195 | phosphatidate phosphatase activity(GO:0008195) |
0.9 | 2.7 | GO:0008427 | calcium-dependent protein kinase inhibitor activity(GO:0008427) |
0.9 | 23.5 | GO:0030507 | spectrin binding(GO:0030507) |
0.9 | 2.7 | GO:0005483 | soluble NSF attachment protein activity(GO:0005483) |
0.9 | 4.4 | GO:0005388 | calcium-transporting ATPase activity(GO:0005388) |
0.9 | 33.4 | GO:0005546 | phosphatidylinositol-4,5-bisphosphate binding(GO:0005546) |
0.9 | 10.5 | GO:0019841 | retinol binding(GO:0019841) |
0.9 | 0.9 | GO:0051870 | methotrexate binding(GO:0051870) |
0.9 | 2.6 | GO:0016774 | phosphotransferase activity, carboxyl group as acceptor(GO:0016774) |
0.8 | 2.5 | GO:0008260 | 3-oxoacid CoA-transferase activity(GO:0008260) |
0.8 | 3.3 | GO:0008934 | inositol monophosphate 1-phosphatase activity(GO:0008934) inositol monophosphate 3-phosphatase activity(GO:0052832) inositol monophosphate 4-phosphatase activity(GO:0052833) inositol monophosphate phosphatase activity(GO:0052834) |
0.8 | 4.1 | GO:0019992 | diacylglycerol binding(GO:0019992) |
0.8 | 2.4 | GO:1990460 | leptin receptor binding(GO:1990460) |
0.8 | 8.1 | GO:0004526 | ribonuclease P activity(GO:0004526) |
0.8 | 1.6 | GO:0070840 | dynein complex binding(GO:0070840) |
0.8 | 4.1 | GO:0016004 | phospholipase activator activity(GO:0016004) |
0.8 | 10.5 | GO:0008553 | hydrogen-exporting ATPase activity, phosphorylative mechanism(GO:0008553) |
0.8 | 3.2 | GO:0004652 | polynucleotide adenylyltransferase activity(GO:0004652) |
0.8 | 3.2 | GO:0032795 | heterotrimeric G-protein binding(GO:0032795) |
0.8 | 2.4 | GO:0004999 | vasoactive intestinal polypeptide receptor activity(GO:0004999) |
0.8 | 4.0 | GO:0001884 | pyrimidine nucleoside binding(GO:0001884) |
0.8 | 15.1 | GO:0017080 | sodium channel regulator activity(GO:0017080) |
0.8 | 3.9 | GO:0004565 | beta-galactosidase activity(GO:0004565) |
0.8 | 8.5 | GO:0004143 | diacylglycerol kinase activity(GO:0004143) |
0.8 | 2.3 | GO:0035939 | microsatellite binding(GO:0035939) |
0.8 | 3.8 | GO:0004983 | neuropeptide Y receptor activity(GO:0004983) |
0.7 | 7.5 | GO:0008301 | DNA binding, bending(GO:0008301) |
0.7 | 3.0 | GO:0016907 | G-protein coupled acetylcholine receptor activity(GO:0016907) |
0.7 | 1.5 | GO:0050815 | phosphoserine binding(GO:0050815) |
0.7 | 0.7 | GO:0051378 | serotonin binding(GO:0051378) |
0.7 | 10.4 | GO:0004889 | acetylcholine-activated cation-selective channel activity(GO:0004889) |
0.7 | 20.0 | GO:0019894 | kinesin binding(GO:0019894) |
0.7 | 11.8 | GO:0008376 | acetylgalactosaminyltransferase activity(GO:0008376) |
0.7 | 10.2 | GO:0043274 | phospholipase binding(GO:0043274) |
0.7 | 15.3 | GO:0043015 | gamma-tubulin binding(GO:0043015) |
0.7 | 2.2 | GO:0008073 | ornithine decarboxylase inhibitor activity(GO:0008073) |
0.7 | 15.8 | GO:0004181 | metallocarboxypeptidase activity(GO:0004181) |
0.7 | 10.0 | GO:0005243 | gap junction channel activity(GO:0005243) |
0.7 | 4.2 | GO:0070991 | medium-chain-acyl-CoA dehydrogenase activity(GO:0070991) |
0.7 | 2.1 | GO:0008454 | alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity(GO:0008454) |
0.7 | 2.8 | GO:0015198 | oligopeptide transporter activity(GO:0015198) |
0.7 | 6.1 | GO:0001162 | RNA polymerase II intronic transcription regulatory region sequence-specific DNA binding(GO:0001162) |
0.7 | 24.4 | GO:0005544 | calcium-dependent phospholipid binding(GO:0005544) |
0.7 | 2.7 | GO:0043237 | laminin-1 binding(GO:0043237) |
0.7 | 6.7 | GO:0051787 | misfolded protein binding(GO:0051787) |
0.7 | 2.0 | GO:0003987 | acetate-CoA ligase activity(GO:0003987) |
0.7 | 12.6 | GO:0071837 | HMG box domain binding(GO:0071837) |
0.7 | 3.3 | GO:0008429 | phosphatidylethanolamine binding(GO:0008429) |
0.7 | 1.3 | GO:0071209 | U7 snRNA binding(GO:0071209) |
0.6 | 1.9 | GO:0004980 | melanocyte-stimulating hormone receptor activity(GO:0004980) |
0.6 | 1.9 | GO:0034513 | box H/ACA snoRNA binding(GO:0034513) |
0.6 | 1.9 | GO:0008898 | S-adenosylmethionine-homocysteine S-methyltransferase activity(GO:0008898) |
0.6 | 5.7 | GO:0008474 | palmitoyl-(protein) hydrolase activity(GO:0008474) palmitoyl hydrolase activity(GO:0098599) |
0.6 | 3.1 | GO:0019784 | NEDD8-specific protease activity(GO:0019784) |
0.6 | 1.9 | GO:0003726 | double-stranded RNA adenosine deaminase activity(GO:0003726) |
0.6 | 2.5 | GO:0017162 | aryl hydrocarbon receptor binding(GO:0017162) |
0.6 | 1.9 | GO:0032139 | dinucleotide insertion or deletion binding(GO:0032139) |
0.6 | 13.0 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
0.6 | 4.3 | GO:0031078 | histone deacetylase activity (H3-K14 specific)(GO:0031078) NAD-dependent histone deacetylase activity (H3-K14 specific)(GO:0032041) |
0.6 | 3.6 | GO:0034790 | enoyl-[acyl-carrier-protein] reductase activity(GO:0016631) 2,3-dihydroxy-2,3-dihydro-phenylpropionate dehydrogenase activity(GO:0018498) cis-2,3-dihydrodiol DDT dehydrogenase activity(GO:0018499) trans-9R,10R-dihydrodiolphenanthrene dehydrogenase activity(GO:0018500) cis-chlorobenzene dihydrodiol dehydrogenase activity(GO:0018501) 2,5-dichloro-2,5-cyclohexadiene-1,4-diol dehydrogenase activity(GO:0018502) trans-1,2-dihydrodiolphenanthrene dehydrogenase activity(GO:0018503) 3,4-dihydroxy-3,4-dihydrofluorene dehydrogenase activity(GO:0034790) benzo(a)pyrene-trans-11,12-dihydrodiol dehydrogenase activity(GO:0034805) benzo(a)pyrene-cis-4,5-dihydrodiol dehydrogenase activity(GO:0034809) citronellyl-CoA dehydrogenase activity(GO:0034824) menthone dehydrogenase activity(GO:0034838) phthalate 3,4-cis-dihydrodiol dehydrogenase activity(GO:0034912) cinnamate reductase activity(GO:0043786) NADPH-dependent curcumin reductase activity(GO:0052849) NADPH-dependent dihydrocurcumin reductase activity(GO:0052850) |
0.6 | 2.4 | GO:0004528 | phosphodiesterase I activity(GO:0004528) |
0.6 | 1.8 | GO:0016649 | electron-transferring-flavoprotein dehydrogenase activity(GO:0004174) oxidoreductase activity, acting on the CH-NH group of donors, quinone or similar compound as acceptor(GO:0016649) |
0.6 | 1.2 | GO:0015222 | serotonin transmembrane transporter activity(GO:0015222) |
0.6 | 16.6 | GO:0005184 | neuropeptide hormone activity(GO:0005184) |
0.6 | 2.3 | GO:0030628 | pre-mRNA 3'-splice site binding(GO:0030628) |
0.6 | 3.5 | GO:0035014 | phosphatidylinositol 3-kinase regulator activity(GO:0035014) |
0.6 | 1.8 | GO:0005290 | L-histidine transmembrane transporter activity(GO:0005290) |
0.6 | 1.2 | GO:0070097 | delta-catenin binding(GO:0070097) |
0.6 | 2.9 | GO:0001665 | alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity(GO:0001665) |
0.6 | 9.3 | GO:0004012 | phospholipid-translocating ATPase activity(GO:0004012) |
0.6 | 2.9 | GO:0005138 | interleukin-6 receptor binding(GO:0005138) |
0.6 | 1.7 | GO:0016882 | cyclo-ligase activity(GO:0016882) |
0.6 | 15.5 | GO:0008188 | neuropeptide receptor activity(GO:0008188) |
0.6 | 8.9 | GO:0004864 | protein phosphatase inhibitor activity(GO:0004864) |
0.5 | 3.3 | GO:0016421 | CoA carboxylase activity(GO:0016421) |
0.5 | 2.2 | GO:0005131 | growth hormone receptor binding(GO:0005131) |
0.5 | 1.6 | GO:0015111 | iodide transmembrane transporter activity(GO:0015111) |
0.5 | 12.9 | GO:0042169 | SH2 domain binding(GO:0042169) |
0.5 | 3.2 | GO:0033691 | sialic acid binding(GO:0033691) |
0.5 | 3.2 | GO:0005112 | Notch binding(GO:0005112) |
0.5 | 14.4 | GO:0035254 | glutamate receptor binding(GO:0035254) |
0.5 | 3.1 | GO:0004176 | ATP-dependent peptidase activity(GO:0004176) |
0.5 | 5.7 | GO:0045295 | gamma-catenin binding(GO:0045295) |
0.5 | 1.6 | GO:0016174 | NAD(P)H oxidase activity(GO:0016174) |
0.5 | 10.3 | GO:0005537 | mannose binding(GO:0005537) |
0.5 | 3.0 | GO:0016681 | ubiquinol-cytochrome-c reductase activity(GO:0008121) oxidoreductase activity, acting on diphenols and related substances as donors, cytochrome as acceptor(GO:0016681) |
0.5 | 1.5 | GO:0043262 | adenosine-diphosphatase activity(GO:0043262) |
0.5 | 1.0 | GO:0008545 | JUN kinase kinase activity(GO:0008545) |
0.5 | 2.0 | GO:0015220 | choline transmembrane transporter activity(GO:0015220) |
0.5 | 7.8 | GO:0015925 | galactosidase activity(GO:0015925) |
0.5 | 5.8 | GO:0070016 | armadillo repeat domain binding(GO:0070016) |
0.5 | 3.8 | GO:0005246 | calcium channel regulator activity(GO:0005246) |
0.5 | 1.0 | GO:0016880 | acid-ammonia (or amide) ligase activity(GO:0016880) |
0.5 | 1.4 | GO:0004813 | alanine-tRNA ligase activity(GO:0004813) |
0.5 | 6.0 | GO:0046875 | ephrin receptor binding(GO:0046875) |
0.5 | 5.5 | GO:0043733 | alkylbase DNA N-glycosylase activity(GO:0003905) DNA-3-methylbase glycosylase activity(GO:0043733) |
0.5 | 1.4 | GO:0045545 | syndecan binding(GO:0045545) |
0.5 | 1.4 | GO:0008475 | procollagen-lysine 5-dioxygenase activity(GO:0008475) |
0.5 | 1.4 | GO:0016647 | oxidoreductase activity, acting on the CH-NH group of donors, oxygen as acceptor(GO:0016647) |
0.4 | 5.4 | GO:0016854 | racemase and epimerase activity(GO:0016854) |
0.4 | 1.7 | GO:0008379 | thioredoxin peroxidase activity(GO:0008379) |
0.4 | 7.3 | GO:0031489 | myosin V binding(GO:0031489) |
0.4 | 1.7 | GO:0016624 | oxidoreductase activity, acting on the aldehyde or oxo group of donors, disulfide as acceptor(GO:0016624) |
0.4 | 2.5 | GO:0015193 | L-proline transmembrane transporter activity(GO:0015193) |
0.4 | 2.5 | GO:0043023 | ribosomal large subunit binding(GO:0043023) |
0.4 | 2.1 | GO:0015349 | thyroid hormone transmembrane transporter activity(GO:0015349) |
0.4 | 0.8 | GO:0031735 | CCR10 chemokine receptor binding(GO:0031735) |
0.4 | 1.2 | GO:0098518 | polynucleotide phosphatase activity(GO:0098518) |
0.4 | 1.6 | GO:0004449 | isocitrate dehydrogenase (NAD+) activity(GO:0004449) |
0.4 | 2.1 | GO:0003847 | 1-alkyl-2-acetylglycerophosphocholine esterase activity(GO:0003847) |
0.4 | 0.8 | GO:0008240 | tripeptidyl-peptidase activity(GO:0008240) |
0.4 | 19.5 | GO:0044823 | integrase activity(GO:0008907) T/G mismatch-specific endonuclease activity(GO:0043765) retroviral integrase activity(GO:0044823) retroviral 3' processing activity(GO:0044824) |
0.4 | 2.0 | GO:0017040 | ceramidase activity(GO:0017040) |
0.4 | 2.0 | GO:0036402 | proteasome-activating ATPase activity(GO:0036402) |
0.4 | 1.2 | GO:0004663 | Rab geranylgeranyltransferase activity(GO:0004663) |
0.4 | 10.3 | GO:0017046 | peptide hormone binding(GO:0017046) |
0.4 | 2.0 | GO:0030594 | neurotransmitter receptor activity(GO:0030594) |
0.4 | 0.4 | GO:0032422 | purine-rich negative regulatory element binding(GO:0032422) |
0.4 | 1.6 | GO:0061505 | DNA topoisomerase type II (ATP-hydrolyzing) activity(GO:0003918) DNA topoisomerase II activity(GO:0061505) |
0.4 | 1.2 | GO:2001069 | glycogen binding(GO:2001069) |
0.4 | 1.2 | GO:0051377 | mannose-ethanolamine phosphotransferase activity(GO:0051377) |
0.4 | 1.9 | GO:0004708 | MAP kinase kinase activity(GO:0004708) |
0.4 | 4.5 | GO:0035198 | miRNA binding(GO:0035198) |
0.4 | 2.6 | GO:0004931 | extracellular ATP-gated cation channel activity(GO:0004931) ATP-gated ion channel activity(GO:0035381) |
0.4 | 3.7 | GO:0070034 | telomerase RNA binding(GO:0070034) |
0.4 | 1.1 | GO:0019862 | IgA binding(GO:0019862) |
0.4 | 4.1 | GO:0070402 | NADPH binding(GO:0070402) |
0.4 | 1.8 | GO:0030976 | thiamine pyrophosphate binding(GO:0030976) |
0.4 | 1.8 | GO:0071723 | lipopeptide binding(GO:0071723) |
0.4 | 7.3 | GO:0005212 | structural constituent of eye lens(GO:0005212) |
0.4 | 3.6 | GO:0005227 | calcium activated cation channel activity(GO:0005227) |
0.4 | 1.1 | GO:0072349 | modified amino acid transmembrane transporter activity(GO:0072349) |
0.4 | 6.9 | GO:0008483 | transaminase activity(GO:0008483) |
0.4 | 1.1 | GO:0005275 | amine transmembrane transporter activity(GO:0005275) |
0.3 | 3.1 | GO:0035250 | UDP-galactosyltransferase activity(GO:0035250) |
0.3 | 1.4 | GO:0008502 | melatonin receptor activity(GO:0008502) |
0.3 | 2.1 | GO:0030957 | Tat protein binding(GO:0030957) |
0.3 | 25.0 | GO:0004725 | protein tyrosine phosphatase activity(GO:0004725) |
0.3 | 7.8 | GO:0030971 | receptor tyrosine kinase binding(GO:0030971) |
0.3 | 1.0 | GO:0004332 | fructose-bisphosphate aldolase activity(GO:0004332) |
0.3 | 6.6 | GO:0004198 | calcium-dependent cysteine-type endopeptidase activity(GO:0004198) |
0.3 | 1.0 | GO:0019776 | Atg8 ligase activity(GO:0019776) |
0.3 | 4.3 | GO:0050750 | low-density lipoprotein particle receptor binding(GO:0050750) |
0.3 | 1.3 | GO:0070728 | leucine binding(GO:0070728) |
0.3 | 2.6 | GO:0052872 | tocotrienol omega-hydroxylase activity(GO:0052872) |
0.3 | 3.6 | GO:0008796 | bis(5'-nucleosyl)-tetraphosphatase activity(GO:0008796) |
0.3 | 4.2 | GO:0017128 | phospholipid scramblase activity(GO:0017128) |
0.3 | 0.6 | GO:0015319 | sodium:inorganic phosphate symporter activity(GO:0015319) |
0.3 | 1.3 | GO:0008559 | xenobiotic-transporting ATPase activity(GO:0008559) |
0.3 | 1.6 | GO:0034452 | dynactin binding(GO:0034452) |
0.3 | 10.5 | GO:0043022 | ribosome binding(GO:0043022) |
0.3 | 3.3 | GO:0016917 | GABA receptor activity(GO:0016917) |
0.3 | 2.1 | GO:0051428 | peptide hormone receptor binding(GO:0051428) |
0.3 | 3.5 | GO:0044183 | protein binding involved in protein folding(GO:0044183) |
0.3 | 0.3 | GO:1901474 | azole transporter activity(GO:0045118) azole transmembrane transporter activity(GO:1901474) |
0.3 | 1.5 | GO:0004467 | long-chain fatty acid-CoA ligase activity(GO:0004467) |
0.3 | 0.3 | GO:0035851 | Krueppel-associated box domain binding(GO:0035851) |
0.3 | 1.1 | GO:0031493 | nucleosomal histone binding(GO:0031493) |
0.3 | 6.1 | GO:0001105 | RNA polymerase II transcription coactivator activity(GO:0001105) |
0.3 | 1.1 | GO:0004594 | pantothenate kinase activity(GO:0004594) |
0.3 | 0.8 | GO:0001161 | intronic transcription regulatory region sequence-specific DNA binding(GO:0001161) |
0.3 | 10.3 | GO:0005080 | protein kinase C binding(GO:0005080) |
0.3 | 1.3 | GO:0042923 | neuropeptide binding(GO:0042923) |
0.3 | 25.8 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
0.3 | 1.8 | GO:0004622 | lysophospholipase activity(GO:0004622) |
0.3 | 0.8 | GO:0004045 | aminoacyl-tRNA hydrolase activity(GO:0004045) |
0.3 | 2.0 | GO:0031210 | phosphatidylcholine binding(GO:0031210) |
0.3 | 1.0 | GO:0004488 | methylenetetrahydrofolate dehydrogenase (NADP+) activity(GO:0004488) |
0.3 | 0.3 | GO:0016743 | carboxyl- or carbamoyltransferase activity(GO:0016743) |
0.3 | 1.8 | GO:0005522 | profilin binding(GO:0005522) |
0.3 | 0.8 | GO:0008900 | hydrogen:potassium-exchanging ATPase activity(GO:0008900) |
0.2 | 10.2 | GO:0051082 | unfolded protein binding(GO:0051082) |
0.2 | 2.2 | GO:0031681 | G-protein beta-subunit binding(GO:0031681) |
0.2 | 0.5 | GO:0031685 | adenosine receptor binding(GO:0031685) |
0.2 | 0.5 | GO:0004886 | 9-cis retinoic acid receptor activity(GO:0004886) |
0.2 | 0.7 | GO:0034562 | mono-butyltin dioxygenase activity(GO:0018586) tri-n-butyltin dioxygenase activity(GO:0018588) di-n-butyltin dioxygenase activity(GO:0018589) methylsilanetriol hydroxylase activity(GO:0018590) methyl tertiary butyl ether 3-monooxygenase activity(GO:0018591) 4-nitrocatechol 4-monooxygenase activity(GO:0018592) 4-chlorophenoxyacetate monooxygenase activity(GO:0018593) tert-butanol 2-monooxygenase activity(GO:0018594) alpha-pinene monooxygenase activity(GO:0018595) dimethylsilanediol hydroxylase activity(GO:0018596) ammonia monooxygenase activity(GO:0018597) hydroxymethylsilanetriol oxidase activity(GO:0018598) 2-hydroxyisobutyrate 3-monooxygenase activity(GO:0018599) alpha-pinene dehydrogenase activity(GO:0018600) bisphenol A hydroxylase B activity(GO:0034559) 2,2-bis(4-hydroxyphenyl)-1-propanol hydroxylase activity(GO:0034562) 9-fluorenone-3,4-dioxygenase activity(GO:0034786) anthracene 9,10-dioxygenase activity(GO:0034816) 2-(methylthio)benzothiazole monooxygenase activity(GO:0034857) 2-hydroxybenzothiazole monooxygenase activity(GO:0034858) benzothiazole monooxygenase activity(GO:0034859) 2,6-dihydroxybenzothiazole monooxygenase activity(GO:0034862) pinacolone 5-monooxygenase activity(GO:0034870) thioacetamide S-oxygenase activity(GO:0034873) thioacetamide S-oxide S-oxygenase activity(GO:0034874) endosulfan monooxygenase I activity(GO:0034888) N-nitrodimethylamine hydroxylase activity(GO:0034893) 4-(1-ethyl-1,4-dimethyl-pentyl)phenol monoxygenase activity(GO:0034897) endosulfan ether monooxygenase activity(GO:0034903) pyrene 4,5-monooxygenase activity(GO:0034925) pyrene 1,2-monooxygenase activity(GO:0034927) 1-hydroxypyrene 6,7-monooxygenase activity(GO:0034928) 1-hydroxypyrene 7,8-monooxygenase activity(GO:0034929) phenylboronic acid monooxygenase activity(GO:0034950) spheroidene monooxygenase activity(GO:0043823) |
0.2 | 0.7 | GO:0008889 | glycerophosphodiester phosphodiesterase activity(GO:0008889) |
0.2 | 1.7 | GO:0070181 | small ribosomal subunit rRNA binding(GO:0070181) |
0.2 | 12.2 | GO:0005089 | Rho guanyl-nucleotide exchange factor activity(GO:0005089) |
0.2 | 1.9 | GO:0016861 | intramolecular oxidoreductase activity, interconverting aldoses and ketoses(GO:0016861) |
0.2 | 3.2 | GO:0030275 | LRR domain binding(GO:0030275) |
0.2 | 0.9 | GO:0008486 | diphosphoinositol-polyphosphate diphosphatase activity(GO:0008486) |
0.2 | 0.7 | GO:0036042 | long-chain fatty acyl-CoA binding(GO:0036042) |
0.2 | 0.9 | GO:0004370 | glycerol kinase activity(GO:0004370) |
0.2 | 0.7 | GO:0042289 | MHC class II protein binding(GO:0042289) |
0.2 | 0.2 | GO:0000253 | 3-keto sterol reductase activity(GO:0000253) |
0.2 | 0.9 | GO:0010997 | anaphase-promoting complex binding(GO:0010997) |
0.2 | 0.9 | GO:0047023 | androsterone dehydrogenase activity(GO:0047023) |
0.2 | 2.3 | GO:0008519 | ammonium transmembrane transporter activity(GO:0008519) |
0.2 | 7.7 | GO:0051219 | phosphoprotein binding(GO:0051219) |
0.2 | 2.0 | GO:0015643 | toxic substance binding(GO:0015643) |
0.2 | 1.8 | GO:0009881 | photoreceptor activity(GO:0009881) |
0.2 | 1.6 | GO:0015298 | solute:cation antiporter activity(GO:0015298) |
0.2 | 0.2 | GO:0070699 | type II activin receptor binding(GO:0070699) |
0.2 | 1.0 | GO:0004111 | creatine kinase activity(GO:0004111) |
0.2 | 4.8 | GO:0017022 | myosin binding(GO:0017022) |
0.2 | 7.0 | GO:0016667 | oxidoreductase activity, acting on a sulfur group of donors(GO:0016667) |
0.2 | 0.8 | GO:0016888 | endodeoxyribonuclease activity, producing 5'-phosphomonoesters(GO:0016888) |
0.2 | 3.8 | GO:0048306 | calcium-dependent protein binding(GO:0048306) |
0.2 | 0.6 | GO:0016508 | long-chain-enoyl-CoA hydratase activity(GO:0016508) |
0.2 | 0.6 | GO:1901702 | urate transmembrane transporter activity(GO:0015143) salt transmembrane transporter activity(GO:1901702) |
0.2 | 0.4 | GO:0042979 | ornithine decarboxylase regulator activity(GO:0042979) |
0.2 | 0.4 | GO:0016595 | glutamate binding(GO:0016595) |
0.2 | 0.5 | GO:0004942 | anaphylatoxin receptor activity(GO:0004942) |
0.2 | 2.6 | GO:0043014 | alpha-tubulin binding(GO:0043014) |
0.2 | 0.2 | GO:0008413 | 8-oxo-7,8-dihydroguanosine triphosphate pyrophosphatase activity(GO:0008413) |
0.2 | 1.1 | GO:0003688 | DNA replication origin binding(GO:0003688) |
0.2 | 0.6 | GO:1904264 | ubiquitin protein ligase activity involved in ERAD pathway(GO:1904264) |
0.2 | 0.5 | GO:0043199 | sulfate binding(GO:0043199) |
0.1 | 1.0 | GO:0016714 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced pteridine as one donor, and incorporation of one atom of oxygen(GO:0016714) |
0.1 | 6.4 | GO:0044325 | ion channel binding(GO:0044325) |
0.1 | 0.6 | GO:0050693 | LBD domain binding(GO:0050693) |
0.1 | 0.3 | GO:0052658 | inositol-1,4,5-trisphosphate 5-phosphatase activity(GO:0052658) |
0.1 | 0.4 | GO:0016015 | morphogen activity(GO:0016015) |
0.1 | 0.4 | GO:1990050 | phosphatidic acid transporter activity(GO:1990050) |
0.1 | 0.4 | GO:0016615 | malate dehydrogenase activity(GO:0016615) |
0.1 | 3.3 | GO:0052770 | coenzyme F390-A hydrolase activity(GO:0052770) coenzyme F390-G hydrolase activity(GO:0052771) |
0.1 | 0.4 | GO:0004833 | tryptophan 2,3-dioxygenase activity(GO:0004833) |
0.1 | 2.1 | GO:0019003 | GDP binding(GO:0019003) |
0.1 | 0.1 | GO:0097603 | temperature-gated ion channel activity(GO:0097603) |
0.1 | 0.1 | GO:0004571 | mannosyl-oligosaccharide 1,2-alpha-mannosidase activity(GO:0004571) |
0.1 | 0.2 | GO:0035175 | histone kinase activity (H3-S10 specific)(GO:0035175) |
0.1 | 5.9 | GO:0004896 | cytokine receptor activity(GO:0004896) |
0.1 | 0.4 | GO:0016623 | aldehyde oxidase activity(GO:0004031) oxidoreductase activity, acting on the aldehyde or oxo group of donors, oxygen as acceptor(GO:0016623) |
0.1 | 0.5 | GO:0019958 | C-X-C chemokine binding(GO:0019958) |
0.1 | 0.5 | GO:0004758 | serine C-palmitoyltransferase activity(GO:0004758) |
0.1 | 0.3 | GO:0080130 | L-phenylalanine:2-oxoglutarate aminotransferase activity(GO:0080130) |
0.1 | 0.6 | GO:0050542 | icosanoid binding(GO:0050542) fatty acid derivative binding(GO:1901567) |
0.1 | 0.9 | GO:0008409 | 5'-3' exonuclease activity(GO:0008409) |
0.1 | 0.6 | GO:0004982 | N-formyl peptide receptor activity(GO:0004982) |
0.1 | 0.3 | GO:0004551 | nucleotide diphosphatase activity(GO:0004551) |
0.1 | 0.5 | GO:0030371 | translation repressor activity(GO:0030371) |
0.1 | 0.4 | GO:0005315 | inorganic phosphate transmembrane transporter activity(GO:0005315) |
0.1 | 0.4 | GO:0005328 | neurotransmitter:sodium symporter activity(GO:0005328) |
0.1 | 0.6 | GO:0004623 | phospholipase A2 activity(GO:0004623) |
0.1 | 1.3 | GO:0001594 | trace-amine receptor activity(GO:0001594) |
0.1 | 0.3 | GO:0043208 | glycosphingolipid binding(GO:0043208) |
0.1 | 0.7 | GO:0004017 | adenylate kinase activity(GO:0004017) |
0.1 | 0.2 | GO:0004022 | alcohol dehydrogenase (NAD) activity(GO:0004022) |
0.1 | 0.2 | GO:0004376 | glycolipid mannosyltransferase activity(GO:0004376) |
0.1 | 0.4 | GO:0005166 | neurotrophin p75 receptor binding(GO:0005166) |
0.1 | 0.2 | GO:0001025 | RNA polymerase III transcription factor binding(GO:0001025) |
0.1 | 0.4 | GO:0051959 | dynein light intermediate chain binding(GO:0051959) |
0.1 | 0.1 | GO:0035870 | dITP diphosphatase activity(GO:0035870) |
0.1 | 27.6 | GO:0004930 | G-protein coupled receptor activity(GO:0004930) |
0.1 | 0.3 | GO:0004634 | phosphopyruvate hydratase activity(GO:0004634) |
0.1 | 0.3 | GO:0031849 | olfactory receptor binding(GO:0031849) |
0.1 | 0.2 | GO:0016713 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced iron-sulfur protein as one donor, and incorporation of one atom of oxygen(GO:0016713) |
0.1 | 0.1 | GO:0070905 | serine binding(GO:0070905) |
0.0 | 0.1 | GO:0043919 | 4-hydroxybenzoate octaprenyltransferase activity(GO:0008412) protoheme IX farnesyltransferase activity(GO:0008495) (S)-2,3-di-O-geranylgeranylglyceryl phosphate synthase activity(GO:0043888) cadaverine aminopropyltransferase activity(GO:0043918) agmatine aminopropyltransferase activity(GO:0043919) 1,4-dihydroxy-2-naphthoate octaprenyltransferase activity(GO:0046428) trans-pentaprenyltranstransferase activity(GO:0048045) ATP dimethylallyltransferase activity(GO:0052622) ADP dimethylallyltransferase activity(GO:0052623) |
0.0 | 0.7 | GO:0016755 | transferase activity, transferring amino-acyl groups(GO:0016755) |
0.0 | 0.3 | GO:0008484 | sulfuric ester hydrolase activity(GO:0008484) |
0.0 | 12.7 | GO:0005509 | calcium ion binding(GO:0005509) |
0.0 | 0.1 | GO:0030621 | U4 snRNA binding(GO:0030621) |
0.0 | 11.2 | GO:0005549 | odorant binding(GO:0005549) |
0.0 | 0.8 | GO:0016709 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen(GO:0016709) |
0.0 | 0.2 | GO:0030742 | GTP-dependent protein binding(GO:0030742) |
0.0 | 0.1 | GO:0004582 | dolichyl-phosphate beta-D-mannosyltransferase activity(GO:0004582) |
0.0 | 0.1 | GO:0050501 | hyaluronan synthase activity(GO:0050501) |
0.0 | 0.0 | GO:0008401 | retinoic acid 4-hydroxylase activity(GO:0008401) |
0.0 | 0.1 | GO:0043008 | ATP-dependent protein binding(GO:0043008) |
0.0 | 0.0 | GO:0004802 | transketolase activity(GO:0004802) |
0.0 | 0.4 | GO:0001106 | RNA polymerase II transcription corepressor activity(GO:0001106) |
0.0 | 0.5 | GO:0003954 | NADH dehydrogenase activity(GO:0003954) |
0.0 | 0.3 | GO:0051990 | (R)-2-hydroxyglutarate dehydrogenase activity(GO:0051990) |
0.0 | 0.1 | GO:0016018 | cyclosporin A binding(GO:0016018) |
0.0 | 2.2 | GO:0003924 | GTPase activity(GO:0003924) |
0.0 | 0.2 | GO:0030515 | snoRNA binding(GO:0030515) |
0.0 | 0.1 | GO:1990380 | Lys48-specific deubiquitinase activity(GO:1990380) |
0.0 | 0.0 | GO:0051021 | GDP-dissociation inhibitor binding(GO:0051021) |
0.0 | 0.0 | GO:0015157 | sucrose:proton symporter activity(GO:0008506) sucrose transmembrane transporter activity(GO:0008515) disaccharide transmembrane transporter activity(GO:0015154) oligosaccharide transmembrane transporter activity(GO:0015157) |
0.0 | 0.1 | GO:0005092 | GDP-dissociation inhibitor activity(GO:0005092) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
4.6 | 4.6 | PID PDGFRA PATHWAY | PDGFR-alpha signaling pathway |
2.2 | 32.8 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
1.9 | 29.2 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
1.7 | 49.7 | PID NETRIN PATHWAY | Netrin-mediated signaling events |
1.5 | 12.0 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
1.4 | 15.3 | PID ARF6 DOWNSTREAM PATHWAY | Arf6 downstream pathway |
1.4 | 35.2 | ST GRANULE CELL SURVIVAL PATHWAY | Granule Cell Survival Pathway is a specific case of more general PAC1 Receptor Pathway. |
1.2 | 39.5 | ST WNT BETA CATENIN PATHWAY | Wnt/beta-catenin Pathway |
1.2 | 1.2 | PID RANBP2 PATHWAY | Sumoylation by RanBP2 regulates transcriptional repression |
1.2 | 10.4 | PID S1P S1P4 PATHWAY | S1P4 pathway |
1.1 | 1.1 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
1.0 | 19.9 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
1.0 | 3.1 | ST G ALPHA S PATHWAY | G alpha s Pathway |
1.0 | 16.1 | PID RET PATHWAY | Signaling events regulated by Ret tyrosine kinase |
0.9 | 24.7 | PID EPHA FWDPATHWAY | EPHA forward signaling |
0.9 | 3.7 | PID ECADHERIN KERATINOCYTE PATHWAY | E-cadherin signaling in keratinocytes |
0.9 | 43.9 | PID TRKR PATHWAY | Neurotrophic factor-mediated Trk receptor signaling |
0.9 | 22.6 | PID ERBB1 INTERNALIZATION PATHWAY | Internalization of ErbB1 |
0.8 | 3.1 | PID PI3K PLC TRK PATHWAY | Trk receptor signaling mediated by PI3K and PLC-gamma |
0.8 | 4.6 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
0.7 | 0.7 | PID S1P S1P2 PATHWAY | S1P2 pathway |
0.6 | 9.6 | PID REELIN PATHWAY | Reelin signaling pathway |
0.6 | 2.5 | PID NECTIN PATHWAY | Nectin adhesion pathway |
0.6 | 13.0 | PID RAS PATHWAY | Regulation of Ras family activation |
0.6 | 5.9 | PID NEPHRIN NEPH1 PATHWAY | Nephrin/Neph1 signaling in the kidney podocyte |
0.5 | 8.4 | ST MYOCYTE AD PATHWAY | Myocyte Adrenergic Pathway is a specific case of the generalized Adrenergic Pathway. |
0.5 | 3.8 | ST G ALPHA I PATHWAY | G alpha i Pathway |
0.4 | 3.0 | PID AR NONGENOMIC PATHWAY | Nongenotropic Androgen signaling |
0.4 | 8.4 | PID INTEGRIN A4B1 PATHWAY | Alpha4 beta1 integrin signaling events |
0.4 | 6.7 | PID DNA PK PATHWAY | DNA-PK pathway in nonhomologous end joining |
0.4 | 16.0 | PID LKB1 PATHWAY | LKB1 signaling events |
0.4 | 2.3 | PID TCR JNK PATHWAY | JNK signaling in the CD4+ TCR pathway |
0.4 | 8.0 | PID NCADHERIN PATHWAY | N-cadherin signaling events |
0.4 | 5.9 | PID INTEGRIN A9B1 PATHWAY | Alpha9 beta1 integrin signaling events |
0.3 | 2.7 | PID EPHB FWD PATHWAY | EPHB forward signaling |
0.3 | 3.9 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
0.3 | 7.3 | PID TCR CALCIUM PATHWAY | Calcium signaling in the CD4+ TCR pathway |
0.3 | 1.8 | PID ECADHERIN NASCENT AJ PATHWAY | E-cadherin signaling in the nascent adherens junction |
0.3 | 1.1 | ST IL 13 PATHWAY | Interleukin 13 (IL-13) Pathway |
0.3 | 4.1 | PID ARF 3PATHWAY | Arf1 pathway |
0.3 | 8.9 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
0.2 | 1.3 | PID S1P S1P1 PATHWAY | S1P1 pathway |
0.2 | 1.5 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
0.2 | 1.4 | PID INSULIN GLUCOSE PATHWAY | Insulin-mediated glucose transport |
0.2 | 0.4 | PID ERBB1 RECEPTOR PROXIMAL PATHWAY | EGF receptor (ErbB1) signaling pathway |
0.2 | 45.9 | NABA SECRETED FACTORS | Genes encoding secreted soluble factors |
0.2 | 0.3 | SA REG CASCADE OF CYCLIN EXPR | Expression of cyclins regulates progression through the cell cycle by activating cyclin-dependent kinases. |
0.2 | 27.8 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
0.1 | 1.9 | PID MAPK TRK PATHWAY | Trk receptor signaling mediated by the MAPK pathway |
0.1 | 0.1 | PID LYMPH ANGIOGENESIS PATHWAY | VEGFR3 signaling in lymphatic endothelium |
0.1 | 4.2 | PID P75 NTR PATHWAY | p75(NTR)-mediated signaling |
0.1 | 2.1 | PID INSULIN PATHWAY | Insulin Pathway |
0.1 | 0.3 | PID EPHA2 FWD PATHWAY | EPHA2 forward signaling |
0.1 | 10.6 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
0.1 | 1.0 | PID TXA2PATHWAY | Thromboxane A2 receptor signaling |
0.1 | 0.1 | PID THROMBIN PAR4 PATHWAY | PAR4-mediated thrombin signaling events |
0.1 | 0.5 | PID IL1 PATHWAY | IL1-mediated signaling events |
0.0 | 0.8 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
0.0 | 0.5 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
0.0 | 0.8 | PID ARF6 TRAFFICKING PATHWAY | Arf6 trafficking events |
0.0 | 0.4 | PID ARF6 PATHWAY | Arf6 signaling events |
0.0 | 0.0 | ST JAK STAT PATHWAY | Jak-STAT Pathway |
0.0 | 0.3 | PID ALPHA SYNUCLEIN PATHWAY | Alpha-synuclein signaling |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
6.8 | 20.4 | REACTOME RAS ACTIVATION UOPN CA2 INFUX THROUGH NMDA RECEPTOR | Genes involved in Ras activation uopn Ca2+ infux through NMDA receptor |
6.6 | 99.6 | REACTOME UNBLOCKING OF NMDA RECEPTOR GLUTAMATE BINDING AND ACTIVATION | Genes involved in Unblocking of NMDA receptor, glutamate binding and activation |
4.8 | 58.1 | REACTOME GABA A RECEPTOR ACTIVATION | Genes involved in GABA A receptor activation |
4.0 | 44.5 | REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
3.9 | 54.2 | REACTOME CLASS C 3 METABOTROPIC GLUTAMATE PHEROMONE RECEPTORS | Genes involved in Class C/3 (Metabotropic glutamate/pheromone receptors) |
3.4 | 47.1 | REACTOME CRMPS IN SEMA3A SIGNALING | Genes involved in CRMPs in Sema3A signaling |
3.2 | 54.5 | REACTOME GABA SYNTHESIS RELEASE REUPTAKE AND DEGRADATION | Genes involved in GABA synthesis, release, reuptake and degradation |
3.2 | 44.1 | REACTOME SYNTHESIS OF VERY LONG CHAIN FATTY ACYL COAS | Genes involved in Synthesis of very long-chain fatty acyl-CoAs |
3.0 | 32.8 | REACTOME IONOTROPIC ACTIVITY OF KAINATE RECEPTORS | Genes involved in Ionotropic activity of Kainate Receptors |
2.9 | 125.8 | REACTOME VOLTAGE GATED POTASSIUM CHANNELS | Genes involved in Voltage gated Potassium channels |
2.7 | 19.2 | REACTOME A TETRASACCHARIDE LINKER SEQUENCE IS REQUIRED FOR GAG SYNTHESIS | Genes involved in A tetrasaccharide linker sequence is required for GAG synthesis |
2.7 | 37.8 | REACTOME N GLYCAN ANTENNAE ELONGATION | Genes involved in N-Glycan antennae elongation |
2.6 | 10.3 | REACTOME DOPAMINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Dopamine Neurotransmitter Release Cycle |
2.4 | 17.0 | REACTOME ROLE OF SECOND MESSENGERS IN NETRIN1 SIGNALING | Genes involved in Role of second messengers in netrin-1 signaling |
2.4 | 4.8 | REACTOME SIGNALLING TO P38 VIA RIT AND RIN | Genes involved in Signalling to p38 via RIT and RIN |
2.4 | 26.1 | REACTOME DSCAM INTERACTIONS | Genes involved in DSCAM interactions |
2.2 | 55.6 | REACTOME NETRIN1 SIGNALING | Genes involved in Netrin-1 signaling |
2.0 | 22.2 | REACTOME SEROTONIN RECEPTORS | Genes involved in Serotonin receptors |
2.0 | 38.3 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
2.0 | 15.7 | REACTOME LIGAND GATED ION CHANNEL TRANSPORT | Genes involved in Ligand-gated ion channel transport |
1.9 | 44.7 | REACTOME ADHERENS JUNCTIONS INTERACTIONS | Genes involved in Adherens junctions interactions |
1.9 | 20.7 | REACTOME INHIBITION OF INSULIN SECRETION BY ADRENALINE NORADRENALINE | Genes involved in Inhibition of Insulin Secretion by Adrenaline/Noradrenaline |
1.8 | 21.3 | REACTOME CS DS DEGRADATION | Genes involved in CS/DS degradation |
1.8 | 33.6 | REACTOME CGMP EFFECTS | Genes involved in cGMP effects |
1.7 | 3.4 | REACTOME SIGNALLING TO RAS | Genes involved in Signalling to RAS |
1.7 | 27.5 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GLP1 | Genes involved in Synthesis, Secretion, and Inactivation of Glucagon-like Peptide-1 (GLP-1) |
1.7 | 1.7 | REACTOME PLC BETA MEDIATED EVENTS | Genes involved in PLC beta mediated events |
1.7 | 50.3 | REACTOME HS GAG BIOSYNTHESIS | Genes involved in HS-GAG biosynthesis |
1.6 | 24.3 | REACTOME INSULIN SYNTHESIS AND PROCESSING | Genes involved in Insulin Synthesis and Processing |
1.6 | 15.8 | REACTOME SYNTHESIS OF PIPS AT THE LATE ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the late endosome membrane |
1.5 | 42.8 | REACTOME TRANSPORT OF VITAMINS NUCLEOSIDES AND RELATED MOLECULES | Genes involved in Transport of vitamins, nucleosides, and related molecules |
1.4 | 14.4 | REACTOME THE NLRP3 INFLAMMASOME | Genes involved in The NLRP3 inflammasome |
1.4 | 2.9 | REACTOME SPRY REGULATION OF FGF SIGNALING | Genes involved in Spry regulation of FGF signaling |
1.4 | 9.7 | REACTOME P38MAPK EVENTS | Genes involved in p38MAPK events |
1.3 | 4.0 | REACTOME SYNTHESIS OF PIPS AT THE EARLY ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the early endosome membrane |
1.3 | 2.5 | REACTOME PEPTIDE CHAIN ELONGATION | Genes involved in Peptide chain elongation |
1.2 | 5.0 | REACTOME NEGATIVE REGULATION OF THE PI3K AKT NETWORK | Genes involved in Negative regulation of the PI3K/AKT network |
1.2 | 40.6 | REACTOME ION CHANNEL TRANSPORT | Genes involved in Ion channel transport |
1.2 | 26.3 | REACTOME IL RECEPTOR SHC SIGNALING | Genes involved in Interleukin receptor SHC signaling |
1.2 | 22.4 | REACTOME FORMATION OF TUBULIN FOLDING INTERMEDIATES BY CCT TRIC | Genes involved in Formation of tubulin folding intermediates by CCT/TriC |
1.2 | 1.2 | REACTOME ADP SIGNALLING THROUGH P2RY1 | Genes involved in ADP signalling through P2Y purinoceptor 1 |
1.1 | 12.6 | REACTOME HIGHLY CALCIUM PERMEABLE POSTSYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Highly calcium permeable postsynaptic nicotinic acetylcholine receptors |
1.1 | 14.8 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |
1.0 | 5.2 | REACTOME HORMONE LIGAND BINDING RECEPTORS | Genes involved in Hormone ligand-binding receptors |
1.0 | 8.0 | REACTOME GLUTAMATE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Glutamate Neurotransmitter Release Cycle |
1.0 | 9.0 | REACTOME RECRUITMENT OF NUMA TO MITOTIC CENTROSOMES | Genes involved in Recruitment of NuMA to mitotic centrosomes |
1.0 | 9.9 | REACTOME SHC RELATED EVENTS | Genes involved in SHC-related events |
1.0 | 9.8 | REACTOME CYTOSOLIC SULFONATION OF SMALL MOLECULES | Genes involved in Cytosolic sulfonation of small molecules |
0.9 | 6.4 | REACTOME CREATION OF C4 AND C2 ACTIVATORS | Genes involved in Creation of C4 and C2 activators |
0.9 | 5.4 | REACTOME RETROGRADE NEUROTROPHIN SIGNALLING | Genes involved in Retrograde neurotrophin signalling |
0.9 | 0.9 | REACTOME MEMBRANE BINDING AND TARGETTING OF GAG PROTEINS | Genes involved in Membrane binding and targetting of GAG proteins |
0.9 | 10.3 | REACTOME RAP1 SIGNALLING | Genes involved in Rap1 signalling |
0.9 | 13.7 | REACTOME ACTIVATED POINT MUTANTS OF FGFR2 | Genes involved in Activated point mutants of FGFR2 |
0.9 | 12.0 | REACTOME GLUCAGON TYPE LIGAND RECEPTORS | Genes involved in Glucagon-type ligand receptors |
0.9 | 13.7 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
0.8 | 5.8 | REACTOME THE ACTIVATION OF ARYLSULFATASES | Genes involved in The activation of arylsulfatases |
0.8 | 9.8 | REACTOME REGULATION OF INSULIN SECRETION | Genes involved in Regulation of Insulin Secretion |
0.8 | 37.9 | REACTOME POTASSIUM CHANNELS | Genes involved in Potassium Channels |
0.8 | 12.4 | REACTOME ACTIVATED NOTCH1 TRANSMITS SIGNAL TO THE NUCLEUS | Genes involved in Activated NOTCH1 Transmits Signal to the Nucleus |
0.7 | 0.7 | REACTOME NOREPINEPHRINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Norepinephrine Neurotransmitter Release Cycle |
0.7 | 0.7 | REACTOME ARMS MEDIATED ACTIVATION | Genes involved in ARMS-mediated activation |
0.7 | 5.8 | REACTOME ADENYLATE CYCLASE ACTIVATING PATHWAY | Genes involved in Adenylate cyclase activating pathway |
0.7 | 6.5 | REACTOME GLYCOPROTEIN HORMONES | Genes involved in Glycoprotein hormones |
0.7 | 0.7 | REACTOME REGULATION OF GLUCOKINASE BY GLUCOKINASE REGULATORY PROTEIN | Genes involved in Regulation of Glucokinase by Glucokinase Regulatory Protein |
0.7 | 8.4 | REACTOME NA CL DEPENDENT NEUROTRANSMITTER TRANSPORTERS | Genes involved in Na+/Cl- dependent neurotransmitter transporters |
0.7 | 0.7 | REACTOME PEPTIDE HORMONE BIOSYNTHESIS | Genes involved in Peptide hormone biosynthesis |
0.7 | 11.9 | REACTOME BRANCHED CHAIN AMINO ACID CATABOLISM | Genes involved in Branched-chain amino acid catabolism |
0.7 | 3.4 | REACTOME G ALPHA Z SIGNALLING EVENTS | Genes involved in G alpha (z) signalling events |
0.7 | 0.7 | REACTOME BINDING AND ENTRY OF HIV VIRION | Genes involved in Binding and entry of HIV virion |
0.6 | 22.1 | REACTOME NRAGE SIGNALS DEATH THROUGH JNK | Genes involved in NRAGE signals death through JNK |
0.6 | 9.9 | REACTOME ABCA TRANSPORTERS IN LIPID HOMEOSTASIS | Genes involved in ABCA transporters in lipid homeostasis |
0.6 | 18.7 | REACTOME P75 NTR RECEPTOR MEDIATED SIGNALLING | Genes involved in p75 NTR receptor-mediated signalling |
0.5 | 3.2 | REACTOME IRAK1 RECRUITS IKK COMPLEX | Genes involved in IRAK1 recruits IKK complex |
0.5 | 7.5 | REACTOME ACYL CHAIN REMODELLING OF PS | Genes involved in Acyl chain remodelling of PS |
0.5 | 6.9 | REACTOME AMINO ACID SYNTHESIS AND INTERCONVERSION TRANSAMINATION | Genes involved in Amino acid synthesis and interconversion (transamination) |
0.5 | 7.3 | REACTOME SYNTHESIS OF SUBSTRATES IN N GLYCAN BIOSYTHESIS | Genes involved in Synthesis of substrates in N-glycan biosythesis |
0.5 | 0.5 | REACTOME CTLA4 INHIBITORY SIGNALING | Genes involved in CTLA4 inhibitory signaling |
0.5 | 8.1 | REACTOME CHONDROITIN SULFATE DERMATAN SULFATE METABOLISM | Genes involved in Chondroitin sulfate/dermatan sulfate metabolism |
0.5 | 3.0 | REACTOME G PROTEIN ACTIVATION | Genes involved in G-protein activation |
0.5 | 6.1 | REACTOME EICOSANOID LIGAND BINDING RECEPTORS | Genes involved in Eicosanoid ligand-binding receptors |
0.5 | 1.5 | REACTOME PRESYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Presynaptic nicotinic acetylcholine receptors |
0.5 | 3.3 | REACTOME APOPTOTIC CLEAVAGE OF CELL ADHESION PROTEINS | Genes involved in Apoptotic cleavage of cell adhesion proteins |
0.5 | 0.5 | REACTOME SCF BETA TRCP MEDIATED DEGRADATION OF EMI1 | Genes involved in SCF-beta-TrCP mediated degradation of Emi1 |
0.5 | 26.9 | REACTOME NEURONAL SYSTEM | Genes involved in Neuronal System |
0.4 | 1.8 | REACTOME REGULATION OF KIT SIGNALING | Genes involved in Regulation of KIT signaling |
0.4 | 4.0 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 24 HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 24-hydroxycholesterol |
0.4 | 4.7 | REACTOME JNK C JUN KINASES PHOSPHORYLATION AND ACTIVATION MEDIATED BY ACTIVATED HUMAN TAK1 | Genes involved in JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 |
0.4 | 14.4 | REACTOME NCAM1 INTERACTIONS | Genes involved in NCAM1 interactions |
0.4 | 1.6 | REACTOME FORMATION OF TRANSCRIPTION COUPLED NER TC NER REPAIR COMPLEX | Genes involved in Formation of transcription-coupled NER (TC-NER) repair complex |
0.4 | 1.5 | REACTOME FATTY ACYL COA BIOSYNTHESIS | Genes involved in Fatty Acyl-CoA Biosynthesis |
0.4 | 1.4 | REACTOME INFLAMMASOMES | Genes involved in Inflammasomes |
0.4 | 0.4 | REACTOME SHC1 EVENTS IN EGFR SIGNALING | Genes involved in SHC1 events in EGFR signaling |
0.3 | 2.8 | REACTOME PLATELET CALCIUM HOMEOSTASIS | Genes involved in Platelet calcium homeostasis |
0.3 | 5.8 | REACTOME DARPP 32 EVENTS | Genes involved in DARPP-32 events |
0.3 | 1.7 | REACTOME PACKAGING OF TELOMERE ENDS | Genes involved in Packaging Of Telomere Ends |
0.3 | 6.2 | REACTOME FORMATION OF INCISION COMPLEX IN GG NER | Genes involved in Formation of incision complex in GG-NER |
0.3 | 14.5 | REACTOME P53 DEPENDENT G1 DNA DAMAGE RESPONSE | Genes involved in p53-Dependent G1 DNA Damage Response |
0.3 | 2.6 | REACTOME COPI MEDIATED TRANSPORT | Genes involved in COPI Mediated Transport |
0.3 | 1.7 | REACTOME PROLACTIN RECEPTOR SIGNALING | Genes involved in Prolactin receptor signaling |
0.3 | 0.8 | REACTOME IL 7 SIGNALING | Genes involved in Interleukin-7 signaling |
0.3 | 12.1 | REACTOME O LINKED GLYCOSYLATION OF MUCINS | Genes involved in O-linked glycosylation of mucins |
0.3 | 3.6 | REACTOME MITOCHONDRIAL FATTY ACID BETA OXIDATION | Genes involved in Mitochondrial Fatty Acid Beta-Oxidation |
0.3 | 1.6 | REACTOME REGULATION OF ORNITHINE DECARBOXYLASE ODC | Genes involved in Regulation of ornithine decarboxylase (ODC) |
0.3 | 4.0 | REACTOME CONVERSION FROM APC C CDC20 TO APC C CDH1 IN LATE ANAPHASE | Genes involved in Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase |
0.2 | 0.2 | REACTOME S PHASE | Genes involved in S Phase |
0.2 | 0.2 | REACTOME DOWNSTREAM SIGNALING EVENTS OF B CELL RECEPTOR BCR | Genes involved in Downstream Signaling Events Of B Cell Receptor (BCR) |
0.2 | 5.2 | REACTOME AMINE LIGAND BINDING RECEPTORS | Genes involved in Amine ligand-binding receptors |
0.2 | 1.8 | REACTOME ACTIVATION OF CHAPERONE GENES BY ATF6 ALPHA | Genes involved in Activation of Chaperone Genes by ATF6-alpha |
0.2 | 4.5 | REACTOME TRANSFERRIN ENDOCYTOSIS AND RECYCLING | Genes involved in Transferrin endocytosis and recycling |
0.2 | 0.2 | REACTOME ACYL CHAIN REMODELLING OF PI | Genes involved in Acyl chain remodelling of PI |
0.2 | 2.7 | REACTOME SYNTHESIS AND INTERCONVERSION OF NUCLEOTIDE DI AND TRIPHOSPHATES | Genes involved in Synthesis and interconversion of nucleotide di- and triphosphates |
0.2 | 0.2 | REACTOME IL 2 SIGNALING | Genes involved in Interleukin-2 signaling |
0.1 | 5.9 | REACTOME METABOLISM OF VITAMINS AND COFACTORS | Genes involved in Metabolism of vitamins and cofactors |
0.1 | 8.0 | REACTOME RESPIRATORY ELECTRON TRANSPORT | Genes involved in Respiratory electron transport |
0.1 | 4.4 | REACTOME COLLAGEN FORMATION | Genes involved in Collagen formation |
0.1 | 1.4 | REACTOME UNWINDING OF DNA | Genes involved in Unwinding of DNA |
0.1 | 1.8 | REACTOME EFFECTS OF PIP2 HYDROLYSIS | Genes involved in Effects of PIP2 hydrolysis |
0.1 | 3.9 | REACTOME RNA POL III TRANSCRIPTION | Genes involved in RNA Polymerase III Transcription |
0.1 | 0.9 | REACTOME ENDOGENOUS STEROLS | Genes involved in Endogenous sterols |
0.1 | 1.7 | REACTOME CIRCADIAN REPRESSION OF EXPRESSION BY REV ERBA | Genes involved in Circadian Repression of Expression by REV-ERBA |
0.1 | 1.2 | REACTOME ABC FAMILY PROTEINS MEDIATED TRANSPORT | Genes involved in ABC-family proteins mediated transport |
0.1 | 0.7 | REACTOME IRON UPTAKE AND TRANSPORT | Genes involved in Iron uptake and transport |
0.1 | 2.5 | REACTOME GOLGI ASSOCIATED VESICLE BIOGENESIS | Genes involved in Golgi Associated Vesicle Biogenesis |
0.0 | 0.4 | REACTOME VIRAL MESSENGER RNA SYNTHESIS | Genes involved in Viral Messenger RNA Synthesis |
0.0 | 0.6 | REACTOME CITRIC ACID CYCLE TCA CYCLE | Genes involved in Citric acid cycle (TCA cycle) |
0.0 | 0.9 | REACTOME GLYCOSPHINGOLIPID METABOLISM | Genes involved in Glycosphingolipid metabolism |
0.0 | 0.2 | REACTOME ETHANOL OXIDATION | Genes involved in Ethanol oxidation |
0.0 | 0.4 | REACTOME REPAIR SYNTHESIS FOR GAP FILLING BY DNA POL IN TC NER | Genes involved in Repair synthesis for gap-filling by DNA polymerase in TC-NER |
0.0 | 0.7 | REACTOME STEROID HORMONES | Genes involved in Steroid hormones |
0.0 | 0.3 | REACTOME DEFENSINS | Genes involved in Defensins |
0.0 | 0.2 | REACTOME SLBP DEPENDENT PROCESSING OF REPLICATION DEPENDENT HISTONE PRE MRNAS | Genes involved in SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs |
0.0 | 3.4 | REACTOME PEPTIDE LIGAND BINDING RECEPTORS | Genes involved in Peptide ligand-binding receptors |